<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD000567.pub6" GROUP_ID="INJ" ID="138499090910485618" MERGED_FROM="" MODIFIED="2013-02-25 15:42:10 +0000" MODIFIED_BY="Emma Sydenham" REVIEW_NO="INJ0042" REVMAN_SUB_VERSION="5.2.1 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="15.0">
<COVER_SHEET MODIFIED="2013-02-25 10:41:20 -0500" MODIFIED_BY="Emma Sydenham">
<TITLE>Colloids versus crystalloids for fluid resuscitation in critically ill patients</TITLE>
<CONTACT>
<PERSON ID="BF155C7882E26AA201E74FE9F137A223" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Pablo</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Perel</LAST_NAME>
<SUFFIX/>
<POSITION>Clinical Lecturer</POSITION>
<EMAIL_1>pablo.perel@Lshtm.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL>http://injuries.cochrane.org</URL>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Cochrane Injuries Group</DEPARTMENT>
<ORGANISATION>London School of Hygiene &amp; Tropical Medicine</ORGANISATION>
<ADDRESS_1>Keppel Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>London</CITY>
<ZIP>WC1E 7HT</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>0207 958 8120</PHONE_1>
<PHONE_2/>
<FAX_1>0207 958 8111</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2013-02-25 10:39:34 -0500" MODIFIED_BY="Emma Sydenham">
<PERSON ID="BF155C7882E26AA201E74FE9F137A223" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Pablo</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Perel</LAST_NAME>
<SUFFIX/>
<POSITION>Clinical Lecturer</POSITION>
<EMAIL_1>pablo.perel@Lshtm.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL>http://injuries.cochrane.org</URL>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Cochrane Injuries Group</DEPARTMENT>
<ORGANISATION>London School of Hygiene &amp; Tropical Medicine</ORGANISATION>
<ADDRESS_1>Keppel Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>London</CITY>
<ZIP>WC1E 7HT</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>0207 958 8120</PHONE_1>
<PHONE_2/>
<FAX_1>0207 958 8111</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="8053" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Ian</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Roberts</LAST_NAME>
<SUFFIX/>
<POSITION>Professor of Epidemiology &amp; Public Health</POSITION>
<EMAIL_1>Ian.Roberts@Lshtm.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL>http://injuries.cochrane.org</URL>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Cochrane Injuries Group</DEPARTMENT>
<ORGANISATION>London School of Hygiene &amp; Tropical Medicine</ORGANISATION>
<ADDRESS_1>North Courtyard</ADDRESS_1>
<ADDRESS_2>Keppel Street</ADDRESS_2>
<CITY>London</CITY>
<ZIP>WC1E 7HT</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 20 7958 8128</PHONE_1>
<PHONE_2/>
<FAX_1>+44 20 7299 4663</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="11125" ROLE="AUTHOR">
<PREFIX>Miss</PREFIX>
<FIRST_NAME>Katharine</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Ker</LAST_NAME>
<SUFFIX/>
<POSITION>Research Fellow</POSITION>
<EMAIL_1>katharine.ker@lshtm.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL>http://injuries.cochrane.org</URL>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Cochrane Injuries Group</DEPARTMENT>
<ORGANISATION>London School of Hygiene &amp; Tropical Medicine</ORGANISATION>
<ADDRESS_1>Room 135</ADDRESS_1>
<ADDRESS_2>Keppel Street</ADDRESS_2>
<CITY>London</CITY>
<ZIP>WC1E 7HT</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 (0) 20 7958 8135</PHONE_1>
<PHONE_2/>
<FAX_1>+44 (0) 20 7958 8111</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2013-02-22 17:38:11 -0500" MODIFIED_BY="Emma Sydenham">
<UP_TO_DATE>
<DATE DAY="17" MONTH="10" YEAR="2012"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="17" MONTH="10" YEAR="2012"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="16" MONTH="7" YEAR="2014"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="1997"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="1997"/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="2013"/>
</DATES>
<WHATS_NEW MODIFIED="2013-02-25 10:41:20 -0500" MODIFIED_BY="Emma M Sydenham">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2013-02-25 10:41:20 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="25" MONTH="2" YEAR="2013"/>
<DESCRIPTION>
<P>Minor corrections made to the results section.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2013-02-25 10:39:56 -0500" MODIFIED_BY="Emma M Sydenham">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2013-02-25 10:39:56 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="31" MONTH="1" YEAR="2013"/>
<DESCRIPTION>
<P>New study data have been included. The conclusions of the review have changed.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-02-25 10:39:54 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="17" MONTH="1" YEAR="2013"/>
<DESCRIPTION>
<P>Four new studies have been included (<LINK REF="STD-Guidet-2012" TYPE="STUDY">Guidet 2012</LINK>, <LINK REF="STD-Lee-2011" TYPE="STUDY">Lee 2011</LINK>, <LINK REF="STD-Myburgh-2012" TYPE="STUDY">Myburgh 2012</LINK>, and <LINK REF="STD-Perner-2012" TYPE="STUDY">Perner 2012</LINK>).</P>
<P>Mortality data from a reply letter (http://bja.oxfordjournals.org/content/107/5/693/reply) of a previous included study was added (<LINK REF="STD-James-2011" TYPE="STUDY">James 2011</LINK>).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2013-01-31 00:03:52 -0500" MODIFIED_BY="[Empty name]">
<DATE DAY="17" MONTH="10" YEAR="2012"/>
<DESCRIPTION>
<P>Copy edits made to graph labels.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2012-10-17 09:32:54 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="8" MONTH="6" YEAR="2012"/>
<DESCRIPTION>
<P>Copy edits made and citation corrected.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2012-11-20 06:47:15 -0500" MODIFIED_BY="Emma M Sydenham">
<DATE DAY="14" MONTH="5" YEAR="2012"/>
<DESCRIPTION>
<P>An updated search was conducted in March 2012. Nine new trials have been included (<LINK REF="STD-Bulger-2011" TYPE="STUDY">Bulger 2011</LINK>; <LINK REF="STD-Cooper-2006" TYPE="STUDY">Cooper 2006</LINK>; <LINK REF="STD-Du-2011" TYPE="STUDY">Du 2011</LINK>; <LINK REF="STD-Dubin-2010" TYPE="STUDY">Dubin 2010</LINK>; <LINK REF="STD-James-2011" TYPE="STUDY">James 2011</LINK>; <LINK REF="STD-Lu-2012" TYPE="STUDY">Lu 2012</LINK>; <LINK REF="STD-Maitland-2011" TYPE="STUDY">Maitland 2011</LINK>; <LINK REF="STD-McIntyre-2008" TYPE="STUDY">McIntyre 2008</LINK>; <LINK REF="STD-Zhu-2011" TYPE="STUDY">Zhu 2011</LINK>) The analysis and results sections have been revised accordingly. The conclusions remain unchanged. 3 ongoing studies were identified (CHEST Trial; <LINK REF="STD-RASP-trial" TYPE="STUDY">RASP trial</LINK>; The 6S trial). We plan to update this review once the CHEST Trial (a large phase 3 trial comparing 6% hydroxyethyl starch and saline) is published.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2012-06-08 08:23:08 -0400" MODIFIED_BY="Emma M Sydenham">
<DATE DAY="16" MONTH="3" YEAR="2012"/>
<DESCRIPTION>
<P>An updated search was conducted in March 2012. </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2012-05-14 12:39:46 -0400" MODIFIED_BY="Emma M Sydenham">
<DATE DAY="10" MONTH="2" YEAR="2011"/>
<DESCRIPTION>
<P>The editorial group is aware that a clinical trial by Prof. Joachim Boldt has been found to have been fabricated (<A HREF="http://archie.cochrane.org/sections/documents/view?document=540099072011521412&amp;format=REVMAN#REF-Boldt-2009">Boldt 2009</A>). As the editors who revealed this fabrication point out (<A HREF="http://archie.cochrane.org/sections/documents/view?document=540099072011521412&amp;format=REVMAN#REF-Reinhart-2011">Reinhart 2011</A>; <A HREF="http://archie.cochrane.org/sections/documents/view?document=540099072011521412&amp;format=REVMAN#REF-Shafer-2011">Shafer 2011</A>), this casts some doubt on the veracity of other studies by the same author. All Cochrane Injuries Group reviews which include studies by this author have therefore been edited to show the results with this author's trials included and excluded. Readers can now judge the potential impact of trials by this author (<LINK REF="STD-Boldt-1986" TYPE="STUDY">Boldt 1986</LINK>, <LINK REF="STD-Boldt-1993" TYPE="STUDY">Boldt 1993</LINK>, <LINK REF="STD-Boldt-2001" TYPE="STUDY">Boldt 2001</LINK>, <LINK REF="STD-Lang-2001" TYPE="STUDY">Lang 2001</LINK>, <LINK REF="STD-Lang-2003" TYPE="STUDY">Lang 2003</LINK>) on the conclusions of the review.</P>
<P>The authors of the review have changed.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2011-02-10 09:48:16 -0500" MODIFIED_BY="Emma M Sydenham">
<DATE DAY="17" MONTH="4" YEAR="2009"/>
<DESCRIPTION>
<P>April 2009</P>
<P>An updated search for new trials was conducted in October 2008. One new study was included (Brunkhorst 2008). The analysis, results and discussion sections have been revised accordingly.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-04-22 07:28:44 -0400" MODIFIED_BY="Emma M Sydenham">
<DATE DAY="16" MONTH="7" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-07-11 18:33:10 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="1" MONTH="7" YEAR="2007"/>
<DESCRIPTION>
<P>August 2007<BR/>An updated search for new trials was conducted in December 2006. Ten new studies were included (Evans 2003, Cifra 2003, Fries 2004, Guo 2003, Lang 2003, Maitland 2005, Moretti 2003, Upadhyay 2004, Verheij 2006, Wills 2005). The analysis, results and discussion sections have been revised accordingly.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Institute of Child Health, University of London</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>UK Cochrane Centre, NHS R&amp;D Programme</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>NHS R&amp;D Programme: Mother and Child Health</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Cochrane Review Incentive Scheme, Department of Health</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2013-02-25 02:26:53 -0500" MODIFIED_BY="Emma M Sydenham">
<SUMMARY MODIFIED="2013-01-31 18:07:02 -0500" MODIFIED_BY="Emma M Sydenham">
<TITLE MODIFIED="2013-01-31 18:07:02 -0500" MODIFIED_BY="Emma M Sydenham">Are colloids more effective than crystalloids in reducing death in people who are critically ill or injured?</TITLE>
<SUMMARY_BODY MODIFIED="2013-01-18 09:43:57 -0500" MODIFIED_BY="Emma M Sydenham">
<P>Trauma, burns or surgery can cause people to lose large amounts of blood. Fluid replacement, giving fluids intravenously (into a vein) to replace lost blood, is used to try to maintain blood pressure and reduce the risk of dying. Blood products, non-blood products or combinations are used, including colloid or crystalloid solutions. Colloids are increasingly used but they are more expensive than crystalloids. This review of trials found no evidence that colloids reduce the risk of dying compared with crystalloids, and one type of colloid (starches) might increase the risk of death.<BR/>
</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2013-01-31 18:05:18 -0500" MODIFIED_BY="Emma M Sydenham">
<ABS_BACKGROUND MODIFIED="2013-01-31 17:57:10 -0500" MODIFIED_BY="[Empty name]">
<P>Colloid solutions are widely used in fluid resuscitation of critically ill patients. There are several choices of colloid, and there is ongoing debate about the relative effectiveness of colloids compared to crystalloid fluids.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To assess the effects of colloids compared to crystalloids for fluid resuscitation in critically ill patients.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2013-01-31 18:00:25 -0500" MODIFIED_BY="Emma M Sydenham">
<P>We searched the Cochrane Injuries Group Specialised Register (17 October 2012), the Cochrane Central Register of Controlled Trials (<I>The Cochrane Library</I>) (Issue 10, 2012), MEDLINE (Ovid) 1946 to October 2012, EMBASE (Ovid) 1980 to October 2012, ISI Web of Science: Science Citation Index Expanded (1970 to October 2012), ISI Web of Science: Conference Proceedings Citation Index-Science (1990 to October 2012), PubMed (October 2012), <A HREF="http://www.clinical trials.gov">www.clinical trials.gov</A> and <A HREF="http://www.controlled-trials.com">www.controlled-trials.com</A>. We also searched the bibliographies of relevant studies and review articles.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2013-01-31 18:01:24 -0500" MODIFIED_BY="Emma M Sydenham">
<P>Randomised controlled trials (RCTs) of colloids compared to crystalloids, in patients requiring volume replacement. We excluded cross-over trials and trials involving pregnant women and neonates.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2012-05-30 08:04:48 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Two review authors independently extracted data and rated quality of allocation concealment. We analysed trials with a 'double-intervention', such as those comparing colloid in hypertonic crystalloid to isotonic crystalloid, separately. We stratified the analysis according to colloid type and quality of allocation concealment.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2013-01-31 18:05:18 -0500" MODIFIED_BY="Emma M Sydenham">
<P>We identified 78 eligible trials; 70 of these presented mortality data.</P>
<P>
<B>Colloids compared to crystalloids</B>
<BR/>
</P>
<P>
<B>
<I>Albumin or plasma protein fraction</I>
</B> <I>-</I> 24 trials reported data on mortality, including a total of 9920 patients. The pooled risk ratio (RR) from these trials was 1.01 (95% confidence interval (CI) 0.93 to 1.10). When we excluded the trial with poor-quality allocation concealment, pooled RR was 1.00 (95% CI 0.92 to 1.09). <B>
<I>Hydroxyethyl starch</I>
</B> - 25 trials compared hydroxyethyl starch with crystalloids and included 9147 patients. The pooled RR was 1.10 (95% CI 1.02 to 1.19). <B>
<I>Modified gelatin</I>
</B> - 11 trials compared modified gelatin with crystalloid and included 506 patients. The pooled RR was 0.91 (95% CI 0.49 to 1.72). (When the trials by Boldt et al were removed from the three preceding analyses, the results were unchanged.) <B>
<I>Dextran</I>
</B> - nine trials compared dextran with a crystalloid and included 834 patients. The pooled RR was 1.24 (95% CI 0.94 to 1.65).</P>
<P>
<B>Colloids in hypertonic crystalloid compared to isotonic crystalloid</B>
<I>
<BR/>
</I>
</P>
<P>Nine trials compared dextran in hypertonic crystalloid with isotonic crystalloid, including 1985 randomised participants. Pooled RR for mortality was 0.91 (95% CI 0.71 to 1.06).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2013-01-31 00:12:53 -0500" MODIFIED_BY="Emma M Sydenham">
<P>There is no evidence from randomised controlled trials that resuscitation with colloids reduces the risk of death, compared to resuscitation with crystalloids, in patients with trauma, burns or following surgery. Furthermore, the use of hydroxyethyl starch might increase mortality. As colloids are not associated with an improvement in survival and are considerably more expensive than crystalloids, it is hard to see how their continued use in clinical practice can be justified.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2013-02-25 02:26:53 -0500" MODIFIED_BY="Emma M Sydenham">
<BACKGROUND MODIFIED="2012-05-30 08:09:50 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Fluid resuscitation for hypovolaemia is a mainstay of the medical management of critically ill patients, whether as a result of trauma, burns, major surgery or sepsis. Although some studies (<LINK REF="REF-Bickell-1994" TYPE="REFERENCE">Bickell 1994</LINK>) have suggested that the timing of volume replacement deserves careful consideration, when it comes to selecting the resuscitation fluid, clinicians are faced with a range of options. At one level the choice is between a colloid or crystalloid solution. Colloids are widely used, having been recommended in a number of resuscitation guidelines and intensive care management algorithms (<LINK REF="REF-Armstrong-1994" TYPE="REFERENCE">Armstrong 1994</LINK>; <LINK REF="REF-Vermeulen-1995" TYPE="REFERENCE">Vermeulen 1995</LINK>).</P>
<P>The US Hospital Consortium Guidelines recommend that colloids are used in haemorrhagic shock prior to the availability of blood products, and in non-haemorrhagic shock following an initial crystalloid infusion. However, a 1995 survey of US academic health centres found that the use of colloids far exceeded even the Hospital Consortium recommendations (<LINK REF="REF-Yim-1995" TYPE="REFERENCE">Yim 1995</LINK>). Surveys of burn care in the US (<LINK REF="REF-Fakhry-1995" TYPE="REFERENCE">Fakhry 1995</LINK>) and in Australia (<LINK REF="REF-Victorian-DUAC-1991" TYPE="REFERENCE">Victorian DUAC 1991</LINK>) found that the use of colloids for resuscitation varied without a set pattern.</P>
<P>The choice of fluid has considerable cost implications. Volume replacement with colloids is considerably more expensive than with crystalloids. Clinical studies have shown that colloids and crystalloids have different effects on a range of important physiological parameters. Because of these differences, all-cause mortality is arguably the most clinically relevant outcome measure in randomised trials comparing the two fluid types.</P>
<IMPORTANCE MODIFIED="2008-07-11 18:34:56 -0400" MODIFIED_BY="[Empty name]">
<P>Although there have been previous meta-analyses of mortality in randomised trials comparing colloids and crystalloids (<LINK REF="REF-Bisonni-1991" TYPE="REFERENCE">Bisonni 1991</LINK>; <LINK REF="REF-Velanovich-1989" TYPE="REFERENCE">Velanovich 1989</LINK>), neither of these satisfy the criteria that have been proposed for scientific overviews (<LINK REF="REF-Oxman-1994" TYPE="REFERENCE">Oxman 1994</LINK>), and they predate most of the trials that have been conducted using synthetic colloids, and hypertonic crystalloid solutions. The purpose of this systematic review is to identify and synthesise all available unconfounded evidence of the effect on mortality in critically ill patients of colloids compared to crystalloids for volume replacement.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES>
<P>To assess the effects on mortality of using colloids compared to crystalloids, during fluid resuscitation in critically ill patients.</P>
</OBJECTIVES>
<METHODS MODIFIED="2013-01-18 11:24:10 -0500" MODIFIED_BY="Emma M Sydenham">
<SELECTION_CRITERIA MODIFIED="2012-05-30 08:13:00 -0400" MODIFIED_BY="Emma M Sydenham">
<CRIT_STUDIES MODIFIED="2009-05-12 08:59:17 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Controlled trials in which participants were randomised to treatment groups (colloid or control) on the basis of random allocation. As the comparison between fluid type was in terms of effects on mortality, we excluded randomised cross-over trials.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2012-05-30 08:12:54 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Critically ill patients (excluding neonates and pregnant women) who required volume replacement. We included patients who were critically ill as a result of trauma, burns, undergoing surgery, or had other critical conditions such as complications of sepsis.</P>
<P>We excluded preoperative elective surgical patients.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2012-05-30 08:13:00 -0400" MODIFIED_BY="Emma M Sydenham">
<P>We considered the following colloids: dextran 70, hydroxyethyl starches, modified gelatins, albumin or plasma protein fraction.</P>
<P>There is overlap between albumin given for volume replacement and albumin given as a nutritional supplement, and many patients with a critical illness have low serum albumin. Where the trial was of total parenteral nutrition with or without albumin, we excluded it. We included trials where the albumin was given as part of volume replacement guided by colloid osmotic pressure or albumin levels.</P>
<P>The control group received crystalloid (isotonic or hypertonic) for fluid replacement. We included trials in which both groups received blood.</P>
<P>We excluded trials of fluids used for other purposes. For example, we excluded trials of pre-loading in preparation for elective surgery, and trials in patients undergoing fluid loading before cardiopulmonary bypass.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES>
<P>The principal outcome measure was mortality from all causes, assessed at the end of the follow-up period scheduled for each trial.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2013-01-18 11:24:10 -0500" MODIFIED_BY="Emma M Sydenham">
<P>We did not restrict the search for trials by date, language or publication status.</P>
<ELECTRONIC_SEARCHES MODIFIED="2013-01-18 11:24:10 -0500" MODIFIED_BY="Emma M Sydenham">
<P>We searched the following electronic databases:</P>
<UL>
<LI>Cochrane Injuries Group Specialised Register (17 October 2012);</LI>
<LI>the Cochrane Central Register of Controlled Trials (<I>The Cochrane Library</I>) (Issue 10, 2012);</LI>
<LI>MEDLINE (OvidSP) 1946 to October, Week 1, 2012;</LI>
<LI>EMBASE (OvidSP) 1980 to 2012, Week 41;</LI>
<LI>ISI Web of Science: Science Citation Index Expanded (1970 to October 2012);</LI>
<LI>ISI Web of Science: Conference Proceedings Citation Index-Science (1990 to October 2012);</LI>
<LI>PubMed (October 2012);</LI>
<LI>National Research Register (2006, Issue 4).</LI>
</UL>
<P>All search strategies are listed in full in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.<BR/>
</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2012-05-08 10:03:12 -0400" MODIFIED_BY="Emma M Sydenham">
<P>We searched the reference lists of all relevant papers and published review articles. We also contacted known trialists to identify any further studies that we may have missed. We searched the online trials registers <A HREF="http://www.clinical trials.gov">www.clinical trials.gov</A> and <A HREF="http://www.controlled-trials.com">www.controlled-trials.com</A> for published and unpublished studies.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2012-05-30 08:18:14 -0400" MODIFIED_BY="Emma M Sydenham">
<P>The Injuries Group Trials Search Coordinator ran the electronic database searches, collated the results and removed duplicates before passing the list of citations to the lead review author (PP) for screening.</P>
<STUDY_SELECTION MODIFIED="2012-05-30 08:16:14 -0400" MODIFIED_BY="[Empty name]">
<P>Two review authors independently examined the list of citations for eligibility. We obtained full-text copies of all relevant records and independently assessed whether each met the pre-defined inclusion criteria. We resolved disagreement by discussion.</P>
</STUDY_SELECTION>
<QUALITY_ASSESSMENT MODIFIED="2012-05-30 08:17:07 -0400" MODIFIED_BY="Emma M Sydenham">
<P>We scored allocation concealment as described by <LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>, assigning 'high risk of bias' to poorest quality and 'low risk of bias' to best quality (the presence of solutions in identical containers was only taken to mean adequate concealment if the fluid containers were used sequentially).<BR/>
</P>
<UL>
<LI>Low risk of bias = trials deemed to have taken adequate measures to conceal allocation (i.e. central randomisation; serially numbered, opaque, sealed envelopes; or other description that contained elements convincing of concealment).</LI>
<LI>Unclear = trials in which the authors either did not report an allocation concealment approach at all or reported an approach that did not fall into one of the other categories.</LI>
<LI>High risk of bias = trials in which concealment was inadequate (such as alternation or reference to case record numbers or to dates of birth).</LI>
</UL>
<P>We collected but did not score information on blinding and loss to follow-up.</P>
</QUALITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2012-05-30 08:17:27 -0400" MODIFIED_BY="Emma M Sydenham">
<P>As a result of comments on the previous version of this review, we have stratified trials by type of fluid rather than type of original injury.</P>
<P>We calculated risk ratios (RRs) and 95% confidence intervals (CI) for each study using a fixed-effect model. We then inspected each comparison visually for evidence of heterogeneity and performed a Chi<SUP>2</SUP> test. If there was no evidence of heterogeneity (visually or with a P value &lt; 0.1) the trials were pooled within each type of fluid, but not combined between type of fluid.</P>
</DATA_SYNTHESIS>
<SENSITIVITY_ANALYSIS MODIFIED="2012-05-30 08:18:14 -0400" MODIFIED_BY="Emma M Sydenham">
<P>We then excluded trials with allocation concealment judged as inadequate and repeated the calculations.</P>
<P>The editorial group is aware that a clinical trial by Professor Joachim Boldt has been found to have been fabricated (<A HREF="http://archie.cochrane.org/sections/documents/view?document=540099072011521412&amp;format=REVMAN#REF-Boldt-2009">Boldt 2009</A>). As the editors who revealed this fabrication point out (<A HREF="http://archie.cochrane.org/sections/documents/view?document=540099072011521412&amp;format=REVMAN#REF-Reinhart-2011">Reinhart 2011</A>; <A HREF="http://archie.cochrane.org/sections/documents/view?document=540099072011521412&amp;format=REVMAN#REF-Shafer-2011">Shafer 2011</A>), this casts some doubt on the veracity of other studies by the same author. All Cochrane Injuries Group reviews that include studies by this author have therefore been edited to show the results with this author's trials included and excluded. Readers can now judge the potential impact of trials by this author on the conclusions of the review.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2013-02-25 02:26:53 -0500" MODIFIED_BY="Emma M Sydenham">
<STUDY_DESCRIPTION MODIFIED="2013-02-25 02:26:53 -0500" MODIFIED_BY="Emma M Sydenham">
<P>We identified 78 trials meeting the inclusion criteria for study design, participants and interventions (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>). We were able to obtain mortality data for 70 of these. We have reported details of the included trials in the '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>' table.</P>
<P>Reasons for exclusion of trials were: the use of a cross-over design, testing a resuscitation algorithm, giving the control group oral fluids, the intervention being directed to the maintenance of serum albumin levels, for haemodilution, for fluid loading and for the reduction of intracranial pressure (see '<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>' table).</P>
<P>Of the 70 trials with data on deaths, the quality of allocation concealment was adequate in 17 trials and unclear in most of the others.</P>
<P>There were 56 trials comparing colloid with crystalloid (add-on colloid), 11 trials comparing colloid in hypertonic crystalloid with isotonic crystalloid, and three trials comparing colloid with hypertonic crystalloid.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2012-05-30 08:20:08 -0400" MODIFIED_BY="Emma M Sydenham">
<P>In general, the design of studies was not well reported. This is reflected in the number of unclear scores given for allocation concealment. We also collected information on blinding and loss to follow-up. Blinding was not well reported and loss to follow-up was generally small. The characteristics for each trial are listed in the '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>' table.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2013-01-31 18:33:29 -0500" MODIFIED_BY="Emma M Sydenham">
<SUBSECTION>
<HEADING LEVEL="3">Colloids compared to crystalloids</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Albumin or plasma protein fraction</HEADING>
<P>Twenty-four trials reported data on mortality, including a total of 9920 patients. The pooled RR was 1.01 (95% CI 0.93 to 1.10). When trials by Boldt were removed, the results were unchanged (RR 1.01; 95% CI 0.93 to 1.10). When we excluded the trial with poor-quality allocation concealment (<LINK REF="STD-Lucas-1978" TYPE="STUDY">Lucas 1978</LINK>), pooled RR was 1.00 (95% CI 0.92 to 1.09).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Hydroxyethyl starch</HEADING>
<P>Twenty-five trials compared hydroxyethyl starch with crystalloids, including a total of 9147 randomised patients. The pooled RR for mortality was 1.10 (95% CI 1.02 to 1.19). When trials by Boldt were removed, the results were unchanged.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Modified gelatin</HEADING>
<P>Eleven trials compared modified gelatin with crystalloid, including a total of 506 randomised patients. The pooled RR for mortality was 0.91 (95% CI 0.49 to 1.72). When trials by Boldt were removed, the results were unchanged.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Dextran</HEADING>
<P>Nine trials compared dextran with a crystalloid, including a total of 834 randomised patients. The pooled RR for mortality was 1.24 (95% CI 0.94 to 1.65).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Colloids in hypertonic crystalloid compared to isotonic crystalloid</HEADING>
<P>One trial compared albumin and hypertonic saline with isotonic crystalloid. The RR of mortality was 0.50 (95% CI 0.06 to 4.33). One trial compared 6% hydroxyethyl starch 130/0.4 and hypertonic saline with Ringer's lactate. The RR of mortality was 0.25 (95% CI 0.03 to 2.15).</P>
<P>Nine trials compared dextran in hypertonic crystalloid with isotonic crystalloid, including 1879 randomised patients. The pooled RR of mortality was 0.91 (95% CI 0.79 to 1.06).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Colloids in isotonic crystalloid compared to hypertonic crystalloid</HEADING>
<P>Three trials compared colloids in isotonic crystalloid with hypertonic crystalloid. In two of these, where the colloid was either gelatin or starch, there were no deaths in either group. In the remaining trial, with 38 patients, there was a RR of death of 7.00 (95% CI 0.39 to 126.93) for use of colloid, based on three deaths in the treatment group and none in the control group.</P>
<SUBSECTION>
<HEADING LEVEL="4">Sensitivity analysis</HEADING>
<P>When all trials authored by Professor Boldt (<LINK REF="STD-Boldt-1986" TYPE="STUDY">Boldt 1986</LINK>; <LINK REF="STD-Boldt-1993" TYPE="STUDY">Boldt 1993</LINK>; <LINK REF="STD-Boldt-2001" TYPE="STUDY">Boldt 2001</LINK>; <LINK REF="STD-Lang-2001" TYPE="STUDY">Lang 2001</LINK>; <LINK REF="STD-Lang-2003" TYPE="STUDY">Lang 2003</LINK>) were excluded conclusions remain unchanged.</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2013-01-31 18:46:04 -0500" MODIFIED_BY="Emma M Sydenham">
<P>This systematic review synthesises the evidence from RCTs comparing colloid and crystalloid fluid resuscitation across a wide variety of clinical conditions. The review has been updated and extensively revised to take into account the comments made since it was first published in 1997. In particular, several commentators pointed out that it is inappropriate to combine effect estimates from studies of different colloids. For example, it was argued that large molecular weight colloids such as hydroxyethyl starch may be better retained in the vascular compartment than albumin and gelatins, and would therefore be more likely to show a favourable effect on mortality (<LINK REF="REF-Gosling-1998" TYPE="REFERENCE">Gosling 1998</LINK>). In response to these concerns, the review has been stratified by type of colloid. However, the pooled RRs fail to show a mortality benefit for resuscitation with any type of colloid.</P>
<P>There is a trend towards a favourable effect on mortality for colloids in hypertonic crystalloid, compared to isotonic crystalloids. Nevertheless, the results are compatible with the play of chance.</P>
<P>Common to all meta-analyses, this systematic review may have included studies whose interventions and patient characteristics are sufficiently incomparable that the calculation of a summary effect measure may be questioned. The resuscitation regimen differed between trials. Some trials randomised participants to an initial quantity of colloid or crystalloid, and then proceeded with some form of standard resuscitation for all participants. Other trials resuscitated with the allocated fluid to pre-determined end points, either resuscitation end points, or in the case of trauma, until corrective surgery. In addition, the type of colloid or crystalloid, the concentration, and the protocol to determine the quantity of fluid varied. Despite these differences, all participants were in need of volume replacement, and we believe that this variation in the intervention would have an impact on the size of the effect, rather than on its direction.</P>
<P>As regards the effects of albumin versus crystalloid, most of the information (as indicated by the weighting in the meta-analysis) was provided by the SAFE (Saline versus Albumin Fluid Evaluation) trial (<LINK REF="STD-SAFE-2004" TYPE="STUDY">SAFE 2004</LINK>) a large, well conducted, and low risk of bias trial. The pooled RR for death with albumin in this updated meta-analysis is 1.01 (95% CI 0.93 to 1.10).</P>
<P>As for hydroxyethyl starch, the updated meta-analysis provides a more precise estimate of its effect on mortality since it includes many thousands of patients and the number of deaths is large. Furthermore, the two studies that contribute 80% of the weight in the meta-analysis (<LINK REF="STD-Myburgh-2012" TYPE="STUDY">Myburgh 2012</LINK>; <LINK REF="STD-Perner-2012" TYPE="STUDY">Perner 2012</LINK>) were of high methodological quality with a low risk of bias. The pooled relative risk of death with hydroxyethyl starch is 1.10 (95% CI 1.02 to 1.19) suggesting that a mortality reduction is highly unlikely and that there may be an increase in the risk of death.</P>
<P>The results of this updated meta-analysis have important policy implications. There is still no evidence that colloids are superior to crystalloids as a treatment for intravascular volume resuscitation in critically ill patients, and some of them may even increase mortality. In addition, colloids are considerably more expensive than crystalloids. The economic opportunity cost of ongoing colloid use is likely to be considerable, and for this reason the ongoing use of colloids is unjustified.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2013-01-31 00:12:45 -0500" MODIFIED_BY="Emma M Sydenham">
<IMPLICATIONS_PRACTICE MODIFIED="2013-01-31 00:12:45 -0500" MODIFIED_BY="Emma M Sydenham">
<P>There is no evidence from randomised controlled trials that resuscitation using colloids compared with crystalloids reduces the risk of death in patients with trauma, burns or following surgery. The use of hydroxyethyl starch might even increase mortality. Since colloid use is not associated with improved survival and colloids are considerably more expensive than crystalloids, it is hard to see how their continued use in clinical practice can be justified.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2012-11-27 09:28:29 -0500" MODIFIED_BY="[Empty name]">
<P>Further clinical trials of colloid use need to justify carefully the potential for patient benefit.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2012-05-30 08:29:45 -0400" MODIFIED_BY="Emma M Sydenham">
<P>We acknowledge the contribution of Phil Alderson, Frances Bunn, Paul Chinnock, Gillian Schierhout and Mia Pearson who were authors of earlier versions of this review.</P>
<P>We would like to acknowledge the Intensive Care National Audit and Research Network in London (UK), for assistance with identification of trials for this review.</P>
<P>We thank Dr. Frank M. Brunkhorst for providing the Supplementary Appendix to the paper <LINK REF="STD-Brunkhorst-2008" TYPE="STUDY">Brunkhorst 2008</LINK>.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.<BR/> </P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2012-11-27 09:28:59 -0500" MODIFIED_BY="Emma M Sydenham">
<P>July 2007: PP and IR examined trials for inclusion or exclusion, reaching agreement by discussion. PP and IR extracted data from the new studies. PP, IR and KK amended the text of the review.</P>
<P>April 2009: IR and MP examined trials for inclusion or exclusion, reaching agreement by discussion. IR and MP extracted data from the new study. MP amended the text of the review. PP edited the final version.</P>
<P>February 2011: The Cochrane Injuries Group amended the text (Emma Sydenham, Managing Editor). Both authors agreed with the changes to the manuscript.</P>
<P>November 2012: PP and IR examined trials for inclusion or exclusion, reaching agreement by discussion. PP and KK extracted data from the new studies. PP amended the text of the review. All the authors agreed with the changes in the manuscript.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES MODIFIED="2012-05-30 08:30:49 -0400" MODIFIED_BY="Emma M Sydenham">
<P>The editorial group is aware that a clinical trial by Professor Joachim Boldt has been found to have been fabricated (<A HREF="http://archie.cochrane.org/sections/documents/view?document=540099072011521412&amp;format=REVMAN#REF-Boldt-2009">Boldt 2009</A>). As the editors who revealed this fabrication point out (<A HREF="http://archie.cochrane.org/sections/documents/view?document=540099072011521412&amp;format=REVMAN#REF-Reinhart-2011">Reinhart 2011</A>; <A HREF="http://archie.cochrane.org/sections/documents/view?document=540099072011521412&amp;format=REVMAN#REF-Shafer-2011">Shafer 2011</A>), this casts some doubt on the veracity of other studies by the same author. All Cochrane Injuries Group reviews that include studies by this author have therefore been edited to show the results with this author's trials included and excluded. Readers can now judge the potential impact of trials by this author (<LINK REF="STD-Boldt-1986" TYPE="STUDY">Boldt 1986</LINK>; <LINK REF="STD-Boldt-1993" TYPE="STUDY">Boldt 1993;</LINK> <LINK REF="STD-Boldt-2001" TYPE="STUDY">Boldt 2001;</LINK> <LINK REF="STD-Lang-2001" TYPE="STUDY">Lang 2001;</LINK> <LINK REF="STD-Lang-2003" TYPE="STUDY">Lang 2003</LINK>) on the conclusions of the review.</P>
<P>Emma Sydenham, Managing Editor, performed the sensitivity analysis.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2013-01-31 19:03:25 -0500" MODIFIED_BY="Emma M Sydenham">
<STUDIES MODIFIED="2013-01-31 19:03:25 -0500" MODIFIED_BY="Emma M Sydenham">
<INCLUDED_STUDIES MODIFIED="2013-01-31 18:58:20 -0500" MODIFIED_BY="Emma M Sydenham">
<STUDY DATA_SOURCE="PUB" ID="STD-Boldt-1986" NAME="Boldt 1986" YEAR="1986">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Boldt J, von Bormann B, Kling D, Borner U, Mulch J, Hempelmann G</AU>
<TI>Volume replacement with a new hydroxyethyl starch preparation (3 percent HES 200/0.5) in heart surgery</TI>
<TO>Volumenersatz mit einem neuen hydroxyathylstarke - praparat (3% HAS 200/0.5) in der herzchirurgie</TO>
<SO>Infusionstherapie und Klinische Ernährung</SO>
<YR>1986</YR>
<VL>13</VL>
<NO>3</NO>
<PG>145-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Boldt-1993" NAME="Boldt 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Boldt J, Knothe C, Zickmann B, Andres P, Dapper F, Hempelmann G</AU>
<TI>Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1993</YR>
<VL>76</VL>
<NO>6</NO>
<PG>1185-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Boldt-2001" MODIFIED="2012-05-30 11:58:10 -0400" MODIFIED_BY="Anne Lawson" NAME="Boldt 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-05-30 11:58:10 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Boldt J, Suttner S, Huttner I, Kumle B, Piper S, Krumholz W</AU>
<TI>Are costs of a crystalloid-based volume replacement regimen lower than of a colloid-based volume replacement strategy</TI>
<SO>Infusion Therapy and Transfusion Medicine</SO>
<YR>2001</YR>
<VL>28</VL>
<PG>144-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Boutros-1979" NAME="Boutros 1979" YEAR="1979">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Boutros AR, Ruess R, Olson L, Hoyt JL, Baker WH</AU>
<TI>Comparison of hemodynamic, pulmonary, and renal effects of use of three types of fluids after major surgical procedures on the abdominal aorta</TI>
<SO>Critical Care Medicine</SO>
<YR>1979</YR>
<VL>7</VL>
<NO>1</NO>
<PG>9-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bowser_x002d_Wallace-1986" NAME="Bowser-Wallace 1986" YEAR="1986">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bowser-Wallace BH, Caldwell FT Jr</AU>
<TI>A prospective analysis of hypertonic lactated saline v. Ringer's lactate-colloid for the resuscitation of severely burned children</TI>
<SO>Burns</SO>
<YR>1986</YR>
<VL>12</VL>
<NO>6</NO>
<PG>402-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Brunkhorst-2008" MODIFIED="2012-05-30 11:58:50 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Brunkhorst 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-05-12 08:59:37 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brunkhorst M, Engel C, Bloos F</AU>
<TI>Intensive insulin therapy and pentastarch resuscitation in severe sepsis</TI>
<SO>New England Journal of Medicine</SO>
<YR>2008</YR>
<VL>358</VL>
<PG>125-39</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-05-30 11:58:50 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="YES" TYPE="UNPUBLISHED">
<AU>Brunkhorst M</AU>
<TI>Supplementary Appendix</TI>
<SO>Provided from Dr. Brunkhorst on 26 March 2009</SO>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bulger-2011" MODIFIED="2013-01-31 18:51:32 -0500" MODIFIED_BY="[Empty name]" NAME="Bulger 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-01-31 18:51:32 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Author Affiliation: (Bulger, May, Emerson) Department of Surgery and Biostatistics, University of Washington, Seattle, United States (Kerby) University of Alabama at Birmingham, Department of Surgery, Birmingham, United States (Stiell) University of Ottawa, Department of Emergency Medicine, Ottawa, Canada (Schreiber) Oregon Health and Science University, Department of Surgery, Portland, United States (Brasel) Medical College of Wisconsin, Department of Surgery, Milwaukee, United States (Tisherman) University of Pittsburgh, Department of Surgery, Pittsburgh, PA, United States (Coimbra) University of California, San Diego Department of Surgery, San Diego, United States (Rizoli) University of Toronto, Department of Surgery, Toronto, ON, Canada (Minei) University of Texas Southwestern, Department of Surgery, Dallas, United States (Hata) University of Iowa, Iowa City, United States (Sopko) National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, United States (Evans) Vancouver General Hospital, Department of Surgery, Vancouver, BC, Canada (Hoyt) American College of Surgeons, Chicago, IL, United StatesNotes: Publication Type: Journal: Article&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 18:51:32 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bulger EM, May S, Kerby JD, Emerson S, Stiell IG, Schreiber MA, et al</AU>
<TI>Out-of-hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial</TI>
<SO>Annals of Surgery</SO>
<YR>2011</YR>
<VL>253</VL>
<NO>3</NO>
<PG>431-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chavez_x002d_Negrete-1991" MODIFIED="2012-05-30 12:00:23 -0400" MODIFIED_BY="Anne Lawson" NAME="Chavez-Negrete 1991" YEAR="1991">
<REFERENCE MODIFIED="2012-05-30 12:00:23 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chavez-Negrete A, Lajluf Cruz S, Frati Munari A, Perches A, Argulero R</AU>
<TI>Treatment of hemorrhagic shock with intraosseus or intravenous infusion of hypertonic saline dextran solution</TI>
<SO>European Surgical Research</SO>
<YR>1991</YR>
<VL>23</VL>
<NO>2</NO>
<PG>123-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cifra-2003" MODIFIED="2012-05-30 12:06:20 -0400" MODIFIED_BY="Anne Lawson" NAME="Cifra 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-05-30 12:06:20 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cifra HL, Velasco JNJ</AU>
<TI>A comparative study of the efficacy of 6% Haes-Steril and Ringer's lactate in the management of dengue shock syndrome 555</TI>
<SO>Critical Care &amp; Shock</SO>
<YR>2003</YR>
<VL>6</VL>
<PG>95-100</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cooper-2006" MODIFIED="2013-01-31 18:51:55 -0500" MODIFIED_BY="[Empty name]" NAME="Cooper 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-01-31 18:51:55 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Author Affiliation: (Cooper) Department of Critical Care Medicine, Sunnybrook and Women's College Health Science Center, B708-2075 Bayview Avenue, North York, Ont. M4N 3M5, CanadaNotes: Publication Type: Journal: Article&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 18:51:55 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cooper AB, Cohn SM, Zhang HS, Hanna K, Stewart TE, Slutsky AS</AU>
<TI>Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score</TI>
<SO>Transfusion</SO>
<YR>2006</YR>
<VL>46</VL>
<NO>1</NO>
<PG>80-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dawidson-1991" NAME="Dawidson 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dawidson IJ, Willms CD, Sandor ZF, Coorpender LL, Reisch JS, Fry WJ</AU>
<TI>Ringer's lactate with or without 3% dextran-60 as volume expanders during abdominal aortic surgery</TI>
<SO>Critical Care Medicine</SO>
<YR>1991</YR>
<VL>19</VL>
<NO>1</NO>
<PG>36-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dehne-2001" NAME="Dehne 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dehne MG, Muhling J, Sablotzki A, Dehn K-L, Sucke N, Hempelmann G</AU>
<TI>Hydroxyethyl starch (HES) does not directly affect renal function in patients with no prior renal impairment</TI>
<SO>Journal of Clinical Anaesthesia</SO>
<YR>2001</YR>
<VL>13</VL>
<NO>2</NO>
<PG>103-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Du-2011" MODIFIED="2013-01-31 18:52:19 -0500" MODIFIED_BY="[Empty name]" NAME="Du 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-01-31 18:52:19 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Du XJ, Hu WM, Xia Q, Huang ZW, Chen GY, Jin XD, et al</AU>
<TI>Hydroxyethyl starch resuscitation reduces the risk of intra-abdominal hypertension in severe acute pancreatitis</TI>
<SO>Pancreas</SO>
<YR>2011</YR>
<VL>40</VL>
<NO>8</NO>
<PG>1220-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dubin-2010" MODIFIED="2013-01-31 18:52:38 -0500" MODIFIED_BY="[Empty name]" NAME="Dubin 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-01-31 18:52:38 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Connective Phrase: PUBMED 20813485Notes: Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 18:52:38 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dubin A, Pozo MO, Casabella CA, Murias G, Pálizas F, Moseinco MC, et al</AU>
<TI>Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal-directed therapy of septic patients</TI>
<SO>Journal of Critical Care</SO>
<YR>2010</YR>
<VL>25</VL>
<NO>4</NO>
<PG>659.e1-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eleftheriadis-1995" NAME="Eleftheriadis 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eleftheriadis S, Sedemund-Adib B, Klotz K-F, Hubner N, Kuppe H</AU>
<TI>Volume replacement after cardiac surgery: comparison of Ringer, HES 6% and Gelatine 3.5%</TI>
<SO>Intensive Care Medicine</SO>
<YR>1995</YR>
<VL>21</VL>
<NO>suppl 1</NO>
<PG>S216</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ernest-1999" NAME="Ernest 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ernest D, Belzberg A, Dodek P</AU>
<TI>Distribution of normal saline and 5% albumin infusions in septic patients</TI>
<SO>Critical Care Medicine</SO>
<YR>1999</YR>
<VL>27</VL>
<NO>1</NO>
<PG>46-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Evans-1996" NAME="Evans 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Evans PA, Garnett M, Boffard K, Kirkman E, Jacobson BF</AU>
<TI>Evaluation of the effect of colloid (Haemaccel) on the bleeding time in the trauma patient</TI>
<SO>Journal of the Royal Society of Medicine</SO>
<YR>1996</YR>
<VL>89</VL>
<NO>2</NO>
<PG>101-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Evans-2003" MODIFIED="2012-05-30 12:08:26 -0400" MODIFIED_BY="Anne Lawson" NAME="Evans 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-05-30 12:08:26 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Evans PA, Heptinstall S, Crowhurst EC, Davies T, Glenn JR, Madira W, et al</AU>
<TI>Prospective double-blind randomized study of the effects of four intravenous fluids on platelet function and hemostasis in elective hip surgery</TI>
<SO>Journal of Thrombosis and Haemostasis</SO>
<YR>2003</YR>
<VL>1</VL>
<PG>2140-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fries-2004" MODIFIED="2012-05-14 12:06:08 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Fries 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-05-14 12:06:08 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fries D, Streif W, Margreiter J, Klingler A, Kuhbacher G, Schobersberger W, et al</AU>
<TI>The effects of perioperatively administered crystalloids and colloids on concentrations of molecular markers of activated coagulation and fibrinolysis</TI>
<SO>Blood Coagulation &amp; Fibrinolysis</SO>
<YR>2004</YR>
<VL>15</VL>
<PG>213-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gallagher-1985" MODIFIED="2009-05-12 09:00:13 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Gallagher 1985" YEAR="1985">
<REFERENCE MODIFIED="2009-05-12 09:00:13 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gallagher JD, Moore RA, Kerns D, Jose AB, Botros SB, Flicker S, et al</AU>
<TI>Effects of colloid or crystalloid administration on pulmonary extravascular water in the postoperative period after coronary artery bypass grafting</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1985</YR>
<VL>64</VL>
<NO>8</NO>
<PG>753-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goodwin-1983" NAME="Goodwin 1983" YEAR="1983">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goodwin CW, Dorethy J, Lam V, Pruitt BA Jr</AU>
<TI>Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury</TI>
<SO>Annals of Surgery</SO>
<YR>1983</YR>
<VL>197</VL>
<NO>5</NO>
<PG>520-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grundmann-1982" NAME="Grundmann 1982" YEAR="1982">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grundmann R, Heistermann S</AU>
<TI>Postoperative albumin infusion therapy based on colloid osmotic pressure. A prospectively randomized trial</TI>
<SO>Archives of Surgery</SO>
<YR>1985</YR>
<VL>120</VL>
<NO>8</NO>
<PG>911-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grundmann R, Meyer H</AU>
<TI>The significance of colloid osmotic pressure measurement after crystalloid and colloid infusions</TI>
<SO>Intensive Care Medicine</SO>
<YR>1982</YR>
<VL>8</VL>
<NO>4</NO>
<PG>179-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guidet-2012" MODIFIED="2012-11-19 06:13:01 -0500" MODIFIED_BY="[Empty name]" NAME="Guidet 2012" YEAR="2012">
<REFERENCE MODIFIED="2012-11-19 06:13:00 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guidet B, Martinet O, Boulain T, Philippart F, Poussel JF, Maizel J, Forceville X, Feissel M, Hasselmann M, Heininger A, Van Aken H</AU>
<TI>Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study</TI>
<SO>Critical Care</SO>
<YR>2012</YR>
<VL>16</VL>
<NO>3</NO>
<PG>R94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guo-2003" NAME="Guo 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guo XY, Xu ZH, Ren HZ, Luo AL, Huang YG, Ye TH</AU>
<TI>Effect of volume replacement with hydroxyethyl starch solution for blood loss on splanchnic oxygenation in patients undergoing cytoreductive surgery for ovarian carcinoma</TI>
<SO>Zhonghua Yi Xue Za Zhi</SO>
<YR>2003</YR>
<VL>83</VL>
<PG>114-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hall-1978" MODIFIED="2013-01-31 00:20:28 -0500" MODIFIED_BY="Anne Lawson" NAME="Hall 1978" YEAR="1978">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hall K, Sorensen B</AU>
<TI>The treatment of burn shock</TI>
<SO>Scandinavian Journal of Plastic and Reconstructive Surgery</SO>
<YR>1973</YR>
<VL>7</VL>
<PG>67-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Hall K, Sorensen B. The treatment of burns shock. In: Vrabec R, Konickova L and Moserova J (eds). Basic problems in burns. Berlin, Springer-Verlag. 1975.&lt;/p&gt;" PRIMARY="NO" TYPE="BOOK_SECTION">
<AU>Hall K, Sorensen B</AU>
<TI>The treatment of burns shock</TI>
<SO>Basic problems in burns</SO>
<YR>1975</YR>
<ED>Vrabec R, Konickova L, Moserova J</ED>
<PB>Springer-Verlag</PB>
<CY>Berlin</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-01-31 00:20:28 -0500" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hall KV, Sorensen B</AU>
<TI>The treatment of burn shock: results of a 5-year randomized, controlled clinical trial of dextran 70 v Ringer lactate solution</TI>
<SO>Burns</SO>
<YR>1978</YR>
<VL>5</VL>
<NO>1</NO>
<PG>107-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hartmann-1993" NAME="Hartmann 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hartmann M, Jonsson K, Zederfeldt B</AU>
<TI>Effects of dextran and crystalloids on subcutaneous oxygen tension and collagen accumulation. A randomized study in surgical patients</TI>
<SO>European Surgical Research</SO>
<YR>1993</YR>
<VL>25</VL>
<PG>270-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-James-2011" MODIFIED="2013-01-31 18:54:20 -0500" MODIFIED_BY="[Empty name]" NAME="James 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-01-31 18:54:20 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Author Affiliation: Department of Anaesthesia, Groote Schuur Hospital and Faculty of Health Sciences, University of Cape Town, Observatory, Cape Town, Western Cape 7925, South Africa. mike.james@uct.ac.za&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 18:54:20 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>James MF, Michell WL, Joubert IA, Nicol AJ, Navsaria PH, Gillespie RS</AU>
<TI>Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma)</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>2011</YR>
<VL>107</VL>
<NO>5</NO>
<PG>693-702</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jelenko-1978" MODIFIED="2012-05-30 12:15:27 -0400" MODIFIED_BY="Anne Lawson" NAME="Jelenko 1978" YEAR="1979">
<REFERENCE MODIFIED="2012-05-30 12:15:27 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jelenko C 3rd, Solenberger RI, Wheeler ML, Callaway BD</AU>
<TI>Shock and resuscitation. III. Accurate refractometric COP determinations in hypovolemia treated with HALFD</TI>
<SO>JACEP</SO>
<YR>1979</YR>
<VL>8</VL>
<NO>7</NO>
<PG>253-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jelenko C 3rd, Wheeler ML, Callaway BD, Divilio LT, Bucklen KR, Holdredge TD</AU>
<TI>Shock and resuscitation. II: Volume repletion with minimal edema using the "HALFD"(Hypertonic Albuminated Fluid Demand) regimen</TI>
<SO>JACEP</SO>
<YR>1978</YR>
<VL>7</VL>
<NO>9</NO>
<PG>326-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-05-30 12:15:10 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jelenko C 3rd, Williams JB, Wheeler ML, Callaway BD, Fackler VK, Albers CA, et al</AU>
<TI>Studies in shock and resuscitation, I: use of a hypertonic, albumin-containing, fluid demand regimen (HALFD) in resuscitation</TI>
<SO>Critical Care Medicine</SO>
<YR>1979</YR>
<VL>7</VL>
<NO>4</NO>
<PG>157-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jelenko C 3rd</AU>
<TI>Fluid therapy and the HALFD method</TI>
<SO>Journal of Trauma</SO>
<YR>1979</YR>
<VL>19</VL>
<NO>11 Suppl</NO>
<PG>866-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karanko-1987" NAME="Karanko 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Karanko M, Klossner J, Laksonen V</AU>
<TI>Restoration of volume by crystalloid versus colloid after coronary artery bypass: haemodynamics, lung water, oxygenation and outcome</TI>
<SO>Critical Care Medicine</SO>
<YR>1987</YR>
<VL>15</VL>
<PG>559-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lang-2001" NAME="Lang 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lang K, Boldt J, Suttner S, Haisch G</AU>
<TI>Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2001</YR>
<VL>93</VL>
<NO>2</NO>
<PG>405-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lang-2003" NAME="Lang 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lang K, Suttner S, Boldt J, Kumle B, Nagel D</AU>
<TI>Volume replacement with HES 130/0.4 may reduce the inflammatory response in patients undergoing major abdominal surgery</TI>
<SO>Canadian Journal of Anaesthesia</SO>
<YR>2003</YR>
<VL>50</VL>
<PG>1009-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-2011" MODIFIED="2013-01-31 00:20:59 -0500" MODIFIED_BY="[Empty name]" NAME="Lee 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-01-31 00:20:59 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lee JS, Ahn SW, Song JW, Shim JK, Yoo KJ, Kwak YL</AU>
<TI>Effect of hydroxyethyl starch 130/0.4 on blood loss and coagulation in patients with recent exposure to dual antiplatelet therapy undergoing off-pump coronary artery bypass graft surgery</TI>
<SO>Circulation Journal</SO>
<YR>2011</YR>
<VL>75</VL>
<NO>10</NO>
<PG>2397-402</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ley-1990" NAME="Ley 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ley SJ, Miller K, Skov P</AU>
<TI>Crystalloid versus colloid fluid therapy after cardiac surgery</TI>
<SO>Clinical Studies in Cardiac Care</SO>
<YR>1990</YR>
<VL>19</VL>
<NO>1</NO>
<PG>31-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lowe-1977" NAME="Lowe 1977" YEAR="1977">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lowe RJ, Moss GS, Jilek J, Levine HD</AU>
<TI>Crystalloid versus colloid in the etiology of pulmonary failure after trauma - a randomized trial in man</TI>
<SO>Critical Care Medicine</SO>
<YR>1979</YR>
<VL>7</VL>
<NO>3</NO>
<PG>107-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lowe RJ, Moss GS, Jilek J, Levine HD</AU>
<TI>Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man</TI>
<SO>Surgery</SO>
<YR>1977</YR>
<VL>1</VL>
<NO>6</NO>
<PG>676-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moss GS, Lowe RJ, Jilek J, Levine HD</AU>
<TI>Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial</TI>
<SO>Surgery</SO>
<YR>1981</YR>
<VL>89</VL>
<NO>4</NO>
<PG>434-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lu-2012" MODIFIED="2013-01-31 18:55:22 -0500" MODIFIED_BY="[Empty name]" NAME="Lu 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-01-31 18:55:22 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Author Affiliation: (Lu, Zhao, Liu, An) Surgical Intensive Care Unit, Peking University People's Hospital, Beijing 100044, ChinaNotes: Publication Type: Journal: Article&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 18:55:22 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lu J, Zhao HY, Liu F, An YZ</AU>
<TI>The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock</TI>
<SO>Chinese Critical Care Medicine</SO>
<YR>2012</YR>
<VL>24</VL>
<NO>1</NO>
<PG>38-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lucas-1978" MODIFIED="2012-11-28 08:23:09 -0500" MODIFIED_BY="Emma M Sydenham" NAME="Lucas 1978" YEAR="1978">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clift DR, Lucas CE, Ledgerwood AM, Sardesai V, Kithier K, Grabow D</AU>
<TI>The effect of albumin resuscitation for shock on the immune response to tetanus toxoid</TI>
<SO>Journal of Surgical Research</SO>
<YR>1982</YR>
<VL>32</VL>
<PG>449-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-05-12 09:00:26 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Johnson SD, Lucas CE, Gerrick SJ, Ledgerwood AM, Higgins R</AU>
<TI>Altered coagulation after albumin supplements for treatment of oligaemic shock</TI>
<SO>Archives of Surgery</SO>
<YR>1979</YR>
<VL>114</VL>
<PG>379-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lucas CE, Bouwman DL, Ledgerwood AM, Higgins R</AU>
<TI>Differential serum protein changes following supplemental albumin resuscitation for hypovolemic shock</TI>
<SO>Journal of Trauma</SO>
<YR>1980</YR>
<VL>20</VL>
<NO>1</NO>
<PG>47-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lucas CE, Weaver D, Higgins RF, Ledgerwood AM, Johnson SD, Bouwman DL</AU>
<TI>Effects of albumin versus non-albumin resuscitation on plasma volume and renal excretory function</TI>
<SO>Journal of Trauma</SO>
<YR>1978</YR>
<VL>18</VL>
<PG>565-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-11-28 08:23:09 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weaver DW, Ledgerwood AM, Lucas CE, Higgins R, Bouwman DL, Johnson SD</AU>
<TI>Pulmonary effects of albumin resuscitation for severe hypovolaemic shock</TI>
<SO>Archives of Surgery</SO>
<YR>1978</YR>
<VL>113</VL>
<PG>387-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maitland-2005" MODIFIED="2009-05-12 09:00:35 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Maitland 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-05-12 09:00:35 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maitland K, Pamba A, English M, Peshu N, Marsh K, Newton C, et al</AU>
<TI>Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>2005</YR>
<VL>40</VL>
<NO>4</NO>
<PG>538-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maitland-2011" MODIFIED="2013-01-31 18:55:54 -0500" MODIFIED_BY="[Empty name]" NAME="Maitland 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-01-31 18:55:54 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Author Affiliation: Kilifi Clinical Trials Facility, Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Kilifi, Kenya. kathryn.maitland@gmail.comNotes: Comments: Comment in: N Engl J Med. 2011 Jun 30;364(26):2543-4; PMID: 21615300&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 18:55:54 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO, et al</AU>
<TI>Mortality after fluid bolus in African children with severe infection</TI>
<SO>New England Journal of Medicine</SO>
<YR>2011</YR>
<VL>364</VL>
<NO>26</NO>
<PG>2483-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mattox-1991" MODIFIED="2009-05-12 09:00:45 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Mattox 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maningas PA, Mattox KL, Pepe PE, Jones RL, Feliciano DV, Burch JM</AU>
<TI>Hypertonic saline-dextran solutions for the prehospital management of traumatic hypotension</TI>
<SO>American Journal of Surgery</SO>
<YR>1989</YR>
<VL>157</VL>
<NO>5</NO>
<PG>528-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-05-12 09:00:45 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mattox KL, Maningas PA, Moore EE, Mateer JR, Marx JA, Aprahamian C, et al</AU>
<TI>Prehospital hypertonic saline/dextran infusion for post-traumatic hypotension. The U.S.A. Multicenter Trial</TI>
<SO>Annals of Surgery</SO>
<YR>1991</YR>
<VL>213</VL>
<NO>5</NO>
<PG>482-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mazher-1998" NAME="Mazher 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mazher R, Samenesco A, Royston D, Rees A</AU>
<TI>Cardiopulmonary effects of 7.2% saline solution compared with gelatin infusion in the early postoperative period after coronary artery bypass grafting</TI>
<SO>Journal of Thoracic and Cardiovascular Surgery</SO>
<YR>1998</YR>
<VL>115</VL>
<NO>1</NO>
<PG>178-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McIntyre-2008" MODIFIED="2013-01-31 18:56:19 -0500" MODIFIED_BY="[Empty name]" NAME="McIntyre 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-01-31 18:56:19 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Document Type: 2009 MayCODEN: RCT&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 18:56:19 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McIntyre LA, Fergusson D, Cook DJ, Rankin N, Dhingra V, Granton J, et al</AU>
<TI>Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial</TI>
<TO>Journal canadien d'anesthésie</TO>
<SO>Canadian Journal of Anaesthesia</SO>
<YR>2008</YR>
<VL>55</VL>
<NO>12</NO>
<PG>819-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McNulty-1993" MODIFIED="2012-05-30 12:21:35 -0400" MODIFIED_BY="Anne Lawson" NAME="McNulty 1993" YEAR="1993">
<REFERENCE MODIFIED="2012-05-30 12:21:35 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McNulty SE, Sharkey SJ, Asam B, Lee JH</AU>
<TI>Evaluation of STAT-CRIT hematocrit determination in comparison to coulter and centrifuge: the effects of isotonic hemodilution and albumin administration</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1993</YR>
<VL>76</VL>
<PG>830-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Metildi-1984" NAME="Metildi 1984" YEAR="1984">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Metildi LA, Shackford SR, Virgilio RW, Peters RM</AU>
<TI>Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency</TI>
<SO>Surgery, Gynecology and Obstetrics</SO>
<YR>1984</YR>
<VL>158</VL>
<NO>3</NO>
<PG>207-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Modig-1983" NAME="Modig 1983" YEAR="1983">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Modig J</AU>
<TI>Advantages of dextran 70 over Ringer acetate solution in shock treatment and in prevention of adult respiratory distress syndrome. A randomized study in man after traumatic-haemorrhagic shock</TI>
<SO>Resuscitation</SO>
<YR>1983</YR>
<VL>10</VL>
<NO>4</NO>
<PG>219-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Modig J</AU>
<TI>Effectiveness of dextran 70 versus Ringer's acetate in traumatic shock and adult respiratory distress syndrome</TI>
<SO>Critical Care Medicine</SO>
<YR>1986</YR>
<VL>14</VL>
<NO>5</NO>
<PG>454-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moretti-2003" NAME="Moretti 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moretti EW, Robertson KM, El Moalem H, Gan TJ</AU>
<TI>Intraoperative colloid administration reduces postoperative nausea and vomiting and improves postoperative outcomes compared with crystalloid administration</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2003</YR>
<VL>96</VL>
<PG>611-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Myburgh-2012" MODIFIED="2013-01-31 00:21:39 -0500" MODIFIED_BY="[Empty name]" NAME="Myburgh 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-01-31 00:21:39 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA; the CHEST Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group</AU>
<TI>Hydroxyethyl Starch or Saline for Fluid Resuscitation in Intensive Care</TI>
<SO>The New England Journal of Medicine</SO>
<YR>2012</YR>
<VL>367</VL>
<NO>20</NO>
<PG>1901-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nagy-1993" NAME="Nagy 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nagy KK, Davis J, Duda J, Fildes J, Roberts R, Barrett J</AU>
<TI>A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock</TI>
<SO>Circulatory Shock</SO>
<YR>1993</YR>
<VL>40</VL>
<NO>4</NO>
<PG>289-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ngo-2001" NAME="Ngo 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ngo NT, Cao XT, Kneen R, Wills B, Nguyen VM, Nguyen TQ, et al</AU>
<TI>Acute management of dengue shock syndrome: a randomised double-blind comparison of 4 intravenous fluid regimes in the first hour</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>2001</YR>
<VL>32</VL>
<NO>2</NO>
<PG>204-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nielsen-1985" MODIFIED="2012-05-30 12:25:07 -0400" MODIFIED_BY="Anne Lawson" NAME="Nielsen 1985" YEAR="1985">
<REFERENCE MODIFIED="2012-05-30 12:25:07 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nielsen OM, Engell HC</AU>
<TI>Extracellular fluid volume and distribution in relation to changes in plasma colloid osmotic pressure after major surgery. A Randomised Study</TI>
<SO>Acta Chirurgica Scandinavica</SO>
<YR>1985</YR>
<VL>151</VL>
<PG>221-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Perner-2012" MODIFIED="2012-11-28 08:22:05 -0500" MODIFIED_BY="[Empty name]" NAME="Perner 2012" YEAR="2012">
<REFERENCE MODIFIED="2012-11-28 08:22:05 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, et al</AU>
<TI>Hydroxyethyl Starch 130/0.42 versus Ringer&#8217;s Acetate in Severe Sepsis</TI>
<SO>The New England Journal of Medicine</SO>
<YR>2012</YR>
<VL>367</VL>
<NO>2</NO>
<PG>124-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pockaj-1994" MODIFIED="2012-05-30 12:25:37 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Pockaj 1994" YEAR="1994">
<REFERENCE MODIFIED="2012-05-30 12:25:37 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pockaj BA, Yang JC, Lotze MT, Lange JR, Spencer WF, Steinberg SM, et al</AU>
<TI>A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin-2 therapy</TI>
<SO>Journal of Immunotherapy</SO>
<YR>1994</YR>
<VL>15</VL>
<NO>1</NO>
<PG>22-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Prien-1990" MODIFIED="2009-05-12 09:01:08 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Prien 1990" YEAR="1990">
<REFERENCE MODIFIED="2009-05-12 09:01:08 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Prein T, Backhaus N, Pelster F, Pircher W, Buente H, Lawin P</AU>
<TI>Effect of intraoperative fluid administration and colloid osmotic pressure on the formation of intestinal edema during gastrointestinal surgery</TI>
<SO>Journal of Clinical Anesthesia</SO>
<YR>1990</YR>
<VL>2</VL>
<PG>317-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rackow-1983" MODIFIED="2009-05-12 09:01:16 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Rackow 1983" YEAR="1983">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Haupt, MT, Rackow, EC</AU>
<TI>Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions</TI>
<SO>Critical Care Medicine</SO>
<YR>1982</YR>
<VL>10</VL>
<NO>3</NO>
<PG>159-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kaufman BS, Rackow EC, Falk JL</AU>
<TI>Fluid resuscitation in circulatory shock. Colloids versus crystalloids</TI>
<SO>Current Studies in Hematology and Blood Transfusion</SO>
<YR>1986</YR>
<VL>53</VL>
<PG>186-98</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-05-12 09:01:16 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rackow EC, Falk JL, Fein IA, Siegel JS, Packman MI, Haupt MT, et al</AU>
<TI>Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock</TI>
<SO>Critical Care Medicine</SO>
<YR>1983</YR>
<VL>11</VL>
<NO>11</NO>
<PG>839-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Rocha-e-Silva-1994" MODIFIED="2012-05-30 12:28:55 -0400" MODIFIED_BY="Anne Lawson" NAME="Rocha e Silva 1994" YEAR="1994">
<REFERENCE MODIFIED="2012-05-30 12:28:55 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Rocha e Silva M, Poli de Figueiredo LF</AU>
<TI>Hypertonic-hyperoncotic saline solution for the treatment of post-traumatic hypotension in the emergency room. The Brazilian multi-center trial</TI>
<SO>SALT 6. International Conference on Hypertonic Resuscitation, Teton Village</SO>
<YR>2-3 June 1994</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-SAFE-2004" NAME="SAFE 2004" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>The SAFE Study Investigators</AU>
<TI>A comparison of albumin and saline for fluid resuscitation in the intensive care unit</TI>
<SO>New England Journal of Medicine</SO>
<YR>2004</YR>
<VL>350</VL>
<NO>22</NO>
<PG>2247-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shah-1977" NAME="Shah 1977" YEAR="1977">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shah DM, Broner BD, Dutton RE, Newell JC, Powers SR</AU>
<TI>Cardiac output and pulmonary wedge pressure. Use for evaluation of fluid replacement in trauma patients</TI>
<SO>Archives of Surgery</SO>
<YR>1977</YR>
<VL>112</VL>
<PG>1161-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shires-1983" MODIFIED="2012-05-31 08:39:31 -0400" MODIFIED_BY="Anne Lawson" NAME="Shires 1983" YEAR="1983">
<REFERENCE MODIFIED="2012-05-31 08:39:31 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shires G, Peitzman A, Albert S, Illner H, Silane M, Perry M, et al</AU>
<TI>Response of extravascular lung water to intraoperative fluids</TI>
<SO>Annals of Surgery</SO>
<YR>1983</YR>
<VL>197</VL>
<PG>515-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sirieix-1999" MODIFIED="2012-05-31 08:39:47 -0400" MODIFIED_BY="Anne Lawson" NAME="Sirieix 1999" YEAR="1999">
<REFERENCE MODIFIED="2012-05-31 08:39:47 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sirieix D, Hongnat J-M, Delayance S, D'Attellis N, Vicaut E, Berribi A, et al</AU>
<TI>Comparison of the acute haemodynamic effects of hypertonic or colloid infusions immediately after mitral valve repair</TI>
<SO>Critical Care Medicine</SO>
<YR>1999</YR>
<VL>27</VL>
<PG>2159-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Skillman-1975" NAME="Skillman 1975" YEAR="1975">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Skillman JJ, Restall DS, Salzman EW</AU>
<TI>Randomized trial of albumin vs. electrolyte solutions during abdominal aortic operations</TI>
<SO>Surgery</SO>
<YR>1975</YR>
<VL>78</VL>
<NO>3</NO>
<PG>291-303</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tollofsrud-1995" MODIFIED="2012-05-30 12:29:48 -0400" MODIFIED_BY="Anne Lawson" NAME="Tollofsrud 1995" YEAR="1995">
<REFERENCE MODIFIED="2012-05-30 12:29:48 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tølløfsrud S, Svennevig JL, Breivik H, Kongsgaard U, Ozer M, Hysing E, et al</AU>
<TI>Fluid balance and pulmonary functions during and after coronary artery bypass surgery: Ringer&#8217;s acetate compared with dextran, polygeline, or albumin</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>1995</YR>
<VL>39</VL>
<PG>671-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tollofsrud-1998" NAME="Tollofsrud 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tollofsrud S, Noddeland H</AU>
<TI>Hypertonic saline and dextran after coronary artery surgery mobilises fluid excess and improves cardiorespiratory functions</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>1998</YR>
<VL>42</VL>
<PG>154-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Upadhyay-2004" MODIFIED="2013-01-31 18:58:20 -0500" MODIFIED_BY="[Empty name]" NAME="Upadhyay 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-01-31 18:58:20 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Upadhyay M, Singhi S, Murlidharan J, Kaur N, Majumdar S</AU>
<TI>Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock</TI>
<SO>Indian Pediatrics</SO>
<YR>2004</YR>
<VL>42</VL>
<NO>3</NO>
<PG>223-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vassar-1990" NAME="Vassar 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vassar MJ, Perry CA, Holcroft JW</AU>
<TI>Analysis of potential risks associated with 7.5% sodium chloride resuscitation of traumatic shock</TI>
<SO>Archives of Surgery</SO>
<YR>1990</YR>
<VL>125</VL>
<NO>10</NO>
<PG>1309-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vassar-1991" NAME="Vassar 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Holcroft JW, Vassar MJ, Turner JE, Derlet RW, Kramer GC</AU>
<TI>3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients</TI>
<SO>Annals of Surgery</SO>
<YR>1987</YR>
<VL>206</VL>
<NO>3</NO>
<PG>279-88</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vassar MJ, Perry CA, Gannaway WL, Holcroft JW</AU>
<TI>7.5% sodium chloride/dextran for resuscitation of trauma patients undergoing helicopter transport</TI>
<SO>Archives of Surgery</SO>
<YR>1991</YR>
<VL>126</VL>
<NO>9</NO>
<PG>1065-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vassar-1993a" NAME="Vassar 1993a" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vassar MJ, Perry CA, Holcroft JW</AU>
<TI>Prehospital resuscitation of hypotensive trauma patients with 7.5% NaCl versus 7.5% NaCl with added dextran: a controlled trial</TI>
<SO>Journal of Trauma</SO>
<YR>1993</YR>
<VL>34</VL>
<NO>5</NO>
<PG>622-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vassar-1993b" MODIFIED="2009-05-12 09:01:32 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Vassar 1993b" YEAR="1993">
<REFERENCE MODIFIED="2009-05-12 09:01:32 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vassar MJ, Fischer RP, O'Brien PE, Bachulis BL, Chambers JA, Hoyt DB, et al</AU>
<TI>A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients</TI>
<SO>Archives of Surgery</SO>
<YR>1993</YR>
<VL>128</VL>
<NO>9</NO>
<PG>1003-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Verheij-2006" MODIFIED="2012-05-30 12:30:55 -0400" MODIFIED_BY="Anne Lawson" NAME="Verheij 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-05-30 12:30:55 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Verheij J, van Lingen A, Beishuizen A, Christiaans HM, de Jong JR, Girbes AR, et al</AU>
<TI>Cardiac response is greater for colloid than saline fluid loading after cardiac or vascular surgery</TI>
<SO>Intensive Care Medicine</SO>
<YR>2006</YR>
<VL>32</VL>
<NO>7</NO>
<PG>1030-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Virgilio-1979" NAME="Virgilio 1979" YEAR="1979">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Virgilio RW, Rice CL, Smith DE, James DR, Zarins CK, Hobelmann CF, et al</AU>
<TI>Crystalloid vs. colloid resuscitation: is one better? A randomized clinical study</TI>
<SO>Surgery</SO>
<YR>1979</YR>
<VL>85</VL>
<NO>2</NO>
<PG>129-39</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wahba-1996" MODIFIED="2012-05-30 12:31:27 -0400" MODIFIED_BY="Anne Lawson" NAME="Wahba 1996" YEAR="1996">
<REFERENCE MODIFIED="2012-05-30 12:31:27 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wahba A, Sendtner E, Strotzer M, Wild K, Birnbaum DE</AU>
<TI>Fluid therapy with Ringer's solution versus Haemaccel following coronary artery bypass surgery</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>1996</YR>
<VL>40</VL>
<PG>1227-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wills-2005" MODIFIED="2012-05-31 08:40:12 -0400" MODIFIED_BY="Anne Lawson" NAME="Wills 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-05-31 08:40:12 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wills BA, Nguyen MD, Ha TL, Dong TH, Tran TN, Le TT, et al</AU>
<TI>Comparison of three fluid solutions for resuscitation in dengue shock syndrome</TI>
<SO>The New England Journal of Medicine</SO>
<YR>2005</YR>
<VL>353</VL>
<PG>877-89</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Woittiez-1997" NAME="Woittiez 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hondebrink Y, Jeekel L, Oude Nijhuis J, Woittiez AJJ</AU>
<TI>Restoration of colloid osmotic pressure in hypoalbuminaemic patients</TI>
<SO>Intensive Care Medicine</SO>
<YR>1997</YR>
<VL>23</VL>
<NO>supp 1</NO>
<PG>S184</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wu-2001" MODIFIED="2009-05-12 09:01:42 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Wu 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-05-12 09:01:42 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wu J, Huang M, Tang G, Kao W, Shih H, Su C, et al</AU>
<TI>Hemodynamic response of modified fluid gelatin compared with lactated ringer's solution for volume expansion in emergency resuscitation of hypovolemic shock patients: preliminary report of a prospective, randomized trial</TI>
<SO>World Journal of Surgery</SO>
<YR>2001</YR>
<VL>25</VL>
<NO>5</NO>
<PG>598-602</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Younes-1992" NAME="Younes 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Younes RN, Aun F, Accioly CQ, Casale LP, Szajnbok I, Birolini D</AU>
<TI>Hypertonic solutions in the treatment of hypovolemic shock: a prospective, randomized study in patients admitted to the emergency room</TI>
<SO>Surgery</SO>
<YR>1992</YR>
<VL>111</VL>
<NO>4</NO>
<PG>380-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Younes-1994" MODIFIED="2012-06-01 07:11:02 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Younes 1994" YEAR="1994">
<REFERENCE MODIFIED="2012-05-14 12:06:37 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Younes R, Aun F, Ching C, Goldenberg D, Franco M, Miura F, et al</AU>
<TI>Prognostic factors to predict outcome following the administration of hypertonic/hyperoncotic solution in hypovolaemic patients</TI>
<SO>Shock</SO>
<YR>1997</YR>
<VL>7</VL>
<PG>79-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-06-01 07:11:02 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Younes RN, Aun F, Ching C, Goldenberg D, Franco M, Miura F, Santos S et al</AU>
<TI>Prognosis following the administration of hypertonic/hyperoncotic solutions in hypovolemic patients</TI>
<SO>SALT 6. International Conference on Hypertonic Resuscitation. Teton Village</SO>
<YR>June 2-3 1994</YR>
<IDENTIFIERS MODIFIED="2012-06-01 07:11:02 -0400" MODIFIED_BY="Emma M Sydenham">
<IDENTIFIER MODIFIED="2012-06-01 07:11:02 -0400" MODIFIED_BY="Emma M Sydenham" TYPE="OTHER" VALUE="http://www.dtic.mil/dtic/tr/fulltext/u2/a286110.pdf"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Younes-1998" NAME="Younes 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Younes R, Yin K, Amino C, Itinoshe M, Rocha e Silva M, Birolini D</AU>
<TI>Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room</TI>
<SO>World Journal of Surgery</SO>
<YR>1998</YR>
<VL>22</VL>
<PG>2-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zetterstrom-1981a" NAME="Zetterstrom 1981a" YEAR="1981">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zetterstrom H, Hedstrand U</AU>
<TI>Albumin treatment following major surgery. I. Effects on plasma oncotic pressure, renal function and peripheral oedema</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>1981</YR>
<VL>25</VL>
<PG>125-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zetterstrom-1981b" NAME="Zetterstrom 1981b" YEAR="1981">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zetterstrom H</AU>
<TI>Albumin treatment following major surgery. II. Effects on postoperative lung function and circulatory adaptation</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>1981</YR>
<VL>25</VL>
<PG>133-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhu-2011" MODIFIED="2012-05-15 09:49:27 -0400" MODIFIED_BY="[Empty name]" NAME="Zhu 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-05-15 09:49:27 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Author Affiliation: Department of Intensive Care Unit, the Affiliated Hospital of Jianghan University, Wuhan 430015, China&lt;/p&gt;" NOTES_MODIFIED="2012-05-15 09:49:27 -0400" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Zhu GC, Quan ZY, Shao YS, Zhao JG, Zhang YT</AU>
<TI>[The study of hypertonic saline and hydroxyethyl starch treating severe sepsis]. [Chinese]</TI>
<TO>Zhongguo Wei Zhong Bing Ji Jiu Yi Xue</TO>
<SO>Chinese Critical Care Medicine</SO>
<YR>2011</YR>
<VL>23</VL>
<NO>3</NO>
<PG>150-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2013-01-31 19:03:25 -0500" MODIFIED_BY="Emma M Sydenham">
<STUDY DATA_SOURCE="PUB" ID="STD-Artru-1989" MODIFIED="2012-05-30 12:43:01 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Artru 1989" YEAR="1989">
<REFERENCE MODIFIED="2012-05-30 12:43:01 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Artru F, Philippon B, Flachaire E, Peyrieux JC, Boissel JP, Ferry S, et al</AU>
<TI>A controlled study of dextran 40: effect on cerebral blood flow and metabolic rates in acute head trauma</TI>
<SO>Intensive Care Medicine</SO>
<YR>1989</YR>
<VL>15</VL>
<NO>8</NO>
<PG>499-504</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bocanegra-1966" NAME="Bocanegra 1966" YEAR="1966">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bocanegra M, Hinostroza F, Kefalides NA, Markley K, Rosenthal SM</AU>
<TI>A long-term study of early fluid therapy in severely burned adults. 3. Simultaneous comparison of saline solution alone or combined with plasma</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1966</YR>
<VL>195</VL>
<NO>4</NO>
<PG>268-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Boldt-1996" NAME="Boldt 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Boldt J, Heesen M, Padberg W, Martin K, Hempelmann G</AU>
<TI>The influence of volume therapy and pentoxifylline infusion on circulating adhesion molecules in trauma patients</TI>
<SO>Anaesthesia</SO>
<YR>1996</YR>
<VL>51</VL>
<PG>529-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Boldt-2007" MODIFIED="2009-04-17 12:47:56 -0400" MODIFIED_BY="[Empty name]" NAME="Boldt 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-04-17 12:47:56 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Boldt J, Schollhorn T, Munchbach J</AU>
<TI>A total balanced volume replacement strategy using a new balanced hydroxyethyl starch preparation (6% HES 130/0.42) in patients undergoing major abdominal surgery</TI>
<SO>European Journal of Medicine</SO>
<YR>2007</YR>
<VL>24</VL>
<PG>267-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bothner-1998" NAME="Bothner 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bothner U, Georgieff M, Vogt N</AU>
<TI>Assessment of the safety and tolerance of 6% hydroxyethyl starch (200/0.5) solution: a randomized, controlled epidemiology study</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1998</YR>
<VL>86</VL>
<PG>850-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Breheme-1993" NAME="Breheme 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brehme S, Keysser G, Turowski A, Schmidt HH</AU>
<TI>Hemorheologic effects of hydroxyethyl starch 200/0.5, dextran 40, oxypolygelatine and full electrolyte solution over 48 hours</TI>
<TO>Hamorheologische Wirkungen von Hydroxyathylstarke 200/0,5, Dextran 40, Oxypolygelatine und Vollelektrolytlosung uber 48 Stunden</TO>
<SO>Zeitschrift für die gesamte innere Medizin und ihre Grenzgebiete</SO>
<YR>1993</YR>
<VL>48</VL>
<NO>10</NO>
<PG>506-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bueno-R-2004" MODIFIED="2009-05-07 12:52:30 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Bueno R 2004" YEAR="2004">
<REFERENCE MODIFIED="2009-05-07 12:52:30 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bueno R, Resende AC, Melo R, Neto VA, Stolf NA</AU>
<TI>Effects of hypertonic saline-dextran solution in cardiac valve surgery with cardiopulmonary bypass</TI>
<SO>Annals of Thoracic Surgery</SO>
<YR>2004</YR>
<VL>77</VL>
<NO>2</NO>
<PG>604-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chin-2006" MODIFIED="2012-05-30 12:44:31 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Chin 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-05-30 12:44:31 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chin Y, Macachor J, Ong KC, Ong BC</AU>
<TI>A comparison of 5% dextrose in 0.9% normal saline versus non-dextrose-containing crystalloids as the initial intravenous replacement fluid in elective surgery</TI>
<SO>Anaesthesia and Intensive Care</SO>
<YR>2006</YR>
<VL>34</VL>
<NO>5</NO>
<PG>613-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Golub-1994" NAME="Golub 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Golub R, Sorrento JJ Jr, Cantu R Jr, Nierman DM, Moideen A, Stein HD</AU>
<TI>Efficacy of albumin supplementation in the surgical intensive care unit: a prospective, randomized study</TI>
<SO>Critical Care Medicine</SO>
<YR>1994</YR>
<VL>22</VL>
<NO>4</NO>
<PG>613-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goslinga-1992" MODIFIED="2012-05-30 12:45:05 -0400" MODIFIED_BY="Anne Lawson" NAME="Goslinga 1992" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goslinga H, Eijzenbach V, Heuvelmans JH, van de Nes JC, Kurk RM, Bezemer PD</AU>
<TI>[Individualized hemodilution in acute brain infarct using a 20% albumin solution and physiological saline solution]</TI>
<SO>Nederlands Tijdschrift voor Geneeskunde</SO>
<YR>1992</YR>
<VL>136</VL>
<NO>49</NO>
<PG>2422-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-05-30 12:45:05 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goslinga H, Eijzenbach V, Heuvelmans JH, van der Laan de Vries E, Melis VM, Schmid-Schönbein H, et al</AU>
<TI>Custom-tailored hemodilution with albumin and crystalloids in acute ischemic stroke</TI>
<SO>Stroke</SO>
<YR>1992</YR>
<VL>23</VL>
<NO>2</NO>
<PG>181-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goslinga H, Heuvelmans JH, Schmid Schonbein H</AU>
<TI>Hemodilution and rehydration in acute ischemic stroke. A preliminary report on the Amsterdam Stroke Study</TI>
<SO>Acta Medica Austriaca</SO>
<YR>1991</YR>
<VL>18</VL>
<NO>Suppl 1</NO>
<PG>41-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Green-2008" MODIFIED="2009-05-12 09:01:55 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Green 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-05-12 09:01:55 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Green RS, Hall RI</AU>
<TI>Con: starches are not preferable to albumin during cardiac surgery: a contrary opinion</TI>
<SO>Journal of Cardiothoracic and Vascular Anesthesia</SO>
<YR>2008</YR>
<VL>22(3)</VL>
<PG>485-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Greenhalgh-1995" MODIFIED="2012-05-31 08:40:34 -0400" MODIFIED_BY="Anne Lawson" NAME="Greenhalgh 1995" YEAR="1995">
<REFERENCE MODIFIED="2012-05-31 08:40:34 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Greenhalgh DG, Housinger TA, Kagan RJ, Rieman M, James L, Novak S, et al</AU>
<TI>Maintenance of serum albumin levels in pediatric burn patients: a prospective, randomized trial</TI>
<SO>Journal of Trauma</SO>
<YR>1995</YR>
<VL>39</VL>
<NO>1</NO>
<PG>67-73; discussion 73-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hauser-1980" MODIFIED="2009-05-10 09:32:59 -0400" MODIFIED_BY="[Empty name]" NAME="Hauser 1980" YEAR="">
<REFERENCE MODIFIED="2009-05-10 09:32:59 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hauser CJ, Shoemaker WC, Turpin I, Goldberg SJ</AU>
<TI>Oxygen transport response to colloids and crystalloids in critically ill surgical patients</TI>
<SO>Surgery</SO>
<YR>1980</YR>
<VL>150</VL>
<NO>6</NO>
<PG>811-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ko-2007" MODIFIED="2012-05-30 12:47:45 -0400" MODIFIED_BY="[Empty name]" NAME="Ko 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-05-30 12:47:45 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ko JS, Kim CS, Cho HS, Choi DH</AU>
<TI>A randomized trial of crystalloid versus colloid solution for prevention of hypotension during spinal or low-dose combined spinal-epidural anesthesia for elective cesarean delivery</TI>
<SO>International Journal of Obstetric Anesthesia</SO>
<YR>2007</YR>
<VL>16(1)</VL>
<PG>8-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krasheninnikov-2007" MODIFIED="2009-05-07 08:57:56 -0400" MODIFIED_BY="[Empty name]" NAME="Krasheninnikov 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-05-07 08:57:54 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Krasheninnikov SV, Levit AL, Malkova OG</AU>
<TI>Effect of various colloidal solutions on pulmonary oxygenizing function in patients with acute lung lesion</TI>
<SO>Anestiziologiia i Reanimatologiia</SO>
<YR>2007</YR>
<VL>3</VL>
<PG>20-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lagonidis-1995" NAME="Lagonidis 1995" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lagonidis D, Magder S</AU>
<TI>Acute volume loading with colloid vs. crystalloid after coronary artery bypass</TI>
<SO>Intensive Care Medicine</SO>
<YR>1992</YR>
<VL>18:</VL>
<NO>suppl 2</NO>
<PG>S225</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lange-2011" MODIFIED="2013-01-31 19:01:13 -0500" MODIFIED_BY="[Empty name]" NAME="Lange 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-01-31 19:01:13 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lange M, Ertmer C, Van Aken H, Westphal M</AU>
<TI>Intravascular volume therapy with colloids in cardiac surgery</TI>
<SO>Journal of Cardiothoracic and Vascular Anesthesia</SO>
<YR>2011</YR>
<VL>25</VL>
<NO>5</NO>
<PG>847-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lobo-2008" MODIFIED="2009-05-07 08:58:58 -0400" MODIFIED_BY="[Empty name]" NAME="Lobo 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-05-07 08:58:56 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lobo SM, Orrico SR, Queiroz MM, Contrim LM, Cury PM</AU>
<TI>Comparison of the effects of the lactated Ringer solution with and without hydroxyethyl starch fluid resuscitation on gut edema during severe splanchnic ischemia</TI>
<SO>Brazilian Journal of Medical and Biological Research</SO>
<YR>2008</YR>
<VL>41(7)</VL>
<PG>634-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marhofer-1999" MODIFIED="2009-05-07 13:02:22 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Marhofer 1999" YEAR="1999">
<REFERENCE MODIFIED="2009-05-07 13:02:22 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marhofer P, Faryniak B, Oismuller C, Koinig H, Kapral S, Mayer N</AU>
<TI>Cardiovascular effects of 6% hetastarch and lactated Ringer's solution during spinal anaesthesia</TI>
<SO>Regional Anesthesia and Pain Medicine</SO>
<YR>1999</YR>
<VL>24</VL>
<PG>399-404</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mittermayr-2007" MODIFIED="2009-05-12 09:02:28 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Mittermayr 2007" YEAR="2008">
<REFERENCE MODIFIED="2009-05-12 09:02:28 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Klingler A, et al</AU>
<TI>Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>2007</YR>
<VL>105</VL>
<NO>4</NO>
<PG>905-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mittermayr-2008" MODIFIED="2009-05-12 09:02:37 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Mittermayr 2008" YEAR="2007">
<REFERENCE MODIFIED="2009-05-12 09:02:37 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Klingler A, et al</AU>
<TI>Effects of colloid and crystalloid solutions on endogenous activation of fibrinolysis and resistance of polymerized fibrin to recombinant tissue plasminogen activator added ex vivo</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>2008</YR>
<VL>100(3)</VL>
<PG>307-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Morrison-2011" MODIFIED="2013-01-31 19:01:56 -0500" MODIFIED_BY="[Empty name]" NAME="Morrison 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-01-31 19:01:56 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Author Affiliation: Rescu, Keenan Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, Ontario, Canada. morrisonl@smh.ca&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 19:01:56 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Morrison LJ, Baker AJ, Rhind SG, Kiss A, MacDonald RD, Schwartz B, et al</AU>
<TI>The Toronto prehospital hypertonic resuscitation - head injury and multiorgan dysfunction trial: feasibility study of a randomized controlled trial</TI>
<SO>Journal of Critical Care</SO>
<YR>2011</YR>
<VL>26</VL>
<NO>4</NO>
<PG>363-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Niemi-2008" MODIFIED="2009-05-07 13:02:43 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Niemi 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-05-07 13:02:43 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Niemi T, Schramko A, Kuitunen A, Kukkonen S, Suojaranta-Ylinen R</AU>
<TI>Haemodynamics and Acid-base equilibrium after cardiac surgery: comparison of rapidly degradable hydroxyethyl starch solutions and albumin</TI>
<SO>Scandinavian Journal of Surgery</SO>
<YR>2008</YR>
<VL>97</VL>
<NO>3</NO>
<PG>259-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nilsson-1980" NAME="Nilsson 1980" YEAR="1980">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nilsson E, Lamke O, Liljedahl SO, Elfstrom K</AU>
<TI>Is albumin therapy worthwhile in surgery for colorectal cancer?</TI>
<SO>Acta Chirurgica Scandinavica</SO>
<YR>1980</YR>
<VL>146</VL>
<PG>619-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oliviera-2002" MODIFIED="2009-05-07 12:52:32 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Oliviera 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-05-07 12:52:32 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Oliviera RP, Weingartner R, Ribas EO, Moraes RS, Friedman G</AU>
<TI>Acute haemodynamic effects of a hypertonic saline/dextran solution in stable patients with severe sepsis</TI>
<SO>Intensive Care Medicine</SO>
<YR>2002</YR>
<VL>28</VL>
<NO>11</NO>
<PG>1574-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Paton_x002d_Gay-2007" MODIFIED="2009-05-12 09:02:53 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Paton-Gay 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-05-12 09:02:53 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Paton-Gay JD, Brindley PG, McDermid RC</AU>
<TI>Best evidence in critical care medicine: fluid management in acute lung injury: friend or foe?</TI>
<SO>Canadian Journal of Anesthesia</SO>
<YR>2007</YR>
<VL>54</VL>
<NO>1</NO>
<PG>73-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Paul-2003" MODIFIED="2009-05-07 12:52:35 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Paul 2003" YEAR="2003">
<REFERENCE MODIFIED="2009-05-07 12:52:35 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Paul M, Dueck M, Joachim Herrman H, Holzki J</AU>
<TI>A randomized, controlled study of fluid management in infants and toddlers during surgery: hydroxyethyl starch 6% (HES 70/0.5) vs lactated Ringer's solution</TI>
<SO>Paediatric Anaesthesia</SO>
<YR>2003</YR>
<VL>13</VL>
<NO>7</NO>
<PG>603-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rehm-2001" MODIFIED="2012-05-30 12:52:44 -0400" MODIFIED_BY="Anne Lawson" NAME="Rehm 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-05-30 12:52:44 -0400" MODIFIED_BY="Anne Lawson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rehm M, Haller M, Orth V, Kreimeier U, Jacob M, Dressel H, et al</AU>
<TI>Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% hetastarch solutions in patients before radical hysterectomy</TI>
<SO>Anesthesiology</SO>
<YR>2001</YR>
<VL>95</VL>
<NO>4</NO>
<PG>849-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Steinberg-1989" NAME="Steinberg 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Steinberg B, Kochs E, Bause H, Schulte am Esch J</AU>
<TI>Effects of low molecular weight hydroxyethyl starch (HES 40) in comparison with Ringer solution on oxygen tension in skeletal muscles of infected patients</TI>
<SO>Anästhesie, Intensivtherapie, Notfallmedizin</SO>
<YR>1989</YR>
<VL>24</VL>
<NO>6</NO>
<PG>377-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tiryakioglu-2008" MODIFIED="2009-05-10 09:35:20 -0400" MODIFIED_BY="[Empty name]" NAME="Tiryakioglu 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-05-10 09:35:20 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tiryakioglu O, Yildiz G, Vural H, Goncu T, Ozyazicioglu A, Yavuz S</AU>
<TI>Hydroxethyl starch versus Ringer solution in cardiopulmonary bypass prime solutions (a randomized controlled trial)</TI>
<SO>Journal of Cardiothoracic Surgery</SO>
<YR>2008</YR>
<VL>3(45)</VL>
<PG>1-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tseng-2008" MODIFIED="2009-05-07 09:05:36 -0400" MODIFIED_BY="[Empty name]" NAME="Tseng 2008" YEAR="2008">
<REFERENCE MODIFIED="2009-05-07 09:05:34 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tseng M, Hutchinson Y, Kirkpatrick P</AU>
<TI>Effects of fluid therapy following aneurysmal subarachnoid haemorrhage: a prospective clinical study</TI>
<SO>British Journal of Neurosurgery</SO>
<YR>2008</YR>
<VL>22(2)</VL>
<PG>257-68</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Valetova-2007" MODIFIED="2009-05-12 09:03:08 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Valetova 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-05-12 09:03:08 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Valetova VV, Khudenko NV, Sakharova EA, Timerbaev VK</AU>
<TI>Role of starch preparations in the intraoperative correction of hypovolemia in patients with large-size uterine myomas</TI>
<SO>Anesteziologiia i Reanimatologiia</SO>
<YR>2007</YR>
<VL>2</VL>
<PG>31-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-van-der-Heijden-2009" MODIFIED="2013-01-31 19:03:25 -0500" MODIFIED_BY="[Empty name]" NAME="van der Heijden 2009" YEAR="">
<REFERENCE MODIFIED="2013-01-31 19:03:25 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Document Type: 2009 AugCODEN: RCT&lt;/p&gt;" NOTES_MODIFIED="2013-01-31 19:03:25 -0500" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van der Heijden M, Verheij J, van Nieuw Amerongen GP, Groeneveld, AB</AU>
<TI>Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia</TI>
<SO>Critical Care Medicine</SO>
<YR>2009</YR>
<VL>37</VL>
<NO>4</NO>
<PG>1275-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vercueil-2006" MODIFIED="2009-05-12 09:03:17 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Vercueil 2006" YEAR="2006">
<REFERENCE MODIFIED="2009-05-12 09:03:17 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vercueil A, Levett D, Grocott M</AU>
<TI>Resuscitation fluids in trauma, part II: which fluid should I give?</TI>
<SO>Trauma</SO>
<YR>2006</YR>
<VL>8</VL>
<NO>2</NO>
<PG>111-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilkes-2001" MODIFIED="2009-05-07 13:03:20 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Wilkes 2001" YEAR="">
<REFERENCE MODIFIED="2009-05-07 13:03:20 -0400" MODIFIED_BY="Emma M Sydenham" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wilkes N, Woolf R, Mutch M, Mallett S, Peache T, Stephens R, et al</AU>
<TI>The effects of balanced versus saline-based heta-starch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients</TI>
<SO>Anaesthesia and Analgesia</SO>
<YR>2001</YR>
<VL>93</VL>
<NO>4</NO>
<PG>811-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Woods-1993" NAME="Woods 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Woods MS, Kelley H</AU>
<TI>Oncotic pressure, albumin and ileus: the effect of albumin replacement on postoperative ileus</TI>
<SO>The American Surgeon</SO>
<YR>1993</YR>
<VL>59</VL>
<PG>758-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2009-05-07 12:52:35 -0400" MODIFIED_BY="Emma M Sydenham"/>
<ONGOING_STUDIES MODIFIED="2012-11-20 06:47:15 -0500" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-RASP-trial" MODIFIED="2012-05-07 11:11:18 -0400" MODIFIED_BY="[Empty name]" NAME="RASP trial" YEAR="">
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2012-05-31 09:15:10 -0400" MODIFIED_BY="Emma M Sydenham">
<ADDITIONAL_REFERENCES MODIFIED="2012-05-31 09:15:10 -0400" MODIFIED_BY="Emma M Sydenham">
<REFERENCE ID="REF-Armstrong-1994" MODIFIED="2012-05-30 12:55:47 -0400" MODIFIED_BY="Anne Lawson" NAME="Armstrong 1994" TYPE="BOOK">
<AU>Armstrong RF, Bullen C, Cohen SL, Singer M, Webb AR</AU>
<SO>Critical care algorithms</SO>
<YR>1994</YR>
<PB>Oxford University Press</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bickell-1994" NAME="Bickell 1994" TYPE="JOURNAL_ARTICLE">
<AU>Bickell WH, Wall MJ, Pepe PE, Martin R, Ginger VF, Allen MK, et al</AU>
<TI>Immediate versus delayed resuscitation for hypotensive patients with penetrating torso injuries</TI>
<SO>New England Journal of Medicine</SO>
<YR>1994</YR>
<VL>331</VL>
<PG>1105-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bisonni-1991" NAME="Bisonni 1991" TYPE="JOURNAL_ARTICLE">
<AU>Bisonni RS, Holtgrave DR, Lawler F, Marley DS</AU>
<TI>Colloids versus crystalloids in fluid resuscitation: an analysis of randomized controlled trials</TI>
<SO>Journal of Family Practice</SO>
<YR>1991</YR>
<VL>32</VL>
<NO>4</NO>
<PG>387-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Boldt-2009" MODIFIED="2012-05-31 07:16:20 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Boldt 2009" TYPE="JOURNAL_ARTICLE">
<AU>Boldt J, Suttner S, Brosch C, Lehmann A, Roehm K, Mengitsu A</AU>
<TI>Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy</TI>
<SO>Anesthesia &amp; Analgesia</SO>
<YR>2009</YR>
<VL>109</VL>
<PG>1752-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fakhry-1995" NAME="Fakhry 1995" TYPE="JOURNAL_ARTICLE">
<AU>Fakhry SM, Alexander J, Smith D, Meyer AA, Peterson HD</AU>
<TI>Regional and institutional variation in burn care</TI>
<SO>Journal of Burn Care and Rehabilitation</SO>
<YR>1995</YR>
<VL>16</VL>
<NO>1</NO>
<PG>86-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gosling-1998" NAME="Gosling 1998" TYPE="JOURNAL_ARTICLE">
<AU>Gosling P</AU>
<TI>Newer synthetic colloids should not be abandoned</TI>
<SO>BMJ</SO>
<YR>1998</YR>
<VL>317</VL>
<PG>277</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2012-05-31 09:15:10 -0400" MODIFIED_BY="Emma M Sydenham" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Oxman-1994" MODIFIED="2012-05-30 12:56:42 -0400" MODIFIED_BY="Anne Lawson" NAME="Oxman 1994" TYPE="JOURNAL_ARTICLE">
<AU>Oxman AD, Cook DJ, Guyatt GH</AU>
<TI>User's guide to the medical literature. VI. How to use an overview</TI>
<SO>Journal of the American Medical Association</SO>
<YR>1994</YR>
<VL>272</VL>
<PG>1367-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Reinhart-2011" MODIFIED="2012-05-30 12:57:05 -0400" MODIFIED_BY="[Empty name]" NAME="Reinhart 2011" TYPE="JOURNAL_ARTICLE">
<AU>Reinhart K, Takala J</AU>
<TI>Hydroxyethyl starches: what do we still know?</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2011</YR>
<VL>112</VL>
<NO>3</NO>
<PG>507-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Shafer-2011" MODIFIED="2012-05-30 12:57:21 -0400" MODIFIED_BY="[Empty name]" NAME="Shafer 2011" TYPE="JOURNAL_ARTICLE">
<AU>Shafer SL</AU>
<TI>Shadow of doubt</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>2011</YR>
<VL>112</VL>
<NO>3</NO>
<PG>498-500</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Velanovich-1989" NAME="Velanovich 1989" TYPE="JOURNAL_ARTICLE">
<AU>Velanovich V</AU>
<TI>Crystalloid versus colloid fluid resuscitation: a meta-analysis of mortality</TI>
<SO>Surgery</SO>
<YR>1989</YR>
<VL>105</VL>
<NO>1</NO>
<PG>65-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vermeulen-1995" NAME="Vermeulen 1995" TYPE="JOURNAL_ARTICLE">
<AU>Vermeulen LC, Ratko TA, Erstad BL, Brecher ME, Matuszewski KA</AU>
<TI>A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1995</YR>
<VL>155</VL>
<NO>4</NO>
<PG>373-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Victorian-DUAC-1991" NAME="Victorian DUAC 1991" TYPE="JOURNAL_ARTICLE">
<AU>Subcommittee of the Victorian Drug Usage Advisory Committee</AU>
<TI>Human albumin solutions: an audit of use in three major metropolitan hospitals</TI>
<SO>Medical Journal of Australia</SO>
<YR>1991</YR>
<VL>154</VL>
<NO>10</NO>
<PG>657-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Yim-1995" NAME="Yim 1995" TYPE="JOURNAL_ARTICLE">
<AU>Yim JM, Vermeulen LC, Erstad BL, Matuszewski KA, Burnett DA, Vlasses PH</AU>
<TI>Albumin and nonprotein colloid solution use in US academic health centers</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1995</YR>
<VL>155</VL>
<NO>22</NO>
<PG>2450-5</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES>
<REFERENCE ID="REF-Schierhout-1998" NAME="Schierhout 1998" TYPE="JOURNAL_ARTICLE">
<AU>Schierhout G, Roberts I</AU>
<TI>Fluid resuscitation with colloids or crystalloid solutions in critically ill patients: a systematic review of randomised controlled trials</TI>
<SO>BMJ</SO>
<YR>1998</YR>
<VL>316</VL>
<PG>961-4</PG>
<IDENTIFIERS/>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2011-02-16 07:48:34 -0500" MODIFIED_BY="Emma M Sydenham"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2013-01-31 00:17:38 -0500" MODIFIED_BY="Emma M Sydenham">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2013-01-31 00:17:38 -0500" MODIFIED_BY="Emma M Sydenham" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2012-05-31 06:40:35 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Boldt-1986">
<CHAR_METHODS MODIFIED="2012-05-30 08:32:37 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, using sealed opaque envelopes<BR/>Information on allocation concealment was obtained on contact with the authors<BR/>Blinding and loss to follow-up not mentioned</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-31 06:40:35 -0400" MODIFIED_BY="Anne Lawson">
<P>55 patients undergoing elective aorta-coronary bypass surgery<BR/>Exclusion criteria: ejection fraction &lt; 50% and LVEDP &gt; 15 mmHg<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 11:47:27 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>300 mL 20% Human albumin solution (n = 15)</LI>
<LI>500 mL 3% HES (n = 13)</LI>
<LI>500 mL 3.5% Gelatin (n = 14)</LI>
<LI>No colloid (n = 13)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 08:33:04 -0400" MODIFIED_BY="Anne Lawson">
<P>Haemodynamic variables were measured<BR/>Deaths not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:43:59 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up until discharge from ICU</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:01 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Boldt-1993">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:00 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation concealment by sealed opaque envelopes (information from author)<BR/>Blinding and loss to follow-up not mentioned<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 11:43:14 -0400" MODIFIED_BY="Anne Lawson">
<P>75 males undergoing elective aortocoronary bypass grafting, who had a pulmonary capillary WP &lt; 5 mmHg after induction of anaesthesia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 08:34:23 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>5% Albumin (n = 15)</LI>
<LI>6% HES, mean molecular weight 450,000 (n = 15)</LI>
<LI>6% HES, mean molecular weight 200,000 (n = 15)</LI>
<LI>3.5% Gelatin (n = 15)</LI>
<LI>No colloid (n = 15)</LI>
</OL>
<P>Fluid used through operation and on intensive care postoperatively<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 08:34:29 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths not reported, author confirmed there were no deaths<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:01 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to 1 day</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 13:10:54 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Boldt-2001">
<CHAR_METHODS MODIFIED="2012-05-30 10:50:49 -0400" MODIFIED_BY="Anne Lawson">
<P>RCT, using a closed-envelope system</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 08:34:39 -0400" MODIFIED_BY="Anne Lawson">
<P>100 patients undergoing major abdominal surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 13:10:54 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>Ringer's lactate (n = 25)</LI>
<LI>6% HES, mean molecular weight 200 kDa, degree of substitution 0.5 (n = 25)</LI>
<LI>6% HES, mean molecular weight 130 kDa, degree of substitution 0.4 (n = 25)</LI>
<LI>4% Modified fluid gelatin, molecular weight 35 kDa (n = 25)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 08:35:05 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths<BR/>Orthostatic problems<BR/>Haemodynamics and laboratory data<BR/>Fluid input and output<BR/>Costs</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 08:35:06 -0400" MODIFIED_BY="[Empty name]">
<P>Follow-up period unclear</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:02 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Boutros-1979">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:01 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT ("randomly divided"), method of allocation concealment not described<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 08:35:15 -0400" MODIFIED_BY="Anne Lawson">
<P>24 people undergoing major operative procedures on the abdominal aorta</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 08:35:27 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>Albumin in 5% dextrose (n = 7)</LI>
<LI>5% Dextrose and Ringer's lactate (n = 8)</LI>
<LI>5% Dextrose in 0.45% saline (n = 9)</LI>
</OL>
<P>Allocated fluids were used on admission to ICU, following surgery, guided by PAWP. Whole blood also given if clinically needed</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 08:35:43 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:02 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to discharge from hospital</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:47:29 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Bowser_x002d_Wallace-1986">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:03 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Quasi-RCT, allocation by alternation<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 08:36:01 -0400" MODIFIED_BY="Anne Lawson">
<P>Admitted for burns of 30% or more<BR/>Age range 5 months to 21 years<BR/>Excluded if already given more than half calculated daily requirement before reaching hospital</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 11:47:29 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>2 mL/kg/%burn Ringer's lactate over 24 hours, then 0.5 mL plasmanate/kg/%burn over 24 hours plus 5% dextrose (n = 19)</LI>
<LI>2 mL/kg/%burn hypertonic lactated saline over 24 hours, then 0.6 mL/kg/%burn hypertonic lactated saline over 24 hours plus oral Haldane's solution (n = 19)</LI>
</OL>
<P>IV fluids stopped at 48 hours (n = 19)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 08:37:07 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported<BR/>Fluid and electrolytes given, weight, haematocrit</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:03 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to 5 days</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 07:37:04 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Brunkhorst-2008">
<CHAR_METHODS MODIFIED="2012-05-31 07:37:04 -0400" MODIFIED_BY="[Empty name]">
<P>Multicentre, RCT</P>
<P>Blinding not mentioned</P>
<P>Use of a 2 x 2 factorial, open label study design</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 11:47:29 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Critically ill patients with severe sepsis or septic shock of at least 18 years of age. Excluded if onset of symptoms commenced &gt; 24 hours before admission to the ICU, if the symptoms commenced &gt; 12 hours after onset in the ICU or if patient had received more than 1000 mL of HES in the 24 hours before randomisation</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-31 06:53:27 -0400" MODIFIED_BY="Emma M Sydenham"/>
<CHAR_OUTCOMES MODIFIED="2012-05-30 08:38:02 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Deaths reported at 28 and 90 days. 90-day mortality rate was cited as it marked the end of the follow-up period</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 08:38:03 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:54:14 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bulger-2011">
<CHAR_METHODS MODIFIED="2012-05-30 10:51:04 -0400" MODIFIED_BY="[Empty name]">
<P>Double-blind RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 08:44:16 -0400" MODIFIED_BY="[Empty name]">
<P>15 years or older with hypovolaemic shock (&lt; 70 mmHg SBP or SBP 71 mmHg to &lt; 90 mmHg and HR &lt; 108 bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-31 06:54:14 -0400" MODIFIED_BY="[Empty name]">
<OL>
<LI>7.5% saline per 6% dextran (n = 220)</LI>
<LI>0.9% saline (n = 376)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 08:39:36 -0400" MODIFIED_BY="[Empty name]">
<P>Primary outcome: 28-day survival </P>
<P>Secondary outcomes: fluid and blood requirements, ARDS, MODS and nosocomial infections</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 08:39:49 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:47:31 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Chavez_x002d_Negrete-1991">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:04 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation by "random numbers"<BR/>Blinding not mentioned<BR/>No loss to follow-up<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 10:45:40 -0400" MODIFIED_BY="Anne Lawson">
<P>Adults admitted to an emergency department with acute GI haemorrhage, SBP &#8804; 90 mmHg for up to 1 hour and normal ECG<BR/>Excluded if pregnant or had renal, cardiac or neurological disease</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 11:47:31 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>Initial infusion of 250 mL 7.5% saline/6% dextran 60 given IV (16 patients) or intraosseous (n = 10)</LI>
<LI>Initial IV infusion of 250 mL Ringer's lactate (n = 23)</LI>
</OL>
<P>Resuscitation continued with red cells, 0.9% saline and dextran 40 according to clinical judgement</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 08:41:48 -0400" MODIFIED_BY="Anne Lawson">
<P>Death<BR/>Haemodynamic variables</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:04 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to 24 hours</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:06 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Cifra-2003">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:05 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Quasi-RCT (allocation by alternation), allocation concealment not reported<BR/>Blinding not reported<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 08:42:11 -0400" MODIFIED_BY="Emma M Sydenham">
<P>27 children with dengue shock syndrome<BR/>Exclusion criteria included: other severe infection, protein-deficient abnormalities, bleeding diathesis, patients who have been given multiple plasma substitutes<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 08:42:33 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>6% Haes-Steril (n = 11)</LI>
<LI>Ringer's lactate (n = 16)</LI>
</OL>
<P>1 patient from group 1 and 3 patients from group 2 were excluded because they needed inotropic support and multiple plasma substitute</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 08:42:50 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Duration of control of shock<BR/>Recurrence of shock<BR/>Length of ICU stay<BR/>Death not reported as an outcome but they reported that 4 patients died</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:06 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Length of follow-up not reported but all outcomes were in hospital</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:54:38 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cooper-2006">
<CHAR_METHODS MODIFIED="2012-05-30 08:44:39 -0400" MODIFIED_BY="[Empty name]">
<P>Multicentre unblinded controlled trial with stratified block randomisation by centre and mortality prediction at enrolment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 08:43:26 -0400" MODIFIED_BY="[Empty name]">
<P>Patients with cutaneous thermal burns of at least 20% TBSA within 12 hours of injury</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-31 06:54:38 -0400" MODIFIED_BY="[Empty name]">
<OL>
<LI>Ringer lactate and 5% albumin (n = 19)</LI>
<LI>Ringer lactate (n = 23)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 08:43:58 -0400" MODIFIED_BY="[Empty name]">
<P>Primary outcome was MODS</P>
<P>Mortality was reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 08:43:55 -0400" MODIFIED_BY="[Empty name]">
<P>The trial was suspended due to slow enrolment</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:07 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Dawidson-1991">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:06 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation by drawing a card from a deck<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 08:45:14 -0400" MODIFIED_BY="Anne Lawson">
<P>Adults undergoing elective abdominal aortic surgery<BR/>No exclusions mentioned</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 08:45:27 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>3% Dextran 70 in Ringer's lactate (n = 10)</LI>
<LI>IV Ringer's lactate (n = 10)</LI>
</OL>
<P>Fluid used during and for 24 hours after operation, guided by haemodynamic variables</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 08:45:30 -0400" MODIFIED_BY="Anne Lawson">
<P>Death<BR/>Volume transfused, weight change, haemodynamic variables</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:07 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to discharge from hospital</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:07 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Dehne-2001">
<CHAR_METHODS MODIFIED="2012-05-30 10:53:36 -0400" MODIFIED_BY="Anne Lawson">
<P>RCT, allocation by sealed envelope assignment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 08:47:28 -0400" MODIFIED_BY="Anne Lawson">
<P>60 male patients (of ASA physical status 1 or 2) scheduled for middle ear surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 08:48:09 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>Ringer's lactate solution (n = 15)</LI>
<LI>6% HES: molecular weight 200 kDa, degree of substitution 0.5 (n = 15)</LI>
<LI>6% HES: molecular weight 200 kDa, degree of substitution 0.60 to 0.66 (n = 15)</LI>
<LI>6% HES: molecular weight 450 kDa, degree of substitution 0.7 (n = 15)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 08:48:21 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths not stated but 'all' patients discharged 10 to 14 days after surgery; therefore no deaths<BR/>Central venous pressure<BR/>Urine output<BR/>Blood osmolality<BR/>Urine osmolality</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:07 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up 2 days</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:55:03 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Du-2011">
<CHAR_METHODS MODIFIED="2012-05-30 08:48:28 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised controlled study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-02 07:44:49 -0400" MODIFIED_BY="[Empty name]">
<P>Participants had confirmed diagnosis of severe acute pancreatitis. Patients were included within 72 hours after the onset of symptoms </P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-31 06:55:03 -0400" MODIFIED_BY="[Empty name]">
<OL>
<LI>6% HES 130/0.4 (n = 20)</LI>
<LI>Ringer's lactate (n = 21)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 08:49:21 -0400" MODIFIED_BY="[Empty name]">
<P>Primary outcome was intra-abdominal pressure. They also reported in-hospital mortality, organ complications, inflammatory markers and fluid requirement</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-02 07:49:41 -0400" MODIFIED_BY="[Empty name]">
<P>Patients were excluded if they died within 72 hours after admission</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:55:19 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dubin-2010">
<CHAR_METHODS MODIFIED="2012-05-30 10:51:10 -0400" MODIFIED_BY="[Empty name]">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 08:49:34 -0400" MODIFIED_BY="[Empty name]">
<P>Patients with severe sepsis</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-31 06:55:19 -0400" MODIFIED_BY="[Empty name]">
<OL>
<LI>6% HES 130/0.4 (n = 12)</LI>
<LI>Normal saline (n = 13)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 08:49:50 -0400" MODIFIED_BY="[Empty name]">
<P>Sublingual microcirculation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-31 06:49:55 -0400" MODIFIED_BY="[Empty name]">
<P>Data on mortality are not clear from the report</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:08 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Eleftheriadis-1995">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:08 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Patients "randomizedly distributed"<BR/>Blinding not mentioned<BR/>Unable to assess loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 08:50:01 -0400" MODIFIED_BY="Anne Lawson">
<P>Participants were undergoing coronary artery bypass surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 08:50:17 -0400" MODIFIED_BY="[Empty name]">
<OL>
<LI>6% HES</LI>
<LI>3.5% Gelatin</LI>
<LI>Ringer's lactate</LI>
</OL>
<P>Allocated fluid was used in the postoperative period only guided by mean arterial pressure</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 08:50:21 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths were not reported<BR/>Haemodynamic variables</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:08 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up period unspecified</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:10 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Ernest-1999">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:09 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation concealment not described<BR/>No blinding<BR/>No loss to follow-up mentioned</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 08:50:28 -0400" MODIFIED_BY="Anne Lawson">
<P>Patients with a clinical diagnosis of sepsis</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 08:50:37 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>5% Albumin (n = 9)</LI>
<LI>0.9% Saline (n = 9)</LI>
</OL>
<P>Volume of infusion guided by PAWP</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 08:50:42 -0400" MODIFIED_BY="Anne Lawson">
<P>Haemodynamic variables and volume measurements<BR/>Deaths not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:10 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to immediately after infusion</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 07:06:41 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Evans-1996">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:10 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Quasi-randomised trial, allocation by day of the week<BR/>Blinding not mentioned<BR/>No loss to follow-up<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 08:51:25 -0400" MODIFIED_BY="Anne Lawson">
<P>Aged &#8805; 16 years, admitted with trauma to an emergency centre within 2 hours after injury, only crystalloid as a pre-hospital infusion<BR/>Excluded if had underlying illness likely to affect clotting</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-31 07:06:41 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>IV Haemaccel (n = 11)</LI>
<LI>IV Ringer's lactate (n = 14)</LI>
</OL>
<P>Fluid was used until vital signs were stable</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 08:51:31 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths from author<BR/>Clotting variables</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:11 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up period unspecified</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:41:03 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Evans-2003">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:11 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation concealment not reported<BR/>Blinding methods not reported<BR/>Loss to follow-up not reported</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-31 06:41:03 -0400" MODIFIED_BY="Anne Lawson">
<P>55 patients undergoing primary unilateral total hip replacement<BR/>Exclusion criteria: pre-existing defect in platelet function or on aspirin that could not be stopped for 2 weeks prior to the operation</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 08:51:50 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>4.5% Albumin (n = 13)</LI>
<LI>Gelofusine (n = 14)</LI>
<LI>Haemaccel (n = 14)</LI>
<LI>0.9% Saline (n = 14)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 08:51:58 -0400" MODIFIED_BY="Anne Lawson">
<P>Haemostatic parameters<BR/>Death not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:12 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Length of follow-up not reported but all outcomes were in-hospital</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:41:15 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Fries-2004">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:12 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, patients "randomly" received crystalloid or colloids<BR/>Method of allocation concealment not reported<BR/>Blinding not reported<BR/>Loss to follow-up not reported</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-31 06:41:15 -0400" MODIFIED_BY="Anne Lawson">
<P>60 patients undergoing knee replacement surgery<BR/>Exclusion criteria: contraindication for regional anaesthesia, known allergies or haemostatic disorders</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 08:52:25 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>HES (n = 20)</LI>
<LI>Modified gelatin (n = 20)</LI>
<LI>Ringer's solution (n = 20)</LI>
</OL>
<P>Groups 1 and 2 also received a basis of Ringer's solution infusion</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 08:52:27 -0400" MODIFIED_BY="Anne Lawson">
<P>Coagulation parameters<BR/>Death not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:13 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Length of follow-up not reported but all outcomes were in-hospital measures</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 08:42:58 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Gallagher-1985">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:14 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, method of allocation concealment not described. Author contacted - allocation concealment by computerised system - patient details were entered before treatment assignment was revealed<BR/>Blinding not mentioned<BR/>No loss to follow-up<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-31 06:41:27 -0400" MODIFIED_BY="Anne Lawson">
<P>Patients after coronary artery bypass graft surgery<BR/>Exclusion criteria: patients with significant left main coronary artery stenosis, poor left ventricular function or poor pulmonary function</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-31 08:42:58 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>IV 5% albumin (n = 5)</LI>
<LI>IV 6% HES (n = 5)</LI>
<LI>IV Ringer's lactate (n = 5)</LI>
</OL>
<P>Fluid used from admission to ICU post operation, guided by PAWP. RBC given if needed</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 08:55:02 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths were not reported. Author contacted and confirmed that there were no deaths in any group<BR/>Haemodynamic data</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 08:55:04 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to 1 day</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 08:46:42 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Goodwin-1983">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:14 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, assigned by "random numbers table", method of allocation concealment unclear<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 08:56:06 -0400" MODIFIED_BY="Anne Lawson">
<P>79 previously healthy young adults admitted with burns<BR/>No exclusion criteria reported</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 11:47:32 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>2.5% Albumin in Ringer's lactate (n = 40)</LI>
<LI>Ringer's lactate (n = 39)</LI>
</OL>
<P>Fluids on day 1 guided by haemodynamic variable. On day 2, given at 0.3 to 0.5 mL/kg/%burn, then 5% dextrose<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-31 08:46:42 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported<BR/>Pulmonary oedema</P>
<P>Infections</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:15 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to discharge from hospital</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:41:35 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Grundmann-1982">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:16 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, method of allocation concealment unclear<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-31 06:41:35 -0400" MODIFIED_BY="Anne Lawson">
<P>20 people undergoing partial gastrectomy<BR/>The average age was 50 years (range 19 to 84 years)<BR/>No exclusion criteria reported</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:00:26 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>Colloid group received human albumin solution (n = 14)</LI>
<LI>Details of crystalloid were not reported (n = 6)</LI>
</OL>
<P>Allocated fluid was continued for 4 days after operation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:00:32 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported<BR/>Volumes of fluid given<BR/>Haemodynamic variables</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:16 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to discharge from hospital</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-31 00:14:52 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Guidet-2012">
<CHAR_METHODS MODIFIED="2013-01-31 00:14:24 -0500" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Double blind</P>
<P>Sequence generation not reported</P>
<P>Two arms were identical in appearance, labelled with randomisation numbers</P>
<P>1 outcome from each group missing at day 90</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-19 08:41:37 -0500" MODIFIED_BY="[Empty name]">
<P>196 patients aged &#8805;18 years, who required fluid resuscitation, and who had clinically defined severe sepsis</P>
<P>Exclusion criteria: Known serum creatinine &gt;3.39 mg/d, Anuria lasting more than 8 hours despite fluid resuscitation, Requirement for renal support</P>
<P>Setting: Germany and France</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-31 00:14:50 -0500" MODIFIED_BY="[Empty name]">
<P>1. 6% HES 130/0.4 (n=100)</P>
<P>2. sodium chloride (NaCl 0.9%) (n=96)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-31 00:14:52 -0500" MODIFIED_BY="[Empty name]">
<P>The primary endpoint was the amount of study drug required to achieve initial HDS The secondary objectives were time taken to achieve initial HDS, total quantity of study drug infused, length of stay (LOS) in the ICU, Sequential Organ Failure Assessment (SOFA) score and kidney function</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:41:46 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Guo-2003">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:17 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation concealment not reported<BR/>Blinding not reported<BR/>No loss to follow-up reported</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-31 06:41:46 -0400" MODIFIED_BY="Emma M Sydenham">
<P>42 patients undergoing elective cytoreductive surgery for ovarian cancer<BR/>Exclusion criteria: preoperative anaemia, allergic response to HES or perioperative administration of cardiovascular agents<BR/>2 patients randomised but excluded because of use of cardiovascular agents</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:00:54 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>Ringer's lactate (n = 20)</LI>
<LI>6% HES (n = 20)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:01:05 -0400" MODIFIED_BY="Anne Lawson">
<P>Splanchnic perfusion<BR/>Death not reported but in results authors mentioned that "all patients were discharged"</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:17 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to discharge from hospital</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 13:10:15 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Hall-1978">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:18 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Quasi-RCT (participants were stratified by age, extent of burn and aetiology, and then allocated by alternation)<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:01:34 -0400" MODIFIED_BY="Anne Lawson">
<P>Burns covering &gt; 10% of the body surface (for children), and &gt; 15% of the body surface (for adults)<BR/>No exclusions mentioned</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 13:10:15 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>120 mL/%burn IV 6% dextran 70 in 0.9% saline over 48 hours plus oral water or IV 5% dextrose for 'metabolic requirements' (n = 86)</LI>
<LI>4 mL/kg/%burn IV Ringer's lactate over 24 hours, then 10% of initial body weight of fluid over 24 hours plus oral water (n = 86)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:02:06 -0400" MODIFIED_BY="Anne Lawson">
<P>Death<BR/>Fluid given, haemodynamic variables</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:18 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to discharge from hospital</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:42:01 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Hartmann-1993">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:19 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, method of allocation unclear<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-31 06:42:01 -0400" MODIFIED_BY="Anne Lawson">
<P>Adults undergoing major abdominal surgery<BR/>Exclusion criteria: cardiorespiratory dysfunction, uraemia, diabetes, taking steroids, anticoagulants or diuretics</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:02:46 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>IV Dextran 70 in saline (concentration not given) with 2.5% dextrose (n = 15)</LI>
<LI>IV Saline (concentration not given) with 2.5% dextrose (n = 14)</LI>
</OL>
<P>Both groups given red cells, plasma, dextran 70 and crystalloids during the operation as decided by the clinician. Postoperative fluids according to the trial group guided by tissue oxygen tension to the end of resuscitation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:02:51 -0400" MODIFIED_BY="Anne Lawson">
<P>Death not reported<BR/>Fluid given, haemodynamic variables</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:20 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to 7 days</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-17 11:11:49 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-James-2011">
<CHAR_METHODS MODIFIED="2012-05-30 10:56:03 -0400" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Double-blind</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:03:12 -0400" MODIFIED_BY="[Empty name]">
<P>Patients with blunt or penetrating trauma requiring more than 3 L volume resuscitation (blunt and penetrating trauma patients were randomised separately)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-31 06:55:59 -0400" MODIFIED_BY="[Empty name]">
<OL>
<LI>HES 130/0.4, penetrating trauma (n = 36)</LI>
<LI>0.9% Saline, penetrating trauma (n = 34)</LI>
<LI>HES 130/0.4, blunt trauma (n = 22)</LI>
<LI>0.9% Saline, blunt trauma (n = 23)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:04:03 -0400" MODIFIED_BY="[Empty name]">
<P>Primary outcomes were the volumes of first fluid needed in the first 24 hours, and normal GI function by day 5</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-01-17 11:11:49 -0500" MODIFIED_BY="[Empty name]">
<P>Mortality was not reported on the main publication but it was available from an author's reply .</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 08:31:04 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Jelenko-1978">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:20 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, method of allocation concealment unclear<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:04:19 -0400" MODIFIED_BY="Anne Lawson">
<P>19 people with burns covering more than 20% of body surface</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-31 08:31:04 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>12.5% Albumin in hypertonic saline (240 mEq/L sodium, 120 mEq/L chloride, 120 mEq/L lactate) (n = 7)</LI>
<LI>Hypertonic saline (240 mEq/L sodium, 120 mEq/L chloride, 120 mEq/L lactate) (n = 5)</LI>
<LI>Ringer's lactate (n = 7)</LI>
</OL>
<P>Allocated fluid was used, guided by haemodynamic variables, to the end of resuscitation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:05:05 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported<BR/>Haemodynamic variables</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:21 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to end of resuscitation</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 08:46:48 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Karanko-1987">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:21 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, description of allocation procedure unclear<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-31 06:42:11 -0400" MODIFIED_BY="Anne Lawson">
<P>32 adult men scheduled for coronary artery bypass surgery<BR/>Exclusion criteria: LVEF &lt; 40%, abnormal lung function</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:05:41 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>6% Dextran 70 (n = 14)</LI>
<LI>Ringer's lactate (n = 18)</LI>
</OL>
<P>Allocated fluid was used to the end of resuscitation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-31 08:46:48 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported<BR/>Haemodynamic variables<BR/>Pulmonary oedema</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:22 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up 2 weeks<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:22 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Lang-2001">
<CHAR_METHODS MODIFIED="2012-05-30 10:51:32 -0400" MODIFIED_BY="Anne Lawson">
<P>RCT, using a closed-envelope system</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:08:07 -0400" MODIFIED_BY="Anne Lawson">
<P>42 patients scheduled for elective major abdominal surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:08:22 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>Ringer's lactate (n = 21)</LI>
<LI>6% HES, molecular weight 139 kDa, degree of substitution 0.4 (n = 21)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:08:26 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths<BR/>Haemodynamics and laboratory data<BR/>Tissue oxygenation<BR/>Volume input and output</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:22 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up period unclear</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:42:18 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Lang-2003">
<CHAR_METHODS MODIFIED="2012-05-30 11:01:39 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation concealment not clearly reported ("closed envelope system")<BR/>Blinding method not reported ("...treatment in the ICU was performed by physicians who were blinded to the study")</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-31 06:42:18 -0400" MODIFIED_BY="Anne Lawson">
<P>36 patients undergoing elective major abdominal surgery<BR/>Exclusion criteria: myocardial failure, renal insufficiency, severe pulmonary disease, liver dysfunction, diabetes mellitus, steroid therapy, pre-existing viral or bacterial infection and known allergic reactions to starch preparations</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:15:02 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>6% HES (n = 18)</LI>
<LI>Ringer's lactate (n = 18)</LI>
</OL>
<P>Additional crystalloid solutions were supplied to equalise insensible fluid loss or as a solvent for drugs in group 1</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:15:23 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Pro- and anti-inflammatory cytokines<BR/>All patients survived</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:23 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Length of follow-up not reported but all outcomes were in-hospital measures</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-19 09:09:12 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lee-2011">
<CHAR_METHODS MODIFIED="2012-11-19 09:02:14 -0500" MODIFIED_BY="[Empty name]">
<P>RCT method of allocation concealment not reported</P>
<P>open label trial but the endpoints were assessed blindly</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-19 09:05:37 -0500" MODIFIED_BY="[Empty name]">
<P>106 patients undergoing off-pump coronary artery bypass surgery and receiving with dual antiplatelet therapy (DAPT) within 5 days of surgery</P>
<P>Exclusion criteria: emergency surgery, myocardial infarction (MI), history of previous cardiac surgery, history of bleeding diathesis or hepatic dysfunction, left ventricular ejection fraction &lt;40%,hemoglobin &lt;12 g/dl, platelet count &lt;100,000 mm3, abnormal<BR/>prothrombin time (international normalization ratio [INR]) and activated partial thromboplastin time (aPTT), creatinine &gt;1.4 mg/dl, and use of glycoprotein IIb/IIIa inhibitors</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-19 09:08:24 -0500" MODIFIED_BY="[Empty name]">
<P>1. HES 130/0.4 (n=53)</P>
<P>2. Crystalloids (n=53)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-19 09:08:46 -0500" MODIFIED_BY="[Empty name]">
<P>Blood loss, infused fluid volume, urine output, and transfusion requirements, stroke, renal dysfunction, cardiac surgery reoperation, prolonged ventilation, wound infection</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-11-19 09:09:12 -0500" MODIFIED_BY="[Empty name]">
<P>Death not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:24 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Ley-1990">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:24 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, method of allocation concealment unclear<BR/>Assessment of chest x-ray blinded<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:15:54 -0400" MODIFIED_BY="Anne Lawson">
<P>21 people undergoing coronary artery bypass grafting or valve surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:16:25 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>6% Hetastarch up to 1.5 L then 5% plasma protein fraction (n = 11)</LI>
<LI>0.9% Saline (n = 10)</LI>
</OL>
<P>Allocated fluid was used for postoperative fluid resuscitation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:16:34 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths were not reported<BR/>Pulmonary and peripheral oedema<BR/>Haemodynamic variables</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:24 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to discharge</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:25 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Lowe-1977">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:25 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation by sealed envelopes<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:16:41 -0400" MODIFIED_BY="Anne Lawson">
<P>Participants with serious trauma</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:16:52 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>25% Albumin in Ringer's lactate (n = 77)</LI>
<LI>Ringer's lactate (n = 94)</LI>
</OL>
<P>Allocated fluid was used throughout the pre- and intraoperative period</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:16:54 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:25 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to 5 days postoperatively. Data on the 30 participants with chest injuries who were left out of the <LINK REF="STD-Lowe-1977" TYPE="STUDY">Lowe 1977</LINK> report, but included in Moss 1981, have been included in the meta-analysis</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:56:22 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lu-2012">
<CHAR_METHODS MODIFIED="2012-05-02 08:26:29 -0400" MODIFIED_BY="[Empty name]">
<P>Randomised controlled study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-02 08:26:55 -0400" MODIFIED_BY="[Empty name]">
<P>42 patients with septic shock </P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-31 06:56:22 -0400" MODIFIED_BY="[Empty name]">
<OL>
<LI>Ringer's lactate (n = 20)</LI>
<LI>HES 130/0.4 (n = 22)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:19:48 -0400" MODIFIED_BY="[Empty name]">
<P>Mortality, fluid replacement, use of vasoactive drugs and inflammatory markers</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 09:20:00 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:32:15 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Lucas-1978">
<CHAR_METHODS MODIFIED="2012-05-30 11:04:52 -0400" MODIFIED_BY="Anne Lawson">
<P>RCT, randomisation was based on the last digit of each patient's case number</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:20:07 -0400" MODIFIED_BY="Anne Lawson">
<P>52 seriously injured patients</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-31 06:32:15 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>Standard resuscitation regimen ('balanced electrolyte', blood, fresh frozen plasma) plus salt-poor albumin, maximum 150 g during surgery and 150 g/day for the next 5 days (n = 27)</LI>
<LI>Standard resuscitation regimen as above (n = 25)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:23:55 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported in some patients</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 09:23:56 -0400" MODIFIED_BY="Anne Lawson">
<P>In the final report of 94 randomised patients deaths were not reported. However, in this preliminary report of 52 injured patients deaths were reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:42:32 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Maitland-2005">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:26 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, open label, random allocation was assigned by the use of sealed cards<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-31 06:42:32 -0400" MODIFIED_BY="Anne Lawson">
<P>159 children with severe malaria and metabolic acidosis<BR/>Exclusion criteria: pulmonary oedema, oedematous malnutrition or papilloedema</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:24:49 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Severe acidosis</P>
<OL>
<LI>4.5% Albumin (n = 23)</LI>
<LI>0.9% Saline (n = 26)</LI>
</OL>
<P>Moderate acidosis</P>
<OL>
<LI>4.5% Albumin (n = 33)</LI>
<LI>0.9% Saline (n = 35)</LI>
<LI>Control (n = 33)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:24:56 -0400" MODIFIED_BY="Anne Lawson">
<P>Reduction in base deficit<BR/>Neurological sequelae<BR/>Death reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:26 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Length of follow-up not reported but all outcomes were in-hospital measures</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:56:41 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Maitland-2011">
<CHAR_METHODS MODIFIED="2012-05-30 11:05:47 -0400" MODIFIED_BY="[Empty name]">
<P>2 stratum multicentre open, RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:25:33 -0400" MODIFIED_BY="[Empty name]">
<P>Children aged between 60 days and 12 years, with severe febrile illness, randomly assigned within 2 strata (stratum A was children with severe febrile illness and impaired perfusion but without severe hypotension; stratum B was children with severe hypotension)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-31 06:56:41 -0400" MODIFIED_BY="[Empty name]">
<P>Children were randomly allocated to rapid volume replacement over the course of 1 hour with either:</P>
<OL>
<LI>20 mL 5% Human albumin solution per kg body weight (n = 1063)</LI>
<LI>20 mL 0.9% Saline solution per kg body weight (n = 1063)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-02 17:30:33 -0400" MODIFIED_BY="[Empty name]">
<P>Mortality at 4 weeks after randomisation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:46:14 -0400" MODIFIED_BY="[Empty name]">
<P>Children (n = 1044) assigned to no treatment were not included in the analysis</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-31 00:16:20 -0500" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Mattox-1991">
<CHAR_METHODS MODIFIED="2013-01-31 00:16:20 -0500" MODIFIED_BY="Anne Lawson">
<P>Randomised, allocation by alternation<BR/>Double-blind<BR/>2 patients excluded from the analysis as code of fluid lost<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:28:04 -0400" MODIFIED_BY="Anne Lawson">
<P>Participants were pre-hospital trauma victims attended to by emergency personnel within 1 hour of injury, with SBP &#8804; 90 mmHg, &#8805; 16 years. 72% of participants had sustained penetrating trauma</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 11:47:53 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>250 mL Dextran 70 in 7.5% saline (n = 211)</LI>
<LI>250 mL Ringer's lactate, saline or plasmalyte (n = 211)</LI>
</OL>
<P>Allocated fluid was for initial pre-hospital resuscitation only</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:28:15 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:27 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to hospital discharge or transfer</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 07:08:30 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Mazher-1998">
<CHAR_METHODS MODIFIED="2012-05-31 06:48:47 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Patients "randomized"<BR/>Blinding of carers by use of pharmacy-prepared solutions<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-31 06:42:40 -0400" MODIFIED_BY="Anne Lawson">
<P>Patients undergoing elective coronary artery surgery<BR/>Exclusion criteria: age &gt; 75 years, ejection fraction &lt; 35%, creatinine &gt; 135 &#956;mol/L, ACE inhibitors</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-31 07:08:30 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>5 mL/kg Polygeline (n = 10)</LI>
<LI>5 mL/kg 7.2% Saline (n = 10)</LI>
</OL>
<P>Allocated fluid given postoperatively over 1 hour. All patients subsequently receive polygeline and RBCs</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:30:22 -0400" MODIFIED_BY="Anne Lawson">
<P>Haemodynamic variables<BR/>Death</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:28 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to discharge from ICU</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:57:08 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McIntyre-2008">
<CHAR_METHODS MODIFIED="2012-05-30 10:51:37 -0400" MODIFIED_BY="[Empty name]">
<P>A feasibility RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:30:47 -0400" MODIFIED_BY="[Empty name]">
<P>Patients with early septic shock defined with at least 2 systemic inflammatory response syndrome criteria, infectious source and persistent hypotension after &gt; 1 L of crystalloid fluid</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-31 06:57:08 -0400" MODIFIED_BY="[Empty name]">
<OL>
<LI>Normal saline (n = 19)</LI>
<LI>Pentastarch (n = 21)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:31:07 -0400" MODIFIED_BY="[Empty name]">
<P>Primary outcomes were feasibility measures for the pilot RCT. ICU and 28-day mortality were also reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 09:31:09 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:30 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-McNulty-1993">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:29 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, method of allocation concealment not described<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:31:33 -0400" MODIFIED_BY="Anne Lawson">
<P>Patients following elective cardiopulmonary bypass</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:31:38 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>5% Albumin and cell-saved blood (n = 14)</LI>
<LI>Plasmalyte and cell-saved blood (n = 14)</LI>
</OL>
<P>Allocated fluid used as part of fluid volume replacement</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:31:57 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths not reported<BR/>Study was designed to look at the effect of protein infusion on the accuracy of a haematocrit measuring device</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:30 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Length of follow-up unspecified</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:31 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Metildi-1984">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:30 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:32:51 -0400" MODIFIED_BY="Anne Lawson">
<P>Participants were admissions to an ICU and a trauma unit with ARDS and established pulmonary failure. Included both trauma and non-trauma patients</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:33:13 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>5% Salt-poor albumin (n = 20)</LI>
<LI>Ringer's lactate (n = 26)</LI>
</OL>
<P>Allocated fluid was used throughout resuscitation, and if an operation was required the allocated fluid was used for volume replacement before and during the operation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:33:15 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported<BR/>Haemodynamic variables</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:31 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to discharge</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-31 00:17:21 -0500" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Modig-1983">
<CHAR_METHODS MODIFIED="2013-01-31 00:17:21 -0500" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation by admission date<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:33:48 -0400" MODIFIED_BY="Anne Lawson">
<P>Participants were trauma admissions to an emergency department with SBP &lt; 70 mmHg. Age range 20 to 58 years</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:34:04 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>Dextran 70 in Ringer's lactate (n = 12)</LI>
<LI>Ringer's lactate (n = 11)</LI>
</OL>
<P>Allocated fluids were given as the initial resuscitation fluid on admission to the emergency department, and continued as needed until after the 6th day when major reconstructive surgery was undertaken</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:34:18 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported<BR/>Development of ARDS</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:32 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to definitive reconstructive surgery</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:57:26 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Moretti-2003">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:32 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation concealment method not clearly reported ("Patients randomized...by using a closed-envelope technique")<BR/>Blinding method not clearly reported ("Researchers were unaware of the patient's randomization")<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-31 06:57:26 -0400" MODIFIED_BY="Emma M Sydenham">
<P>90 adult patients undergoing major elective general, gynaecological, orthopaedic or urological surgery with an anticipated blood loss &gt; 500 mL<BR/>Exclusion criteria: age &lt; 16 years, coagulopathy, renal or hepatic dysfunction and congestive heart failure</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:35:06 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>Hetastarch-normal saline (n = 30)</LI>
<LI>Hetastarch-balanced salt (n = 30)</LI>
<LI>Ringer's lactate (n = 30)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:35:10 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Postoperative nausea and vomiting<BR/>Death not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:33 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to discharge</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-31 00:17:38 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Myburgh-2012">
<CHAR_METHODS MODIFIED="2013-01-31 00:17:38 -0500" MODIFIED_BY="[Empty name]">
<P>RCT, randomly assigned over an encrypted Web-based randomization system</P>
<P>Less than 5% loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-19 09:14:35 -0500" MODIFIED_BY="[Empty name]">
<P>7000 patients 18 years or older addmited in ICU whom the treating clinician judged to require fluid resuscitation</P>
<P>Exclusion criteria: Patients who had received more than 1000 ml of HES before screening, those with impending or current dialysis-dependent renal failure, and those with evidence of intracranial hemorrhage </P>
<P>Setting: New Zealand and Australia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-19 09:15:17 -0500" MODIFIED_BY="[Empty name]">
<P>1. 6% HES 130/0.4 in 0.9% sodium chloride (n=3,500)</P>
<P>2. 0.9% sodium chloride (n=3,500)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-19 09:15:38 -0500" MODIFIED_BY="[Empty name]">
<P>All-cause mortality at 90 days, kidney injury, organ failure, duration of mechanical ventilation and renal replacement therapy, cause-specific mortality</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:34 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Nagy-1993">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:34 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, contact with author showed it was an open-label study<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:35:35 -0400" MODIFIED_BY="Anne Lawson">
<P>Participants were adult admissions to a trauma unit, with measurable SBP &lt; 90 mmHg<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:35:52 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>Pentastarch in 0.9% saline (n = 21)</LI>
<LI>Ringer's lactate (n = 20)</LI>
</OL>
<P>Allocated fluid was used throughout resuscitation with the exception that colloid patients received a maximum 4 L of pentastarch, after which Ringer's lactate was given</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:35:56 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths were not reported<BR/>Haemodynamic variables</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:34 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to discharge</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:35 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Ngo-2001">
<CHAR_METHODS MODIFIED="2012-05-30 10:51:42 -0400" MODIFIED_BY="Anne Lawson">
<P>RCT, opaque envelopes containing only treatment pack number</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:36:03 -0400" MODIFIED_BY="Anne Lawson">
<P>230 children with dengue shock syndrome</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:36:18 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>Dextran 70 (n = 55)</LI>
<LI>3% Gelatin (n = 56)</LI>
<LI>Ringer's lactate (n = 55)</LI>
<LI>'Normal' saline (n = 56)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:37:02 -0400" MODIFIED_BY="Anne Lawson">
<P>Initial pulse recovery time<BR/>Occurrence of timing and subsequent episodes of shock<BR/>Decrease in haematocrit<BR/>Volume of fluid administered until recovery<BR/>Complications<BR/>No deaths in any group</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:35 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up period unclear</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:36 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Nielsen-1985">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:35 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, method of allocation concealment not described<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:39:43 -0400" MODIFIED_BY="Anne Lawson">
<P>26 patients admitted for reconstructive surgery of the abdominal aorta</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:40:05 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>Whole blood, crystalloid plus 80 g albumin on the day of the operation, and 20 g/day for the next 3 days. Albumin given as 100 mL 20% human albumin solution (n = 13)</LI>
<LI>Whole blood and crystalloid, type not specified (n = 13)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:40:10 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths not reported<BR/>Author when contacted confirmed that there were no deaths in either group</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:36 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Length of follow-up 4 days</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-11-19 09:33:30 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Perner-2012">
<CHAR_METHODS MODIFIED="2012-11-19 09:27:38 -0500" MODIFIED_BY="[Empty name]">
<P>RCT</P>
<P>Computer-generated allocation sequence and centralized, blinded allocation</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-11-19 09:30:48 -0500" MODIFIED_BY="[Empty name]">
<P>804 patients 18 years of age or older who needed fluid resuscitation in the ICU, and who fulfilled the criteria for severe sepsis within the previous 24 hours</P>
<P>Exclusion criteria: renal replacement therapy, kidney or liver transpant, burn injury (&gt;10%), intracranial bleeding, K &gt; 6mmol per litre, received &gt;1000 ml colloid, included in another ICU trial, withdrew from active therapy</P>
<P>Setting: Denmark, Norway, Finland and Iceland</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-11-19 09:30:00 -0500" MODIFIED_BY="[Empty name]">
<P>1. 6% HES 130/0.42 (n=400)</P>
<P>2. Ringer acetate (n=400)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-11-19 09:31:21 -0500" MODIFIED_BY="[Empty name]">
<P>Death at 28 days 90 days and at time of latest follow-up , dependence on dialysis 90 days after randomization, severe bleeding, severe allergic reaction, SOFA score, acidosis, days alive without renal replacement, days alive without mechanical ventilation, days alive out of the hospital in the 90 days after randomisation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-11-19 09:33:30 -0500" MODIFIED_BY="[Empty name]">
<P>Four patients were excluded after randomisation and two patients had incomplete outcome data in the 6% HES 130/0.42 group</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:36 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Pockaj-1994">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:36 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation concealment unclear<BR/>Blinding not mentioned<BR/>Loss to follow-up: 18/54 in colloid group, 13/53 in saline group</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:41:33 -0400" MODIFIED_BY="Anne Lawson">
<P>Participants required fluid resuscitation as a result of vascular leak syndrome associated with interleukin-2 therapy for metastatic cancer</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:42:01 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>250 mL Bolus of 5% albumin in saline (n = 36 reported)</LI>
<LI>250 mL Bolus of 0.9% normal saline (n = 40 reported)</LI>
</OL>
<P>Boluses guided by haemodynamic variables. Both groups also received 0.45% saline with 10 mmol/L KCl</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:42:09 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths<BR/>Toxic effects of chemotherapy<BR/>Haemodynamic variables</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 09:42:11 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:57:39 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Prien-1990">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:37 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:42:17 -0400" MODIFIED_BY="Anne Lawson">
<P>Participants were undergoing modified Whipple's operation</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-31 06:57:39 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>10% HES in 0.9% saline plus plasma protein fraction if requirements &gt; 20 mL/kg (n = 6)</LI>
<LI>20% human albumin solution (n = 6)</LI>
<LI>Ringer's lactate (n = 6)</LI>
</OL>
<P>Allocated fluid was administered intraoperatively only</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:43:05 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths<BR/>Intestinal oedema formation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:38 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up period was unspecified</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:39 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Rackow-1983">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:38 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation concealment unclear<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:45:13 -0400" MODIFIED_BY="Anne Lawson">
<P>Participants were aged 54 to 97 years, and had any 1 of the following pre-determined indicators of shock: SBP &#8804; 90 mmHg, cardiac index &lt; 2.2 L/minute/m<SUP>2</SUP>, serum arterial lactate &gt; 18 mg/dL and WP &lt; 15 mmHg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:45:29 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>6% HES (n = 9)</LI>
<LI>5% Albumin (n = 9)</LI>
<LI>0.9% Saline (n = 8)</LI>
</OL>
<P>Allocated fluid was given as needed until the end of resuscitation<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:45:33 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported<BR/>Fluid balance</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:39 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to discharge from hospital</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:39 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Rocha-e-Silva-1994">
<CHAR_METHODS MODIFIED="2012-05-30 10:51:45 -0400" MODIFIED_BY="Anne Lawson">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:47:00 -0400" MODIFIED_BY="Anne Lawson">
<P>Participants were admissions to the emergency department, with SBP &#8804; 90 mmHg and &#8805; 16 years of age</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 10:47:35 -0400" MODIFIED_BY="Anne Lawson">
<OL>
<LI>6% Dextran 70 in 7.5% saline</LI>
<LI>Ringer's lactate</LI>
</OL>
<P>Allocated fluid was used for the first IV infusion only</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:48:55 -0400" MODIFIED_BY="Anne Lawson">
<P>Death was the main outcome measure, but the data are unpublished</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:39 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to 30 days. By April 1994, 125 patients had been entered into the study</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:41 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-SAFE-2004">
<CHAR_METHODS MODIFIED="2012-05-30 10:51:46 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT. Randomisation by minimisation algorithm accessed through secure website</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:49:55 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Patients aged &#8805; 18 years admitted to closed multidisciplinary ICUs in 16 tertiary hospitals in Australia over 19-month period</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:50:02 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>4% Albumin (Albumex, CSL) (n = 3499)</LI>
<LI>Normal saline (n = 3501)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:50:13 -0400" MODIFIED_BY="Anne Lawson">
<P>Death<BR/>Patients with new single- or multiple-organ failure<BR/>Mean number of days: in ICU, in hospital, on mechanical ventilation, on renal replacement therapy</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:41 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to 28 days</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:42 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Shah-1977">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:41 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation by sealed envelope<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:50:42 -0400" MODIFIED_BY="Anne Lawson">
<P>Patients with severe, multiple trauma and SBP &lt; 90 mmHg. All patients were adults and both sexes were included</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:50:54 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>5% Salt-poor albumin in Ringer's lactate (n = 9)</LI>
<LI>Ringer's lactate (n = 11)</LI>
</OL>
<P>Volume infused guided by physiological parameters</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:50:59 -0400" MODIFIED_BY="Anne Lawson">
<P>Death reported<BR/>Haemodynamic variables</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:42 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Length of follow-up not stated</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 08:46:09 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Shires-1983">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:42 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Patients 'assigned randomly'<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:51:11 -0400" MODIFIED_BY="Anne Lawson">
<P>People undergoing aortic reconstruction surgery<BR/>No exclusion criteria mentioned</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:51:21 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>Plasmanate (n = 9)</LI>
<LI>Ringer's lactate (n = 9)</LI>
</OL>
<P>Allocated fluid used guided by haemodynamic variables until the first postoperative morning. All patients then received 0.45% saline</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-31 08:46:09 -0400" MODIFIED_BY="Anne Lawson">
<P>Pulmonary oedema<BR/>Haemodynamic variables<BR/>Death</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:43 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to 2 days postoperative</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:57:53 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Sirieix-1999">
<CHAR_METHODS MODIFIED="2012-05-31 06:57:53 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Patients "randomly assigned"</P>
<P>Blinding not described<BR/>2 patients excluded after randomisation due to arrhythmias on giving the fluid (both in hypertonic saline group)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-31 06:43:02 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Patients undergoing mitral valve repair<BR/>Exclusion criteria: LVEF &lt; 0.4, systolic PAP &gt; 50 mmHg, coagulation disorders, creatinine &gt; 150 mmoL/L, electrolyte imbalance, diabetes, previous atrial fibrillation lasting &gt; 1 year</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:54:38 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>250 mL 7.2% Hypertonic saline, 6% HES (n = 8)</LI>
<LI>250 mL 7.2% Hypertonic saline (n = 10)</LI>
<LI>250 mL 6% HES (n = 8)</LI>
</OL>
<P>Fluid given over 15 minutes, 1 hour after admission to postoperative ICU</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:56:24 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Haemodynamic variables<BR/>Deaths reported<BR/>Side effects (severe hypotension: 1 patient in group 1 and 2 patients in group 2; arrhythmias: 1 patient in group 1, 3 patients in group 2 and 1 patient in group 3)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:43 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to discharge from hospital (all within 10 days)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:44 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Skillman-1975">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:44 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation concealment unclear<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:56:32 -0400" MODIFIED_BY="Anne Lawson">
<P>Participants were undergoing elective abdominal reconstructive surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:56:47 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>25% Salt-poor albumin 1 g/kg and 5% albumin 1 L (n = 7)</LI>
<LI>Ringer's lactate</LI>
</OL>
<P>Allocated fluid was given intraoperatively. All patients received crystalloids only for pre-loading before surgery</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:56:48 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths were not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 09:56:50 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:45 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Tollofsrud-1995">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:44 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation by sealed envelopes<BR/>Blinding not mentioned<BR/>No loss to follow-up<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:57:08 -0400" MODIFIED_BY="Anne Lawson">
<P>Participants were adults in need of volume replacement during and after coronary artery bypass surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:57:13 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>Haemaccel (n = 10)</LI>
<LI>Dextran 70 (n = 10)</LI>
<LI>Albumin 40 (n = 10)</LI>
<LI>Ringer's lactate (n = 10)</LI>
</OL>
<P>Allocated fluid was used throughout resuscitation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:57:14 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported<BR/>Fluid balance</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:45 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to 48 hours</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:58:01 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Tollofsrud-1998">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:46 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation by sealed envelope</P>
<P>Described as double blind</P>
<P>No loss to follow-up mentioned</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-31 06:58:01 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Patients with 3 vessel coronary artery disease undergoing elective coronary artery surgery</P>
<P>Exclusion criteria: LVEF &lt; 0.4, ventricular aneurysm, significant arrhythmia, diabetes, renal failure, lung disease</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:58:36 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>4 mL/kg of 75 mg/mL hypertonic saline in dextran 70 60 mg/mL over 30 minutes (n = 10)</LI>
<LI>Same volume and rate of isotonic saline (n = 10)</LI>
</OL>
<P>Fluid given just after surgery while still in operating theatre. Ringer's lactate for additional fluid</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:59:11 -0400" MODIFIED_BY="Anne Lawson">
<P>Fluid balance<BR/>Haemodynamic variables<BR/>Deaths not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:46 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to 48 hours</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:47 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Upadhyay-2004">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:47 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Open-label randomised trial, allocation by sealed envelope<BR/>No loss to follow-up mentioned</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 09:59:42 -0400" MODIFIED_BY="Emma M Sydenham">
<P>60 patients with septic shock aged 1 month to 12 years<BR/>Exclusion criteria: age &lt; 1 month, multiorgan failure and immunodeficiency states</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 09:59:55 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>Normal saline (n = 31)</LI>
<LI>Polymer from degraded gelatin in saline (n = 29)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 09:59:58 -0400" MODIFIED_BY="Anne Lawson">
<P>Haemodynamic data<BR/>Death reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:47 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Length of follow-up not reported but all outcomes were in-hospital measures</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:49 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Vassar-1990">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:48 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation concealment unclear<BR/>Double-blind study (solutions prepared in identical containers)<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 10:01:56 -0400" MODIFIED_BY="Anne Lawson">
<P>Participants were emergency department admissions with trauma and SBP &lt; 80 mmHg and &#8805; 18 years of age<BR/>Exclusion criteria: pregnant women and people with pre-existing cardiac, hepatic or renal disease</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 10:02:09 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>6% Dextran 70 in 7.5% saline (n = 23)</LI>
<LI>Ringer's lactate (n = 24)</LI>
</OL>
<P>Allocated fluids were given as the initial resuscitation in the emergency department. Additional isotonic crystalloids (Ringer's lactate) were given as needed</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 10:02:12 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported<BR/>Haemodynamic variables</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:49 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to hospital discharge</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:43:14 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Vassar-1991">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:49 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation by randomised sequence of coded containers<BR/>Double-blind study<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-31 06:43:14 -0400" MODIFIED_BY="Anne Lawson">
<P>Participants were pre-hospital trauma cases undergoing helicopter transport to an emergency centre, with SBP &#8804; 100 mmHg and &#8805; 18 years<BR/>Exclusion criteria: pre-existing cardiac renal, hepatic or neurological disease; peripheral oedema</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 10:04:35 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>4.2% Dextran 70 in 7.5% saline or 6% dextran 70 in 7.5% saline (n = 83)</LI>
<LI>Ringer's lactate (n = 83)</LI>
</OL>
<P>Fluids were given as the initial resuscitation fluid in the pre-hospital setting. Supplemental isotonic fluids were given at the discretion of the flight nurses</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 10:04:37 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Deaths reported<BR/>Haemodynamic variables</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:50 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to discharge. Allocation was to 4.2% dextran 70, to 6% dextran 70, or to crystalloid; for the calculation of the summary effect measure, the 2 dextran groups were combined</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:43:22 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Vassar-1993a">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:51 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation concealed by random sequence of identical containers<BR/>Double-blind study<BR/>36 people excluded post randomisation as deemed not to have met eligibility criteria<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-31 06:43:22 -0400" MODIFIED_BY="Anne Lawson">
<P>Participants, who were undergoing ambulance transport to an emergency centre, SBP &#8804; 90 mmHg, &#8805; 18 years<BR/>Exclusion criteria: asystolic; undergoing CPR; lack sinus complex on ECG; &gt; 2 hours after trauma; pregnant; pre-existing seizures; bleeding disorder; hepatic, cardiac or renal disease</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 10:07:38 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>6% Dextran 70 in 7.5% saline (n = 89)</LI>
<LI>7.5% Saline (n = 85)</LI>
<LI>0.9% Saline (n = 84)</LI>
</OL>
<P>Participants received 250 mL of the allocated fluid in the pre-hospital setting. Additional isotonic crystalloids were given as needed</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 10:07:42 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported<BR/>Haemodynamic variables<BR/>Trauma scores</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:52 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up was to discharge from hospital</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:43:28 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Vassar-1993b">
<CHAR_METHODS MODIFIED="2012-05-30 10:51:56 -0400" MODIFIED_BY="Anne Lawson">
<P>RCT, allocation concealed by sequential use of coded identical containers<BR/>Double-blind study<BR/>39/233 patients excluded as deemed not to meet eligibility criteria, unclear from which groups</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-31 06:43:28 -0400" MODIFIED_BY="Anne Lawson">
<P>Participants were pre-hospital trauma cases undergoing helicopter transport to an emergency centre, SBP &#8804; 100 mmHg, &#8805; 18 years<BR/>Exclusion criteria: asystolic; undergoing CPR; lack sinus complex on ECG; &gt; 2 hours after trauma; pregnant; pre-existing seizures; bleeding disorder; hepatic, cardiac or renal disease</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 10:09:30 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>12% Dextran 70 in 7.5% saline (n = 49)</LI>
<LI>6% Dextran 70 in 7.5% saline (n = 50)</LI>
<LI>7.5% Saline (n = 50)</LI>
<LI>Ringer's lactate (n = 45)</LI>
</OL>
<P>Participants received 250 mL of the allocated fluid in the pre-hospital setting. Additional isotonic crystalloids were given as needed</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 10:09:34 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported<BR/>Haemodynamic variables<BR/>Trauma scores and neurological outcome scores</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:52 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to hospital discharge</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:43:35 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Verheij-2006">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:53 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation concealment by "the sealed envelope method"<BR/>Blinding method not reported<BR/>No loss to follow-up<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-31 06:43:35 -0400" MODIFIED_BY="Emma M Sydenham">
<P>67 patients with presumed hypovolaemia after cardiac and major vascular surgery<BR/>Exclusion criteria: age &gt; 79 years and known anaphylactoid reaction to colloids</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 10:09:56 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>Saline (n = 16)</LI>
<LI>Gelatin (n = 16)</LI>
<LI>HES (n = 16)</LI>
<LI>Albumin (n = 16)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 10:10:02 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Haemodynamic data<BR/>Death not reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:53 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Length of follow-up not reported but all outcomes were in-hospital measures</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:54 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Virgilio-1979">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:54 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Allocation "by random number"<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 10:10:20 -0400" MODIFIED_BY="Anne Lawson">
<P>Participants were undergoing abdominal aortic surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 10:11:05 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>5% Albumin (n = 15)</LI>
<LI>Ringer's lactate (n = 14)</LI>
</OL>
<P>Allocated fluid was used during operation for maintenance of pre-defined physiological parameters, and the resuscitation was continued with the allocated fluid until the day following the operation. This was followed by 5% dextrose in half-normal saline, with potassium chloride as needed</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 10:11:06 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:54 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up 2.5 weeks</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:43:45 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Wahba-1996">
<CHAR_METHODS MODIFIED="2012-05-30 10:11:28 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Patients "randomly allocated"<BR/>Blinding not mentioned<BR/>2 patients excluded as they required reoperation for bleeding</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-31 06:43:45 -0400" MODIFIED_BY="Anne Lawson">
<P>22 adults in need of volume replacement following coronary artery bypass surgery<BR/>Exclusion criteria: abnormal left ventricular function, platelet active medication or heparin</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 10:47:08 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>Haemaccel (n = 10)</LI>
<LI>Ringer's lactate (n = 10)</LI>
</OL>
<P>Allocated fluid was used from the time of admission to ICU following operation, to the end of resuscitation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 10:12:08 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported<BR/>Pulmonary oedema</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:55 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to discharge</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:56 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Wills-2005">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:55 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation concealed by specially prepared cardboard containers<BR/>Method of blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 10:12:34 -0400" MODIFIED_BY="Emma M Sydenham">
<P>512 children with dengue shock syndrome aged 2 to 15 years<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 10:23:23 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Children with immoderately severe shock were randomised to the 3 interventions</P>
<OL>
<LI>Ringer's lactate (n = 128)</LI>
<LI>6% Dextran 70 (n = 126)</LI>
<LI>6% HES 200/0.5 (n = 129)</LI>
</OL>
<P>Children with severe shock were randomised only to either of the 2 colloids interventions:</P>
<OL>
<LI>6% Dextran 70 (n = 67)</LI>
<LI>6% HES 200/0.5 (n = 62)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 10:23:59 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Requirement for supplemental intervention with rescue colloid<BR/>Time taken to achieve initial cardiovascular stability<BR/>Time taken to achieve sustained cardiovascular stability<BR/>Volume required<BR/>Change in haematocrit<BR/>Days in hospital<BR/>1 death reported but not specified in which group</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:56 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Length of follow-up not clear<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 07:09:48 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Woittiez-1997">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:56 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation concealment by sealed opaque envelopes<BR/>No information on blinding or loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 10:24:49 -0400" MODIFIED_BY="Emma M Sydenham">
<P>60 patients who had developed hypoalbuminaemia (&lt; 20 g/L) after major surgery<BR/>2 patients died after randomisation and before treatment started. They were excluded from the analysis</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-31 07:09:48 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>Saline (500 mL/24 hours) (n = 16)</LI>
<LI>20% Albumin (300 mL/24 hours) (n = 15)</LI>
<LI>10% HES (500 mL/24 hours) for 3 days (n = 27)</LI>
</OL>
<P>Aim was to restore COP<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 10:26:11 -0400" MODIFIED_BY="Anne Lawson">
<P>Changes in fluid balance, serum albumin, COP and clinical signs of oedema were followed daily<BR/>Death rates supplied by the author<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:57 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Length of follow-up unspecified</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:44:58 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Wu-2001">
<CHAR_METHODS MODIFIED="2012-05-30 10:52:00 -0400" MODIFIED_BY="Anne Lawson">
<P>RCT. No details given of randomisation method</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 10:27:08 -0400" MODIFIED_BY="Anne Lawson">
<P>41 adolescent or adult patients in emergency department suffering from shock</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 10:27:36 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>4% Modified fluid gelatin: succinated gelatin 40 g/L, sodium chloride 7 g/L, sodium hydroxide 1.36 g/L (n = 18)</LI>
<LI>Ringer's lactate (n = 16)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 10:27:43 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Death<BR/>Haemodynamic variables</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:58 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Not intention-to-treat: 5 patients who received blood transfusion and 2 who had surgery within the first hour of resuscitation were dropped from the analysis<BR/>Length of follow-up not clear</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:43:51 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Younes-1992">
<CHAR_METHODS MODIFIED="2012-05-30 11:44:58 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Randomised "in a double blind fashion"<BR/>Blinding by use of similar bottles<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-31 06:43:51 -0400" MODIFIED_BY="Anne Lawson">
<P>Participants were emergency department admissions, SBP &lt; 80 mmHg, &#8805; 19 years<BR/>Exclusion criteria: pregnant, pre-existing cardiac or metabolic disease</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 10:29:02 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>6% Dextran 70 in 7.5% saline (n = 35)</LI>
<LI>7.5% Saline (n = 35)</LI>
<LI>0.9% Saline (n = 35)</LI>
</OL>
<P>Allocated fluid was for initial bolus of 250 mL, followed by isotonic crystalloids as needed</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 10:29:04 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported<BR/>Fluid balance</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:59 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to discharge from hospital</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:43:58 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Younes-1994">
<CHAR_METHODS MODIFIED="2012-05-30 10:29:37 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Trial conducted in a "double blind randomised fashion"<BR/>Blinding by use of coded, identical containers<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-31 06:43:58 -0400" MODIFIED_BY="Anne Lawson">
<P>Participants were trauma admissions to the emergency department requiring treatment for haemorrhagic hypovolaemia; all were over 15 years old<BR/>Exclusion criteria: pregnant, cardiac or renal failure, cardiac arrest on arrival</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 10:47:39 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>6% Dextran 70 in 7.5% saline (n = 101)</LI>
<LI>0.9% Saline (n = 111)</LI>
</OL>
<P>Allocated fluid was for the first IV infusion only</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 10:29:59 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported<BR/>Complications</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:44:59 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up period was 30 days</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:45:00 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Younes-1998">
<CHAR_METHODS MODIFIED="2012-05-30 11:45:00 -0400" MODIFIED_BY="Emma M Sydenham">
<P>RCT, allocation by sealed envelope</P>
<P>Blinding not mentioned</P>
<P>No apparent loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 10:30:39 -0400" MODIFIED_BY="Anne Lawson">
<P>Trauma patients SBP &lt; 90 mmHg admitted to the emergency department, with no previous treatment</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 10:31:00 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>10% Pentastarch (n = 12)</LI>
<LI>0.9% Saline (n = 11)</LI>
</OL>
<P>Fluid given in 250 mL boluses until systolic blood pressure &gt; 100 mmHg</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 10:31:04 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported<BR/>No complications reported in either group</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:45:00 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to 24 hours</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:45:01 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Zetterstrom-1981a">
<CHAR_METHODS MODIFIED="2012-05-30 11:45:01 -0400" MODIFIED_BY="Emma M Sydenham">
<P>The patients were randomly divided into 2 groups<BR/>Allocation concealment was by sealed opaque envelopes (information supplied by study author)<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 10:32:06 -0400" MODIFIED_BY="Anne Lawson">
<P>Adults undergoing elective major abdominal surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 10:33:37 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>Standard volume replacement regimen (1 L dextran 70 then up to 4 units of RBC with electrolyte, then whole blood or RBC with plasma; postoperative patients were given crystalloids and whole blood) plus 20% human albumin solution 100 mL at end of operation, 200 mL to 300 mL on same day, then 200 mL on first postoperative day, then 100 mL for next 3 days (n = 15)</LI>
<LI>Standard volume replacement regimen (as above) (n = 15)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 10:33:41 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported<BR/>Haemodynamic variables</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:45:01 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Length of follow-up unspecified</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-30 11:45:03 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Zetterstrom-1981b">
<CHAR_METHODS MODIFIED="2012-05-30 11:45:02 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Patients were randomly divided into 2 groups<BR/>Allocation concealment was by sealed opaque envelopes (information supplied by study author)<BR/>Blinding not mentioned<BR/>No loss to follow-up</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 10:34:06 -0400" MODIFIED_BY="Anne Lawson">
<P>18 patients who had undergone elective abdominal aortic surgery<BR/>No exclusions mentioned</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 10:34:13 -0400" MODIFIED_BY="Emma M Sydenham">
<OL>
<LI>5% Human albumin solution (n = 9)</LI>
<LI>Ringer's lactate solution (n = 9)</LI>
</OL>
<P>Administration guided by pulmonary arterial occlusion pressure</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 10:34:10 -0400" MODIFIED_BY="Anne Lawson">
<P>Deaths reported<BR/>Haemodynamic variables<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 11:45:03 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Follow-up to discharge from hospital</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-05-31 06:58:48 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhu-2011">
<CHAR_METHODS MODIFIED="2012-05-30 11:30:37 -0400" MODIFIED_BY="[Empty name]">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-02 09:01:20 -0400" MODIFIED_BY="[Empty name]">
<P>135 participants with severe sepsis</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-31 06:58:48 -0400" MODIFIED_BY="[Empty name]">
<OL>
<LI>7.5% Hypertonic saline plus 6% HES 130/0.4 (n = 45)</LI>
<LI>Ringer's lactate plus 6% HES 130/0.4 (n = 45)</LI>
<LI>Ringer's lactate (n = 45)</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 10:35:21 -0400" MODIFIED_BY="[Empty name]">
<P>Biomarkers, fluid requirements, and MODS. Mortality was also reported</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-05-30 10:35:20 -0400" MODIFIED_BY="Anne Lawson">
<P>-</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ACE: angiotensin-converting enzyme; ARDS: adult respiratory distress syndrome; ASA: American Society of Anesthesiologists; bpm: beats per minute; COP: colloid osmotic pressure; CPR: cardiopulmonary resuscitation; GI: gastrointestinal; HES: hydroxyethyl starch; HR: heart rate; ICU: intensive care unit; IV: intravenous; LVEDP: left ventricular end diastolic pressure; LVEF: left ventricular ejection fraction; MODS: multiple organ dysfunction score; PAP: pulmonary artery pressure; PAWP: pulmonary artery wedge pressure; RBC: red blood cell; RCT: randomised controlled trial; SBP: systolic blood pressure; TBSA: total body surface area; WP: wedge pressure.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2012-05-31 07:34:12 -0400" MODIFIED_BY="Emma M Sydenham" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:48:57 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Artru-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:48:57 -0400" MODIFIED_BY="Anne Lawson">
<P>Intervention to control intracranial pressure not directed at fluid resuscitation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:49:22 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Bocanegra-1966">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:49:22 -0400" MODIFIED_BY="Anne Lawson">
<P>Study contained 2 quasi-randomised comparisons of colloid with glucose and plasma/saline with saline. In both studies, the control solution was only given IV if the patient was in coma or shock. It was therefore not a reasonable comparison of colloid and crystalloid</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:49:24 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Boldt-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:49:24 -0400" MODIFIED_BY="Anne Lawson">
<P>All groups received some colloid</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:49:28 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Boldt-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:49:28 -0400" MODIFIED_BY="[Empty name]">
<P>Comparison was not between colloids and crystalloids, rather 2 different colloid solutions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:49:32 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Bothner-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:49:32 -0400" MODIFIED_BY="Anne Lawson">
<P>Participants were having minor elective surgery, therefore not considered to be critically ill</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:49:36 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Breheme-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:49:36 -0400" MODIFIED_BY="Anne Lawson">
<P>Intervention directed at haemodilution, not at volume replacement</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:49:37 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Bueno-R-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:49:37 -0400" MODIFIED_BY="Emma M Sydenham">
<P>The participants had elective surgery</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:49:39 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Chin-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:49:39 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Participants were undergoing elective surgery, therefore not considered to be critically ill</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:49:41 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Golub-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:49:41 -0400" MODIFIED_BY="Anne Lawson">
<P>Albumin given solely as a nutritional supplement</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:49:45 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Goslinga-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:49:45 -0400" MODIFIED_BY="Anne Lawson">
<P>Intervention directed at haemodilution, not volume replacement</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:49:47 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Green-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:49:47 -0400" MODIFIED_BY="[Empty name]">
<P>Article is a review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:49:50 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Greenhalgh-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:49:50 -0400" MODIFIED_BY="Anne Lawson">
<P>Intervention directed at the maintenance of serum albumin levels, not for volume replacement</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:49:51 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Hauser-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:49:51 -0400" MODIFIED_BY="Anne Lawson">
<P>Cross-over trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:49:56 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ko-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:49:56 -0400" MODIFIED_BY="[Empty name]">
<P>Comparison of crystalloids and colloids as pre-loading solutions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:50:03 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Krasheninnikov-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:50:03 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:50:06 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Lagonidis-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:50:06 -0400" MODIFIED_BY="Anne Lawson">
<P>Intervention was pre-loading for coronary artery bypass surgery</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-08 03:50:06 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lange-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-08 03:50:06 -0400" MODIFIED_BY="[Empty name]">
<P>Article was a review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:50:10 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lobo-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:50:10 -0400" MODIFIED_BY="[Empty name]">
<P>Experiment conducted on rabbits</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:50:16 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Marhofer-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:50:16 -0400" MODIFIED_BY="Anne Lawson">
<P>Trial of fluid for pre-loading before spinal anaesthesia</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:50:26 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mittermayr-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:50:26 -0400" MODIFIED_BY="[Empty name]">
<P>Patients were undergoing elective surgery</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:50:29 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mittermayr-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:50:29 -0400" MODIFIED_BY="[Empty name]">
<P>Outcome was the change in concentration of tissue-type plasminogen activator</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-08 03:51:06 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Morrison-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-08 03:51:06 -0400" MODIFIED_BY="[Empty name]">
<P>Study evaluated the effect of hypertonic saline in patients with blunt head injury</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:50:31 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Niemi-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:50:31 -0400" MODIFIED_BY="[Empty name]">
<P>Solutions were used for pump priming</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:50:33 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Nilsson-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:50:33 -0400" MODIFIED_BY="Anne Lawson">
<P>Albumin given as a nutritional supplement</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:50:35 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Oliviera-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:50:35 -0400" MODIFIED_BY="Emma M Sydenham">
<P>The participants had sepsis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:50:37 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Paton_x002d_Gay-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:50:37 -0400" MODIFIED_BY="Emma M Sydenham">
<P>The outcome was non-relevant to comparing crystalloids and colloids</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:50:39 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Paul-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:50:39 -0400" MODIFIED_BY="Emma M Sydenham">
<P>The participants had elective surgery</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:50:44 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Rehm-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:50:44 -0400" MODIFIED_BY="Anne Lawson">
<P>2 colloids (albumin and hetastarch) compared</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:50:46 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Steinberg-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:50:46 -0400" MODIFIED_BY="Anne Lawson">
<P>Cross-over trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:50:51 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tiryakioglu-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:50:51 -0400" MODIFIED_BY="[Empty name]">
<P>Patients were undergoing elective surgery and not considered critically ill. Also, the solutions were used as priming solutions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:50:52 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tseng-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:50:52 -0400" MODIFIED_BY="[Empty name]">
<P>Crystalloid and colloid treatment was not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:50:54 -0400" MODIFIED_BY="Emma M Sydenham" STUDY_ID="STD-Valetova-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:50:54 -0400" MODIFIED_BY="Emma M Sydenham">
<P>Patients were randomised depending upon their treatment not prior to treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:51:13 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-van-der-Heijden-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:51:13 -0400" MODIFIED_BY="[Empty name]">
<P>The report did not provide separate data for the 3 arms that received colloids (gelatin 4%, hydroxyethyl starch 6% and albumin 5%)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:51:15 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vercueil-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:51:15 -0400" MODIFIED_BY="[Empty name]">
<P>Article is a review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-31 07:34:12 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Wilkes-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-31 07:34:12 -0400" MODIFIED_BY="Anne Lawson">
<P>1 group received saline plus hetastarch, the other received 'balanced' fluid plus hetastarch. Thus, each group received both a colloid and a crystalloid. This conflicts with the purpose our review, which compares patients who had 1 of these with patients who had the other</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-05-30 11:51:56 -0400" MODIFIED_BY="Anne Lawson" STUDY_ID="STD-Woods-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-05-30 11:51:56 -0400" MODIFIED_BY="Anne Lawson">
<P>This quasi-randomised trial looked at albumin supplementation in postoperative patients, with the aim of maintaining the serum albumin. Since the main aim of giving albumin was not to replace volume, the study was excluded</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2009-05-07 12:52:35 -0400" MODIFIED_BY="Emma M Sydenham" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2012-11-20 06:47:15 -0500" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2012-05-30 11:55:28 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-RASP-trial">
<CHAR_STUDY_NAME MODIFIED="2012-05-07 11:11:25 -0400" MODIFIED_BY="[Empty name]">
<P>Lactated Ringer Versus Albumin in Early Sepsis Therapy (RASP)</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2012-05-30 11:54:10 -0400" MODIFIED_BY="[Empty name]">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-05-30 11:54:13 -0400" MODIFIED_BY="[Empty name]">
<P>360 patients with severe sepsis or septic shock</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-05-30 11:55:28 -0400" MODIFIED_BY="[Empty name]">
<OL>
<LI>Ringer's lactate</LI>
<LI>4% Albumin</LI>
</OL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-05-30 11:55:00 -0400" MODIFIED_BY="[Empty name]">
<P>28 days all-cause mortality</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2012-05-07 11:13:30 -0400" MODIFIED_BY="[Empty name]">
<P>May 2012</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-05-07 11:13:58 -0400" MODIFIED_BY="[Empty name]">
<P>Juliano P Almeida, Cancer Institute of Sao Paulo, School of Medicine, University of Sao Paulo</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2012-05-07 11:14:38 -0400" MODIFIED_BY="[Empty name]">
<P>
<A HREF="http://clinicaltrials.gov/ct2/show/NCT01337934">NCT01337934</A>
</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES>
<P>HES: hydroxyethyl starch; ICU: intensive care unit; RCT: randomised controlled trial.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2012-11-19 09:33:56 -0500" MODIFIED_BY="Emma M Sydenham">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2012-11-19 09:33:56 -0500" MODIFIED_BY="Emma M Sydenham" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:25:50 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Boldt-1986">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:25:53 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Boldt-1993">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:26:06 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Boldt-2001">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:26:12 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Boutros-1979">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-30 08:37:09 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="NO" STUDY_ID="STD-Bowser_x002d_Wallace-1986">
<DESCRIPTION>
<P>Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:26:43 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Brunkhorst-2008">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-30 08:40:01 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bulger-2011">
<DESCRIPTION>
<P>All care providers, investigators and patients remained blinded to the treatment assignment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-30 08:41:54 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Chavez_x002d_Negrete-1991">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:27:25 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Cifra-2003">
<DESCRIPTION>
<P>Not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-30 08:44:54 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cooper-2006">
<DESCRIPTION>
<P>Patients were allocated to study groups with stratified randomisation with a computer-generated randomisation list and sequentially numbered sealed, opaque envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:27:39 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="NO" STUDY_ID="STD-Dawidson-1991">
<DESCRIPTION>
<P>Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:27:48 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Dehne-2001">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-02 07:50:07 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Du-2011">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-30 08:49:55 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Dubin-2010">
<DESCRIPTION>
<P>sealed enveloped were used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:27:54 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Eleftheriadis-1995">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:28:01 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Ernest-1999">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:28:07 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="NO" STUDY_ID="STD-Evans-1996">
<DESCRIPTION>
<P>Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:28:19 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Evans-2003">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:28:29 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Fries-2004">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:28:36 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="YES" STUDY_ID="STD-Gallagher-1985">
<DESCRIPTION>
<P>Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:28:42 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Goodwin-1983">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:28:51 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Grundmann-1982">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-19 08:42:35 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Guidet-2012">
<DESCRIPTION>
<P>The investigational and control drugs were identical in appearance and packaging, and were labeled with randomization numbers using a blinding methodology </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:29:02 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Guo-2003">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:29:09 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="NO" STUDY_ID="STD-Hall-1978">
<DESCRIPTION>
<P>Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:29:20 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Hartmann-1993">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-02 08:21:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-James-2011">
<DESCRIPTION>
<P>Plastic bags with concealed label were randomly selected and placed sequentially in a warming cabinet</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:29:24 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Jelenko-1978">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:29:36 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Karanko-1987">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:29:44 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="YES" STUDY_ID="STD-Lang-2001">
<DESCRIPTION>
<P>Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:30:12 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Lang-2003">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-19 09:09:17 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lee-2011">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:30:19 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Ley-1990">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:30:24 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Lowe-1977">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-02 08:29:31 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lu-2012">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:30:31 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="NO" STUDY_ID="STD-Lucas-1978">
<DESCRIPTION>
<P>Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:30:41 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Maitland-2005">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-30 09:26:42 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Maitland-2011">
<DESCRIPTION>
<P>Trial numbers kept inside opaque, sealed envelopes. Opened in numerical order by clinician</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:30:52 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="NO" STUDY_ID="STD-Mattox-1991">
<DESCRIPTION>
<P>Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:30:59 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Mazher-1998">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-30 09:31:22 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McIntyre-2008">
<DESCRIPTION>
<P>Only the designated research pharmacist at each institution was aware of the treatment allocation for individual patients. Study fluids were prepared and blinded ahead of time by the site research pharmacist</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:31:02 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-McNulty-1993">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:31:06 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Metildi-1984">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:31:09 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="NO" STUDY_ID="STD-Modig-1983">
<DESCRIPTION>
<P>Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:31:27 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Moretti-2003">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-19 09:24:34 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Myburgh-2012">
<DESCRIPTION>
<P>web-based allocation and identical packaging</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:31:35 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="NO" STUDY_ID="STD-Nagy-1993">
<DESCRIPTION>
<P>Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:31:41 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="YES" STUDY_ID="STD-Ngo-2001">
<DESCRIPTION>
<P>Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:31:57 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Nielsen-1985">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-19 09:33:56 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perner-2012">
<DESCRIPTION>
<P>centralised blinded allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:32:09 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Pockaj-1994">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:32:13 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Prien-1990">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:32:21 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Rackow-1983">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:32:26 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Rocha-e-Silva-1994">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:32:37 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="YES" STUDY_ID="STD-SAFE-2004">
<DESCRIPTION>
<P>Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:32:55 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Shah-1977">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:32:59 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Shires-1983">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:33:10 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Sirieix-1999">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:33:21 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Skillman-1975">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:33:28 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Tollofsrud-1995">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:33:35 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Tollofsrud-1998">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:33:46 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Upadhyay-2004">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:33:56 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Vassar-1990">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:34:12 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="YES" STUDY_ID="STD-Vassar-1991">
<DESCRIPTION>
<P>Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:34:27 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="YES" STUDY_ID="STD-Vassar-1993a">
<DESCRIPTION>
<P>Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:34:44 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="YES" STUDY_ID="STD-Vassar-1993b">
<DESCRIPTION>
<P>Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:35:02 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Verheij-2006">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:36:23 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Virgilio-1979">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:36:30 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Wahba-1996">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:37:16 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="YES" STUDY_ID="STD-Wills-2005">
<DESCRIPTION>
<P>Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:37:23 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Woittiez-1997">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:37:32 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Wu-2001">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:37:43 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Younes-1992">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:37:58 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Younes-1994">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:38:11 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Younes-1998">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:38:22 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Zetterstrom-1981a">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-01 11:38:29 -0400" MODIFIED_BY="Emma M Sydenham" RESULT="UNKNOWN" STUDY_ID="STD-Zetterstrom-1981b">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-05-07 09:02:56 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhu-2011">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2013-01-17 11:44:59 -0500" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2013-01-17 11:16:04 -0500" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Colloid versus crystalloid (add-on colloid)</NAME>
<DICH_OUTCOME CHI2="41.28034140778635" CI_END="1.1205820433836358" CI_START="1.004456769004073" CI_STUDY="95" CI_TOTAL="95" DF="44" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0609317691072828" ESTIMABLE="YES" EVENTS_1="2033" EVENTS_2="1898" I2="0.0" I2_Q="18.316101968978284" ID="CMP-001.01" LOG_CI_END="0.04944365889374572" LOG_CI_START="0.0019312498080087516" LOG_EFFECT_SIZE="0.025687454350877235" METHOD="MH" MODIFIED="2013-01-17 11:16:04 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5888550961633888" P_Q="0.2990454062482504" P_Z="0.03406525998071297" Q="3.6726944628189355" RANDOM="NO" SCALE="3.465427232489703" SORT_BY="STUDY" STUDIES="56" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="10202" TOTAL_2="10205" WEIGHT="400.0" Z="2.119298362302993">
<NAME>Deaths</NAME>
<GROUP_LABEL_1>Colloid</GROUP_LABEL_1>
<GROUP_LABEL_2>Crystalloid</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours colloid</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours crystalloid</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="19.951674873394225" CI_END="1.0970036535321201" CI_START="0.9317297052508124" DF="17" EFFECT_SIZE="1.010995000365752" ESTIMABLE="YES" EVENTS_1="922" EVENTS_2="914" I2="14.7941207548962" ID="CMP-001.01.01" LOG_CI_END="0.04020807397963091" LOG_CI_START="-0.03071005818622291" LOG_EFFECT_SIZE="0.004749007896704026" MODIFIED="2012-05-30 13:00:34 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.2767086121116282" P_Z="0.792938603222149" STUDIES="24" TAU2="0.0" TOTAL_1="4951" TOTAL_2="4969" WEIGHT="99.99999999999997" Z="0.2624966043400063">
<NAME>Albumin or plasma protein fraction</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-05-07 09:27:19 -0400" MODIFIED_BY="[Empty name]" ORDER="16421" O_E="0.0" SE="0.0" STUDY_ID="STD-Boldt-1993" TOTAL_1="15" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="8.342871369855674" CI_START="0.024272218882778133" EFFECT_SIZE="0.45" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.9213155476959477" LOG_CI_START="-1.6148905201452604" LOG_EFFECT_SIZE="-0.3467874862246563" ORDER="16422" O_E="0.0" SE="1.4897799986724365" STUDY_ID="STD-Boutros-1979" TOTAL_1="7" TOTAL_2="17" VAR="2.2194444444444446" WEIGHT="0.1680970793502944"/>
<DICH_DATA CI_END="32.12858772731981" CI_START="0.41048693963460786" EFFECT_SIZE="3.6315789473684212" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.506891635737884" LOG_CI_START="-0.3867006561690314" LOG_EFFECT_SIZE="0.5600954897844264" MODIFIED="2012-05-07 05:46:40 -0400" MODIFIED_BY="[Empty name]" ORDER="78" O_E="0.0" SE="1.11230548569914" STUDY_ID="STD-Cooper-2006" TOTAL_1="19" TOTAL_2="23" VAR="1.2372234935163997" WEIGHT="0.09885709190362552"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16440" O_E="0.0" SE="0.0" STUDY_ID="STD-Evans-2003" TOTAL_1="13" TOTAL_2="14" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16423" O_E="0.0" SE="0.0" STUDY_ID="STD-Gallagher-1985" TOTAL_1="5" TOTAL_2="5" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="11.845556486122447" CI_START="1.078938335651265" EFFECT_SIZE="3.575" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="3" LOG_CI_END="1.073555468028416" LOG_CI_START="0.03299662424578267" LOG_EFFECT_SIZE="0.5532760461370995" ORDER="16424" O_E="0.0" SE="0.6112294156872675" STUDY_ID="STD-Goodwin-1983" TOTAL_1="40" TOTAL_2="39" VAR="0.3736013986013985" WEIGHT="0.33193853643855603"/>
<DICH_DATA CI_END="30.228038706605464" CI_START="0.06484046216242599" EFFECT_SIZE="1.4" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.4804099696544584" LOG_CI_START="-1.1881538982979825" LOG_EFFECT_SIZE="0.146128035678238" ORDER="16425" O_E="0.0" SE="1.5675276256394517" STUDY_ID="STD-Grundmann-1982" TOTAL_1="14" TOTAL_2="6" VAR="2.457142857142857" WEIGHT="0.07449756925751683"/>
<DICH_DATA CI_END="8.904801215485792" CI_START="0.057295392596230954" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="0.9496242290231592" LOG_CI_START="-1.2418803003796353" LOG_EFFECT_SIZE="-0.146128035678238" ORDER="16426" O_E="0.0" SE="1.2873006086935783" STUDY_ID="STD-Jelenko-1978" TOTAL_1="7" TOTAL_2="5" VAR="1.6571428571428573" WEIGHT="0.1274736185073066"/>
<DICH_DATA CI_END="3.9674660696056505" CI_START="0.21129224733215649" EFFECT_SIZE="0.9155844155844156" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5985132212879958" LOG_CI_START="-0.6751164376501622" LOG_EFFECT_SIZE="-0.03830160818108315" ORDER="16427" O_E="0.0" SE="0.7481363662287644" STUDY_ID="STD-Lowe-1977" TOTAL_1="77" TOTAL_2="94" VAR="0.5597080224739799" WEIGHT="0.3936027518822098"/>
<DICH_DATA CI_END="250.24188037027548" CI_START="0.8991300723407052" EFFECT_SIZE="15.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.398359994772363" LOG_CI_START="-0.046177476661000354" LOG_EFFECT_SIZE="1.1760912590556813" MODIFIED="2012-05-07 09:27:52 -0400" MODIFIED_BY="[Empty name]" ORDER="16442" O_E="0.0" SE="1.435933411375598" STUDY_ID="STD-Lucas-1978" TOTAL_1="27" TOTAL_2="27" VAR="2.061904761904762" WEIGHT="0.05463155078884568"/>
<DICH_DATA CI_END="0.8547847499096302" CI_START="0.045888247457992734" EFFECT_SIZE="0.19805194805194806" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="-0.06814323462352277" LOG_CI_START="-1.3382985283558315" LOG_EFFECT_SIZE="-0.7032208814896772" ORDER="16439" O_E="0.0" SE="0.7460955069084636" STUDY_ID="STD-Maitland-2005" TOTAL_1="56" TOTAL_2="61" VAR="0.5566585054289972" WEIGHT="1.1505311208864595"/>
<DICH_DATA CI_END="1.2670216867246324" CI_START="0.8128109559275828" EFFECT_SIZE="1.0148148148148148" ESTIMABLE="YES" EVENTS_1="137" EVENTS_2="135" LOG_CI_END="0.10278404846215773" LOG_CI_START="-0.09001045113935645" LOG_EFFECT_SIZE="0.006386798661400661" MODIFIED="2012-05-02 17:34:26 -0400" MODIFIED_BY="[Empty name]" ORDER="77" O_E="0.0" SE="0.11324844341409401" STUDY_ID="STD-Maitland-2011" TOTAL_1="1063" TOTAL_2="1063" VAR="0.012825209935715254" WEIGHT="14.750518712988333"/>
<DICH_DATA CI_END="2.2489686133195415" CI_START="0.751455573897722" EFFECT_SIZE="1.3" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.35198339444975146" LOG_CI_START="-0.12409668983607791" LOG_EFFECT_SIZE="0.11394335230683679" ORDER="16428" O_E="0.0" SE="0.2796517981439207" STUDY_ID="STD-Metildi-1984" TOTAL_1="20" TOTAL_2="26" VAR="0.07820512820512819" WEIGHT="1.1401367121150403"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16429" O_E="0.0" SE="0.0" STUDY_ID="STD-Prien-1990" TOTAL_1="6" TOTAL_2="6" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.637782360776234" CI_START="0.4824349533326522" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.21425618936955568" LOG_CI_START="-0.3165612342643183" LOG_EFFECT_SIZE="-0.05115252244738131" ORDER="16430" O_E="0.0" SE="0.31180478223116176" STUDY_ID="STD-Rackow-1983" TOTAL_1="9" TOTAL_2="8" VAR="0.09722222222222221" WEIGHT="0.6941420570818039"/>
<DICH_DATA CI_END="1.0870568125934916" CI_START="0.9055419488365517" EFFECT_SIZE="0.9921570160876556" ESTIMABLE="YES" EVENTS_1="726" EVENTS_2="729" LOG_CI_END="0.03625224210938089" LOG_CI_START="-0.04309142638111411" LOG_EFFECT_SIZE="-0.003419592135866623" ORDER="16431" O_E="0.0" SE="0.046606863628810065" STUDY_ID="STD-SAFE-2004" TOTAL_1="3473" TOTAL_2="3460" VAR="0.0021721997373144986" WEIGHT="79.80215723269171"/>
<DICH_DATA CI_END="3.86707806650227" CI_START="0.17168600452956775" EFFECT_SIZE="0.8148148148148148" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5873829394661192" LOG_CI_START="-0.7652651061396814" LOG_EFFECT_SIZE="-0.0889410833367811" ORDER="16432" O_E="0.0" SE="0.7945521577046601" STUDY_ID="STD-Shah-1977" TOTAL_1="9" TOTAL_2="11" VAR="0.6313131313131312" WEIGHT="0.2950103742597667"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16433" O_E="0.0" SE="0.0" STUDY_ID="STD-Shires-1983" TOTAL_1="9" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.3225436971144395" CI_START="0.015173840636129785" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8646619720038995" LOG_CI_START="-1.8189044814432243" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="16434" O_E="0.0" SE="1.5763402186230246" STUDY_ID="STD-Tollofsrud-1995" TOTAL_1="10" TOTAL_2="10" VAR="2.484848484848485" WEIGHT="0.16389465236653702"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16441" O_E="0.0" SE="0.0" STUDY_ID="STD-Verheij-2006" TOTAL_1="18" TOTAL_2="16" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="13.53677361466875" CI_START="0.06435145743791972" EFFECT_SIZE="0.9333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.131515165950651" LOG_CI_START="-1.1914416127055376" LOG_EFFECT_SIZE="-0.02996322337744321" ORDER="16435" O_E="0.0" SE="1.3645163106041502" STUDY_ID="STD-Virgilio-1979" TOTAL_1="15" TOTAL_2="14" VAR="1.861904761904762" WEIGHT="0.11303079473554278"/>
<DICH_DATA CI_END="5.637647472365331" CI_START="0.8072713190066934" EFFECT_SIZE="2.1333333333333333" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.751097915524032" LOG_CI_START="-0.09298047699558253" LOG_EFFECT_SIZE="0.32905871926422475" ORDER="16436" O_E="0.0" SE="0.4958158260214506" STUDY_ID="STD-Woittiez-1997" TOTAL_1="15" TOTAL_2="16" VAR="0.24583333333333335" WEIGHT="0.4229539415910633"/>
<DICH_DATA CI_END="7.584304769707433" CI_START="0.014650137947370117" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.87991577648491" LOG_CI_START="-1.8341582859242351" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="16437" O_E="0.0" SE="1.5942605391424158" STUDY_ID="STD-Zetterstrom-1981a" TOTAL_1="15" TOTAL_2="15" VAR="2.5416666666666665" WEIGHT="0.16389465236653702"/>
<DICH_DATA CI_END="91.51787421498676" CI_START="0.2731706807488985" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.9615059237367205" LOG_CI_START="-0.5635659150646829" LOG_EFFECT_SIZE="0.6989700043360189" ORDER="16438" O_E="0.0" SE="1.4832396974191324" STUDY_ID="STD-Zetterstrom-1981b" TOTAL_1="9" TOTAL_2="9" VAR="2.1999999999999997" WEIGHT="0.05463155078884568"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="12.972498468958912" CI_END="1.1885339310144956" CI_START="1.0191702064187764" DF="14" EFFECT_SIZE="1.1005990967685568" ESTIMABLE="YES" EVENTS_1="1002" EVENTS_2="912" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="0.07501158475331288" LOG_CI_START="0.008246719370154268" LOG_EFFECT_SIZE="0.04162915206173355" MODIFIED="2013-01-17 11:16:04 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.5286903710232385" P_Z="0.014519429548802759" STUDIES="25" TAU2="0.0" TOTAL_1="4615" TOTAL_2="4532" WEIGHT="100.0" Z="2.4441489780497796">
<NAME>Hydroxyethyl starch</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-05-07 09:29:57 -0400" MODIFIED_BY="[Empty name]" ORDER="16443" O_E="0.0" SE="0.0" STUDY_ID="STD-Boldt-1993" TOTAL_1="30" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-05-07 09:29:57 -0400" MODIFIED_BY="[Empty name]" ORDER="16444" O_E="0.0" SE="0.0" STUDY_ID="STD-Boldt-2001" TOTAL_1="50" TOTAL_2="25" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.505303545114617" CI_START="0.9691649173568184" EFFECT_SIZE="1.2078441066205248" ESTIMABLE="YES" EVENTS_1="107" EVENTS_2="93" LOG_CI_END="0.17762408443206137" LOG_CI_START="-0.01360231520529837" LOG_EFFECT_SIZE="0.08201088461338149" MODIFIED="2009-04-22 04:02:44 -0400" MODIFIED_BY="[Empty name]" ORDER="285" O_E="0.0" SE="0.11232733373292964" STUDY_ID="STD-Brunkhorst-2008" TOTAL_1="261" TOTAL_2="274" VAR="0.01261742990354895" WEIGHT="9.964848699446843"/>
<DICH_DATA CI_END="4.075847370320707" CI_START="0.05767587249994946" EFFECT_SIZE="0.48484848484848486" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.6102179124618181" LOG_CI_START="-1.2390058269057436" LOG_EFFECT_SIZE="-0.31439395722196267" MODIFIED="2012-11-20 06:35:32 -0500" MODIFIED_BY="[Empty name]" ORDER="16453" O_E="0.0" SE="1.0862431783096465" STUDY_ID="STD-Cifra-2003" TOTAL_1="11" TOTAL_2="16" VAR="1.1799242424242424" WEIGHT="0.2684424605127997"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16445" O_E="0.0" SE="0.0" STUDY_ID="STD-Dehne-2001" TOTAL_1="45" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="6.451402929711635" CI_START="0.15500504477786478" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8096541670972182" LOG_CI_START="-0.8096541670972182" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-11-20 06:36:30 -0500" MODIFIED_BY="[Empty name]" ORDER="76" O_E="0.0" SE="0.9511897312113418" STUDY_ID="STD-Du-2011" TOTAL_1="21" TOTAL_2="21" VAR="0.9047619047619047" WEIGHT="0.21963474041956335"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16457" O_E="0.0" SE="0.0" STUDY_ID="STD-Fries-2004" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.7364166721411052" CI_START="0.8285961295740035" EFFECT_SIZE="1.1994949494949494" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="32" LOG_CI_END="0.23965394704924875" LOG_CI_START="-0.0816570996505403" LOG_EFFECT_SIZE="0.07899842369935423" MODIFIED="2012-11-19 08:44:09 -0500" MODIFIED_BY="[Empty name]" ORDER="80" O_E="0.0" SE="0.18873969934678878" STUDY_ID="STD-Guidet-2012" TOTAL_1="99" TOTAL_2="95" VAR="0.035622674109516216" WEIGHT="3.586612668294725"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16455" O_E="0.0" SE="0.0" STUDY_ID="STD-Guo-2003" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.879326174589124" CI_START="0.7917605603574246" EFFECT_SIZE="1.9655172413793103" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" LOG_CI_END="0.6883598509241875" LOG_CI_START="-0.10140613537711689" LOG_EFFECT_SIZE="0.29347685777353527" MODIFIED="2013-01-17 11:16:04 -0500" MODIFIED_BY="[Empty name]" ORDER="83" O_E="0.0" SE="0.46391244975806845" STUDY_ID="STD-James-2011" TOTAL_1="58" TOTAL_2="57" VAR="0.21521476104053236" WEIGHT="0.6646338231826786"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16446" O_E="0.0" SE="0.0" STUDY_ID="STD-Lang-2001" TOTAL_1="21" TOTAL_2="21" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16454" O_E="0.0" SE="0.0" STUDY_ID="STD-Lang-2003" TOTAL_1="18" TOTAL_2="18" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.0772007808020516" CI_START="0.26106674722161605" EFFECT_SIZE="0.5303030303030303" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="12" LOG_CI_END="0.032296659535146405" LOG_CI_START="-0.5832484419183325" LOG_EFFECT_SIZE="-0.27547589119159305" MODIFIED="2012-05-02 08:32:30 -0400" MODIFIED_BY="[Empty name]" ORDER="78" O_E="0.0" SE="0.3615742395911671" STUDY_ID="STD-Lu-2012" TOTAL_1="22" TOTAL_2="20" VAR="0.1307359307359307" WEIGHT="1.3805612254943982"/>
<DICH_DATA CI_END="3.0993496723818956" CI_START="0.5942655490299676" EFFECT_SIZE="1.3571428571428572" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="6" LOG_CI_END="0.4912705766326519" LOG_CI_START="-0.22601944608347005" LOG_EFFECT_SIZE="0.13262556527459096" MODIFIED="2012-05-07 08:27:59 -0400" MODIFIED_BY="[Empty name]" ORDER="79" O_E="0.0" SE="0.4213397099863265" STUDY_ID="STD-McIntyre-2008" TOTAL_1="21" TOTAL_2="19" VAR="0.17752715121136176" WEIGHT="0.6918494323216245"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16456" O_E="0.0" SE="0.0" STUDY_ID="STD-Moretti-2003" TOTAL_1="60" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.1783263635851748" CI_START="0.9561702427005621" EFFECT_SIZE="1.0614521209407928" ESTIMABLE="YES" EVENTS_1="597" EVENTS_2="566" LOG_CI_END="0.07126559458826211" LOG_CI_START="-0.019464776256248446" LOG_EFFECT_SIZE="0.025900409166006836" MODIFIED="2012-11-19 08:46:51 -0500" MODIFIED_BY="[Empty name]" ORDER="82" O_E="0.0" SE="0.05329546895664453" STUDY_ID="STD-Myburgh-2012" TOTAL_1="3315" TOTAL_2="3336" VAR="0.002840407011308661" WEIGHT="61.96037695110848"/>
<DICH_DATA CI_END="6.129129984162686" CI_START="0.14798666055406898" EFFECT_SIZE="0.9523809523809523" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7873988317952468" LOG_CI_START="-0.8297774299351232" LOG_EFFECT_SIZE="-0.021189299069938095" ORDER="16447" O_E="0.0" SE="0.9499373412920203" STUDY_ID="STD-Nagy-1993" TOTAL_1="21" TOTAL_2="20" VAR="0.9023809523809523" WEIGHT="0.22499168530784538"/>
<DICH_DATA CI_END="1.360972824342287" CI_START="1.011847161630929" EFFECT_SIZE="1.1734975455311238" ESTIMABLE="YES" EVENTS_1="202" EVENTS_2="173" LOG_CI_END="0.13384945337672297" LOG_CI_START="0.005114917767482821" LOG_EFFECT_SIZE="0.06948218557210291" MODIFIED="2012-11-19 08:47:17 -0500" MODIFIED_BY="[Empty name]" ORDER="83" O_E="0.0" SE="0.07561930346309628" STUDY_ID="STD-Perner-2012" TOTAL_1="398" TOTAL_2="400" VAR="0.005718279056243846" WEIGHT="18.950789996050897"/>
<DICH_DATA CI_END="61.7381697935959" CI_START="0.14577691612966426" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7905537508292086" LOG_CI_START="-0.8363112413898837" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="16448" O_E="0.0" SE="1.5430334996209192" STUDY_ID="STD-Prien-1990" TOTAL_1="6" TOTAL_2="6" VAR="2.380952380952381" WEIGHT="0.05490868510489084"/>
<DICH_DATA CI_END="1.5039257435017601" CI_START="0.36484304319144667" EFFECT_SIZE="0.7407407407407407" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.17722639344739768" LOG_CI_START="-0.43789393043741" LOG_EFFECT_SIZE="-0.13033376849500614" ORDER="16449" O_E="0.0" SE="0.3613247231446467" STUDY_ID="STD-Rackow-1983" TOTAL_1="9" TOTAL_2="8" VAR="0.1305555555555556" WEIGHT="0.6976632930974365"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16450" O_E="0.0" SE="0.0" STUDY_ID="STD-Sirieix-1999" TOTAL_1="8" TOTAL_2="8" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16458" O_E="0.0" SE="0.0" STUDY_ID="STD-Verheij-2006" TOTAL_1="17" TOTAL_2="16" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.903826995880221" CI_START="0.75638693519771" EFFECT_SIZE="1.9259259259259258" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="4" LOG_CI_END="0.6905351401278331" LOG_CI_START="-0.12125598117620948" LOG_EFFECT_SIZE="0.2846395794758118" ORDER="16451" O_E="0.0" SE="0.47685012308485347" STUDY_ID="STD-Woittiez-1997" TOTAL_1="27" TOTAL_2="16" VAR="0.2273860398860399" WEIGHT="0.5516407433793684"/>
<DICH_DATA CI_END="3.0002895242613046" CI_START="0.12447358400033243" EFFECT_SIZE="0.6111111111111112" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.47716316562701144" LOG_CI_START="-0.9049228055171734" LOG_EFFECT_SIZE="-0.21387981994508098" ORDER="16452" O_E="0.0" SE="0.8118441408859887" STUDY_ID="STD-Younes-1998" TOTAL_1="12" TOTAL_2="11" VAR="0.659090909090909" WEIGHT="0.3437761154393166"/>
<DICH_DATA CI_END="2.5939212184173286" CI_START="0.09637917999396164" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.41395678172254163" LOG_CI_START="-1.016016773050504" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2012-05-07 09:04:37 -0400" MODIFIED_BY="[Empty name]" ORDER="80" O_E="0.0" SE="0.8399735445569435" STUDY_ID="STD-Zhu-2011" TOTAL_1="45" TOTAL_2="45" VAR="0.7055555555555555" WEIGHT="0.4392694808391267"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.4816337839404974" CI_END="1.7212174648114797" CI_START="0.48607330819819905" DF="4" EFFECT_SIZE="0.9146791061620645" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="15" I2="0.0" ID="CMP-001.01.03" LOG_CI_END="0.23583574412256297" LOG_CI_START="-0.31329822673559493" LOG_EFFECT_SIZE="-0.03873124130651596" MODIFIED="2012-05-30 13:00:51 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.8298898515796156" P_Z="0.782180655751031" STUDIES="11" TAU2="0.0" TOTAL_1="224" TOTAL_2="282" WEIGHT="100.0" Z="0.2764783898496402">
<NAME>Modified gelatin</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-05-07 09:31:17 -0400" MODIFIED_BY="[Empty name]" ORDER="16459" O_E="0.0" SE="0.0" STUDY_ID="STD-Boldt-1993" TOTAL_1="15" TOTAL_2="15" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-05-07 09:31:18 -0400" MODIFIED_BY="[Empty name]" ORDER="16460" O_E="0.0" SE="0.0" STUDY_ID="STD-Boldt-2001" TOTAL_1="25" TOTAL_2="25" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="6.140200195576986" CI_START="0.06595203165813017" EFFECT_SIZE="0.6363636363636364" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7881825311439379" LOG_CI_START="-1.1807718214318743" LOG_EFFECT_SIZE="-0.19629464514396822" ORDER="16461" O_E="0.0" SE="1.1565735331842666" STUDY_ID="STD-Evans-1996" TOTAL_1="11" TOTAL_2="14" VAR="1.3376623376623378" WEIGHT="11.255736964863441"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16467" O_E="0.0" SE="0.0" STUDY_ID="STD-Evans-2003" TOTAL_1="14" TOTAL_2="14" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16468" O_E="0.0" SE="0.0" STUDY_ID="STD-Fries-2004" TOTAL_1="20" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16462" O_E="0.0" SE="0.0" STUDY_ID="STD-Ngo-2001" TOTAL_1="56" TOTAL_2="111" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.3225436971144395" CI_START="0.015173840636129785" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8646619720038995" LOG_CI_START="-1.8189044814432243" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="16463" O_E="0.0" SE="1.5763402186230246" STUDY_ID="STD-Tollofsrud-1995" TOTAL_1="10" TOTAL_2="10" VAR="2.484848484848485" WEIGHT="9.592957640508615"/>
<DICH_DATA CI_END="2.315272325147821" CI_START="0.49354335757378925" EFFECT_SIZE="1.0689655172413792" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.3646020806037427" LOG_CI_START="-0.3066746887331096" LOG_EFFECT_SIZE="0.028963695935316558" ORDER="16466" O_E="0.0" SE="0.3943112971820659" STUDY_ID="STD-Upadhyay-2004" TOTAL_1="29" TOTAL_2="31" VAR="0.1554813990854035" WEIGHT="55.63915431494996"/>
<DICH_DATA CI_END="68.56773372198825" CI_START="0.13125707255384883" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8361197955452926" LOG_CI_START="-0.8818772861059678" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="16469" O_E="0.0" SE="1.5965649400644928" STUDY_ID="STD-Verheij-2006" TOTAL_1="16" TOTAL_2="16" VAR="2.5490196078431375" WEIGHT="3.197652546836205"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16464" O_E="0.0" SE="0.0" STUDY_ID="STD-Wahba-1996" TOTAL_1="10" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.1092255797323554" CI_START="0.11294323032870428" EFFECT_SIZE="0.5925925925925926" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.49265223200749847" LOG_CI_START="-0.9471397950136234" LOG_EFFECT_SIZE="-0.22724378150306254" ORDER="16465" O_E="0.0" SE="0.8457409637576849" STUDY_ID="STD-Wu-2001" TOTAL_1="18" TOTAL_2="16" VAR="0.7152777777777777" WEIGHT="20.31449853284177"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.7638113927389405" CI_END="1.6461724349135858" CI_START="0.9408508822866255" DF="6" EFFECT_SIZE="1.2445090549226108" ESTIMABLE="YES" EVENTS_1="96" EVENTS_2="57" I2="0.0" ID="CMP-001.01.04" LOG_CI_END="0.21647532517097998" LOG_CI_START="-0.026479203492896754" LOG_EFFECT_SIZE="0.09499806083904162" MODIFIED="2012-05-30 13:01:00 -0400" MODIFIED_BY="Anne Lawson" NO="4" P_CHI2="0.837853372260897" P_Z="0.1253405061612585" STUDIES="9" TAU2="0.0" TOTAL_1="412" TOTAL_2="422" WEIGHT="100.0" Z="1.532737659755755">
<NAME>Dextran</NAME>
<DICH_DATA CI_END="13.867772482168174" CI_START="0.07210963413813187" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1420067079086855" LOG_CI_START="-1.1420067079086855" LOG_EFFECT_SIZE="0.0" ORDER="16470" O_E="0.0" SE="1.3416407864998738" STUDY_ID="STD-Dawidson-1991" TOTAL_1="10" TOTAL_2="10" VAR="1.7999999999999998" WEIGHT="1.5467046609031938"/>
<DICH_DATA CI_END="2.0569976196557502" CI_START="0.6152778145712241" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="16" LOG_CI_END="0.31323378913226857" LOG_CI_START="-0.21092874423750596" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="16471" O_E="0.0" SE="0.3078956667477917" STUDY_ID="STD-Hall-1978" TOTAL_1="86" TOTAL_2="86" VAR="0.0947997416020672" WEIGHT="24.7472745744511"/>
<DICH_DATA CI_END="9.640496365333176" CI_START="0.018491952922603534" EFFECT_SIZE="0.4222222222222222" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9840993952280964" LOG_CI_START="-1.7330172208731258" LOG_EFFECT_SIZE="-0.3744589128225147" ORDER="16472" O_E="0.0" SE="1.5960477502420256" STUDY_ID="STD-Karanko-1987" TOTAL_1="14" TOTAL_2="18" VAR="2.547368421052631" WEIGHT="2.047109110018933"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16473" O_E="0.0" SE="0.0" STUDY_ID="STD-Modig-1983" TOTAL_1="14" TOTAL_2="17" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16474" O_E="0.0" SE="0.0" STUDY_ID="STD-Ngo-2001" TOTAL_1="55" TOTAL_2="111" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.3225436971144395" CI_START="0.015173840636129785" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8646619720038995" LOG_CI_START="-1.8189044814432243" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="16475" O_E="0.0" SE="1.5763402186230246" STUDY_ID="STD-Tollofsrud-1995" TOTAL_1="10" TOTAL_2="10" VAR="2.484848484848485" WEIGHT="2.320056991354791"/>
<DICH_DATA CI_END="3.549549671316272" CI_START="0.9365647314069974" EFFECT_SIZE="1.8232890704800817" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="11" LOG_CI_END="0.5501732579373183" LOG_CI_START="-0.02846220064716999" LOG_EFFECT_SIZE="0.26085552864507416" ORDER="16476" O_E="0.0" SE="0.3398933326642431" STUDY_ID="STD-Vassar-1993a" TOTAL_1="89" TOTAL_2="85" VAR="0.11552747758960581" WEIGHT="17.404871988784215"/>
<DICH_DATA CI_END="1.8339756952776125" CI_START="0.8348495402009601" EFFECT_SIZE="1.2373737373737375" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="20" LOG_CI_END="0.26339357589411166" LOG_CI_START="-0.0783917876881089" LOG_EFFECT_SIZE="0.09250089410300139" ORDER="16477" O_E="0.0" SE="0.20076641443303214" STUDY_ID="STD-Vassar-1993b" TOTAL_1="99" TOTAL_2="50" VAR="0.04030715316429602" WEIGHT="41.10705004816542"/>
<DICH_DATA CI_END="2.552420210041579" CI_START="0.3917850188091521" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.4069521747039928" LOG_CI_START="-0.4069521747039928" LOG_EFFECT_SIZE="0.0" ORDER="16478" O_E="0.0" SE="0.4780914437337574" STUDY_ID="STD-Younes-1992" TOTAL_1="35" TOTAL_2="35" VAR="0.22857142857142854" WEIGHT="10.826932626322357"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2012-10-17 09:32:15 -0400" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Colloid and hypertonic crystalloid versus isotonic crystalloid</NAME>
<DICH_OUTCOME CHI2="7.810301260690352" CI_END="1.0409825827338492" CI_START="0.7763989164541375" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8990093154590725" ESTIMABLE="YES" EVENTS_1="240" EVENTS_2="282" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.017443463145637602" LOG_CI_START="-0.109915079386608" LOG_EFFECT_SIZE="-0.0462358081204852" METHOD="MH" MODIFIED="2012-10-17 09:32:15 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6473605032238017" P_Q="0.43308979962988137" P_Z="0.15471377856347204" Q="1.6736215754072679" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="939" TOTAL_2="1044" WEIGHT="300.0" Z="1.423077194673637">
<NAME>Deaths</NAME>
<GROUP_LABEL_1>Colloid</GROUP_LABEL_1>
<GROUP_LABEL_2>Crystalloid</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours colloid</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours crystalloid</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.334593955143527" CI_START="0.05767552914693297" DF="0" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-002.01.01" LOG_CI_END="0.6369484210048896" LOG_CI_START="-1.2390084123328522" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2012-05-30 13:01:24 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="1.0" P_Z="0.5293354316475322" STUDIES="1" TAU2="0.0" TOTAL_1="7" TOTAL_2="7" WEIGHT="100.0" Z="0.6290208167720974">
<NAME>Albumin or plasma protein fraction</NAME>
<DICH_DATA CI_END="4.334593955143529" CI_START="0.05767552914693294" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6369484210048898" LOG_CI_START="-1.2390084123328524" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="16479" O_E="0.0" SE="1.1019463300386796" STUDY_ID="STD-Jelenko-1978" TOTAL_1="7" TOTAL_2="7" VAR="1.2142857142857144" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.1505053392953415" CI_START="0.029062936444733234" DF="0" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" I2="0.0" ID="CMP-002.01.02" LOG_CI_END="0.33254052516196625" LOG_CI_START="-1.5366605078178912" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2012-05-30 13:01:30 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.2067371142065293" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="45" WEIGHT="100.0" Z="1.2625885377926813">
<NAME>Hydroxyethyl starch</NAME>
<DICH_DATA CI_END="2.1505053392953424" CI_START="0.029062936444733234" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.3325405251619664" LOG_CI_START="-1.5366605078178912" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2012-05-07 09:05:46 -0400" MODIFIED_BY="[Empty name]" ORDER="81" O_E="0.0" SE="1.097977939466707" STUDY_ID="STD-Zhu-2011" TOTAL_1="45" TOTAL_2="45" VAR="1.2055555555555557" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-002.01.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2012-05-30 13:01:42 -0400" MODIFIED_BY="Anne Lawson" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Modified gelatin</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.085551564948382" CI_END="1.0570475724971995" CI_START="0.7871588939913502" DF="8" EFFECT_SIZE="0.9121756399198222" ESTIMABLE="YES" EVENTS_1="238" EVENTS_2="276" I2="0.0" ID="CMP-002.01.04" LOG_CI_END="0.024094533199672374" LOG_CI_START="-0.10393759315756691" LOG_EFFECT_SIZE="-0.03992152997894727" MODIFIED="2012-05-30 13:01:49 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.6376494419375058" P_Z="0.22160646407331053" STUDIES="9" TAU2="0.0" TOTAL_1="887" TOTAL_2="992" WEIGHT="100.0" Z="1.2222676166160313">
<NAME>Dextran</NAME>
<DICH_DATA CI_END="1.3104451232758594" CI_START="0.7429234634591112" EFFECT_SIZE="0.9866916588566073" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="97" LOG_CI_END="0.11741883897396974" LOG_CI_START="-0.12905592528314905" LOG_EFFECT_SIZE="-0.005818543154589645" MODIFIED="2012-05-07 09:52:06 -0400" MODIFIED_BY="[Empty name]" ORDER="75" O_E="0.0" SE="0.14478049659439168" STUDY_ID="STD-Bulger-2011" TOTAL_1="220" TOTAL_2="376" VAR="0.020961392194118664" WEIGHT="27.779454567980704"/>
<DICH_DATA CI_END="1.405500761865322" CI_START="0.022270905855921827" EFFECT_SIZE="0.17692307692307693" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.14783108535706005" LOG_CI_START="-1.652262117935548" LOG_EFFECT_SIZE="-0.7522155162892439" ORDER="16480" O_E="0.0" SE="1.0573836582191425" STUDY_ID="STD-Chavez_x002d_Negrete-1991" TOTAL_1="26" TOTAL_2="23" VAR="1.1180602006688962" WEIGHT="2.0583670982223143"/>
<DICH_DATA CI_END="1.250624648911557" CI_START="0.5552780724806865" EFFECT_SIZE="0.8333333333333334" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="42" LOG_CI_END="0.09712698406061054" LOG_CI_START="-0.2554894761558601" LOG_EFFECT_SIZE="-0.0791812460476248" ORDER="16481" O_E="0.0" SE="0.20712865421078366" STUDY_ID="STD-Mattox-1991" TOTAL_1="211" TOTAL_2="211" VAR="0.042902279395170384" WEIGHT="16.29276726208278"/>
<DICH_DATA CI_END="1.6481837600984675" CI_START="0.5629074133390798" EFFECT_SIZE="0.9632107023411371" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="13" LOG_CI_END="0.21700563063033773" LOG_CI_START="-0.24956303176073527" LOG_EFFECT_SIZE="-0.016278700565198787" ORDER="16482" O_E="0.0" SE="0.2740647418406431" STUDY_ID="STD-Vassar-1990" TOTAL_1="23" TOTAL_2="24" VAR="0.07511148272017837" WEIGHT="4.935701531269252"/>
<DICH_DATA CI_END="1.2971266932669188" CI_START="0.6002086895937166" EFFECT_SIZE="0.8823529411764706" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="34" LOG_CI_END="0.11298239666970812" LOG_CI_START="-0.22169772131489351" LOG_EFFECT_SIZE="-0.0543576623225927" ORDER="16483" O_E="0.0" SE="0.19659275799745782" STUDY_ID="STD-Vassar-1991" TOTAL_1="83" TOTAL_2="83" VAR="0.038648712497047016" WEIGHT="13.18938302168606"/>
<DICH_DATA CI_END="2.597692726427482" CI_START="0.7715663854058933" EFFECT_SIZE="1.4157303370786516" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="14" LOG_CI_END="0.41458777833469534" LOG_CI_START="-0.1126267013893952" LOG_EFFECT_SIZE="0.15098053847265008" ORDER="16484" O_E="0.0" SE="0.309688395143695" STUDY_ID="STD-Vassar-1993a" TOTAL_1="89" TOTAL_2="84" VAR="0.09590690208667736" WEIGHT="5.5878854964368685"/>
<DICH_DATA CI_END="1.3717352776111218" CI_START="0.6836295369675938" EFFECT_SIZE="0.9683794466403162" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="23" LOG_CI_END="0.13727030775161486" LOG_CI_START="-0.16517918137418583" LOG_EFFECT_SIZE="-0.013954436811285472" ORDER="16485" O_E="0.0" SE="0.1776603270616122" STUDY_ID="STD-Vassar-1993b" TOTAL_1="99" TOTAL_2="45" VAR="0.03156319181163901" WEIGHT="12.268065825318283"/>
<DICH_DATA CI_END="2.1514954095824685" CI_START="0.3558571385232849" EFFECT_SIZE="0.875" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.3327404238114954" LOG_CI_START="-0.4487243177668689" LOG_EFFECT_SIZE="-0.057991946977686754" ORDER="16486" O_E="0.0" SE="0.45903625751598937" STUDY_ID="STD-Younes-1992" TOTAL_1="35" TOTAL_2="35" VAR="0.2107142857142857" WEIGHT="3.10338424039672"/>
<DICH_DATA CI_END="1.114486547599251" CI_START="0.49378276241896907" EFFECT_SIZE="0.7418316831683168" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="40" LOG_CI_END="0.04707483069990546" LOG_CI_START="-0.3064640750298259" LOG_EFFECT_SIZE="-0.12969462216496022" ORDER="16487" O_E="0.0" SE="0.20767050327145192" STUDY_ID="STD-Younes-1994" TOTAL_1="101" TOTAL_2="111" VAR="0.043127037929018126" WEIGHT="14.784990956607016"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2013-01-17 11:44:59 -0500" MODIFIED_BY="Anne Lawson" NO="3">
<NAME>Colloid versus hypertonic crystalloid</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-01-17 11:44:59 -0500" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="37" TOTAL_2="37" WEIGHT="0.0" Z="0.0">
<NAME>Deaths</NAME>
<GROUP_LABEL_1>Colloid</GROUP_LABEL_1>
<GROUP_LABEL_2>Crystalloid</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours colloid</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours crystalloid</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="0" I2="0.0" ID="CMP-003.01.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2012-05-30 13:02:37 -0400" MODIFIED_BY="Anne Lawson" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="19" TOTAL_2="19" WEIGHT="0.0" Z="0.0">
<NAME>Albumin or plasma protein fraction</NAME>
<DICH_DATA CI_END="126.91943808755991" CI_START="0.38607167458617" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.103528140673787" LOG_CI_START="-0.4133320606452736" LOG_EFFECT_SIZE="0.8450980400142568" ORDER="16488" O_E="0.0" SE="1.4784161409137435" STUDY_ID="STD-Bowser_x002d_Wallace-1986" TOTAL_1="19" TOTAL_2="19" VAR="2.185714285714286" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.01.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2012-05-30 13:02:45 -0400" MODIFIED_BY="Anne Lawson" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="8" WEIGHT="0.0" Z="0.0">
<NAME>Hydroxyethyl starch</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16489" O_E="0.0" SE="0.0" STUDY_ID="STD-Sirieix-1999" TOTAL_1="8" TOTAL_2="8" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.01.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2012-05-30 13:02:52 -0400" MODIFIED_BY="Anne Lawson" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>Modified gelatin</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="16490" O_E="0.0" SE="0.0" STUDY_ID="STD-Mazher-1998" TOTAL_1="10" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-003.01.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2012-05-30 13:03:02 -0400" MODIFIED_BY="Anne Lawson" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Dextran</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2013-02-22 17:43:12 -0500" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2013-01-22 12:26:23 -0500" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram: the numbers reflect the most recent update only (17th October 2012)</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2013-01-18 11:28:48 -0500" MODIFIED_BY="Emma M Sydenham">
<APPENDIX ID="APP-01" MODIFIED="2013-01-18 11:28:48 -0500" MODIFIED_BY="Emma M Sydenham" NO="1">
<TITLE MODIFIED="2009-05-01 11:07:15 -0400" MODIFIED_BY="Emma M Sydenham">Search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2013-01-18 11:28:48 -0500" MODIFIED_BY="Emma M Sydenham">
<P>
<B>Cochrane Injuries Group Specialised Register </B>
<BR/>colloid* or hydrocolloid* or crystalloid*<BR/>
<BR/>
<B>Cochrane Central Register of Controlled Trials (<I>The Cochrane Library</I>)</B>
<BR/>#1 MeSH descriptor Plasma Volume explode all trees<BR/>#2 MeSH descriptor Fluid Therapy explode all trees<BR/>#3 MeSH descriptor Resuscitation explode all trees<BR/>#4 (fluid* OR volume OR plasma OR rehydrat* OR blood OR oral) next (replac* OR therapy OR substitut* OR restor* OR resuscitat* OR rehydrat*):ti,ab,kw<BR/>#5 (#1 OR #2 OR #3 or #4)<BR/>#6 MeSH descriptor Colloids explode all trees<BR/>#7 MeSH descriptor Hetastarch explode all trees<BR/>#8 MeSH descriptor Rehydration Solutions explode all trees<BR/>#9 MeSH descriptor Isotonic Solutions explode all trees<BR/>#10 MeSH descriptor Serum explode all trees<BR/>#11 MeSH descriptor Plasma explode all trees<BR/>#12 MeSH descriptor Plasma Substitutes explode all trees<BR/>#13 MeSH descriptor Albumins explode all trees<BR/>#14 MeSH descriptor Serum Albumin explode all trees<BR/>#15 (colloid* OR hydrocolloid* or crystalloid* OR albumin* OR albumen* OR plasma OR starch* OR dextran* OR gelofus* OR hemaccel* OR haemaccel* OR serum OR hetastarch OR isotonic OR ringer* OR gelatin* OR gentran* OR pentastarch* OR pentaspan* OR hartman OR sodium OR potassium OR saline):ti<BR/>#16 (Isotonic next saline next solution*) OR (Blood next substitut*) OR (blood next expan*) OR (plasma next volume next expan*) OR (volume next expan*)<BR/>#17 (#6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16)<BR/>#18 (#5 AND #17)<BR/>
<BR/>
<B>MEDLINE (OvidSP) </B>
<BR/>1. exp Plasma Volume/<BR/>2. exp Fluid Therapy/<BR/>3. exp Resuscitation/<BR/>4. ((fluid* or volume or plasma or rehydrat* or blood or oral) adj1 (replac* or therapy or substitut* or restor* or resuscitat* or rehydrat*)).ab,ti.<BR/>5. 1 or 2 or 3 or 4<BR/>6. exp Colloids/<BR/>7. exp Hetastarch/<BR/>8. exp Rehydration Solutions/<BR/>9. exp Isotonic Solutions/<BR/>10. exp Serum/<BR/>11. exp Plasma/<BR/>12. exp Plasma Substitutes/<BR/>13. exp Albumins/<BR/>14. exp Serum Albumin/<BR/>15. (colloid* or hydrocolloid* or crystalloid* or albumin* or albumen* or plasma or starch* or dextran* or gelofus* or hemaccel* or haemaccel* or serum or hetastarch or isotonic or ringer* or gelatin* or gentran* or pentastarch* or pentaspan* or hartman or sodium or potassium or saline).ti.<BR/>16. ((Isotonic adj1 saline adj1 solution*) or (Blood adj1 substitut*) or (blood adj1 expan*) or (plasma adj1 volume adj1 expan*) or (volume adj1 expan*)).ab,ti.<BR/>17. or/6-16<BR/>18. 5 and 17<BR/>19. randomi?ed.ab,ti.<BR/>20. randomized controlled trial.pt.<BR/>21. controlled clinical trial.pt.<BR/>22. placebo.ab.<BR/>23. clinical trials as topic.sh.<BR/>24. randomly.ab.<BR/>25. trial.ti.<BR/>26. 19 or 20 or 21 or 22 or 23 or 24 or 25<BR/>27. (animals not (humans and animals)).sh.<BR/>28. 26 not 27<BR/>29. 18 and 28<BR/>
<BR/>
<BR/>
<B>EMBASE (OvidSP) </B>
<BR/>1. exp plasma volume/<BR/>2. exp fluid therapy/<BR/>3. exp fluid resuscitation/<BR/>4. ((fluid* or volume or plasma or rehydrat* or blood or oral) adj1 (replac* or therapy or substitut* or restor* or resuscitat* or rehydrat*)).ab,ti.<BR/>5. 1 or 2 or 3 or 4<BR/>6. exp colloid/<BR/>7. exp hetastarch/<BR/>8. exp "solution and solubility"/<BR/>9. exp isotonic solution/<BR/>10. exp serum/<BR/>11. exp serum albumin/<BR/>12. exp crystalloid/<BR/>13. exp hetastarch/<BR/>14. exp plasma/<BR/>15. exp plasma substitute/<BR/>16. exp albumin/<BR/>17. exp serum albumin/<BR/>18. or/6-17<BR/>19. (th or ad or iv).fs.<BR/>20. 18 and 19<BR/>21. (colloid* or hydrocolloid* or crystalloid* or albumin* or albumen* or plasma or starch* or dextran* or gelofus* or hemaccel* or haemaccel* or serum or hetastarch or isotonic or ringer* or gelatin* or gentran* or pentastarch* or pentaspan* or hartman or sodium or potassium or saline).ti.<BR/>22. ((Isotonic adj1 saline adj1 solution*) or (Blood adj1 substitut*) or (blood adj1 expan*) or (plasma adj1 volume adj1 expan*) or (volume adj1 expan*)).ab,ti.<BR/>23. 20 or 21 or 22<BR/>24. exp Randomized Controlled Trial/<BR/>25. exp controlled clinical trial/<BR/>26. randomi?ed.ab,ti.<BR/>27. placebo.ab.<BR/>28. *Clinical Trial/<BR/>29. randomly.ab.<BR/>30. trial.ti.<BR/>31. 24 or 25 or 26 or 27 or 28 or 29 or 30<BR/>32. exp animal/ not (exp human/ and exp animal/)<BR/>33. 31 not 32<BR/>34. 5 and 23 and 33<BR/>
<BR/>
<BR/>
<B>ISI Web of Science: Science Citation Index Expanded, ISI Web of Science: Conference Proceedings Citation Index-Science </B>
<BR/>#1 colloid* OR hydrocolloid* or crystalloid*)<BR/>#2 (Isotonic NEAR/1 saline NEAR/1 solution*) OR (Blood NEAR/1 substitut*) OR (blood NEAR/1 expan*) OR (plasma NEAR/1 volume NEAR/1 expan*) OR (volume NEAR/1 expan*))<BR/>#3 #1 OR #2<BR/>#4 (fluid* OR volume OR plasma OR rehydrat* OR blood OR oral) NEAR/2 (replac* OR therapy OR substitut* OR restor* OR resuscitat* OR rehydrat*))<BR/>#5 (random*) NEAR/3 (study or trial)<BR/>#6 (singl* OR doubl* OR trebl* OR tripl*) NEAR/3 (blind* OR mask*) NEAR/3 (study or trial)<BR/>
<BR/>
<B>PubMed </B>
<BR/>(((((((colloid* OR hydrocolloid* OR crystalloid* OR albumin* OR albumen* OR plasma OR starch* OR dextran* OR gelofus* OR hemaccel* OR haemaccel* OR serum OR hetastarch OR isotonic OR ringer* OR gelatin* OR gentran* OR pentastarch* OR pentaspan* OR hartman OR sodium OR potassium OR saline) AND title)) OR (colloids[MeSH Terms]))) AND ((((fluid* OR volume OR plasma OR rehydrat* OR blood OR oral) AND (replac* OR therapy OR substitut* OR restor* OR resuscitat* OR rehydrat*))) OR (((plasma volume[MeSH Terms]) OR fluid therapy) OR resuscitation)))) AND ((randomised OR randomized OR randomly OR random order OR random sequence OR random allocation OR randomly allocated OR at random OR randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized controlled trials[mh]) NOT ((models, animal[mh] OR Animals[mh] OR Animal Experimentation[mh] OR Disease Models, Animal[mh] OR Animals, Laboratory[mh]) NOT (Humans[mh])))<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;# of studies included in quantitative synthesis (meta-analysis)&lt;/p&gt;&lt;p&gt;4&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;# of studies included in qualitative synthesis&lt;/p&gt;&lt;p&gt;4&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;# of full-text articles assessed for eligibility&lt;/p&gt;&lt;p&gt;4&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;# of records screened&lt;/p&gt;&lt;p&gt;182&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;# of records after duplicates removed&lt;/p&gt;&lt;p&gt;182&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;# of records identified through database searching&lt;/p&gt;&lt;p&gt;246&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;# of additional records identified through other sources&lt;/p&gt;&lt;p&gt;0&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;# of records excluded&lt;/p&gt;&lt;p&gt;178&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;# of full-text articles excluded, with reasons&lt;/p&gt;&lt;p&gt;0&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>